CN1960699B - Keratin-binding polypeptides - Google Patents
Keratin-binding polypeptides Download PDFInfo
- Publication number
- CN1960699B CN1960699B CN2005800167278A CN200580016727A CN1960699B CN 1960699 B CN1960699 B CN 1960699B CN 2005800167278 A CN2005800167278 A CN 2005800167278A CN 200580016727 A CN200580016727 A CN 200580016727A CN 1960699 B CN1960699 B CN 1960699B
- Authority
- CN
- China
- Prior art keywords
- keratin
- peptide sequence
- acid
- binding
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000011782 Keratins Human genes 0.000 title claims abstract description 204
- 108010076876 Keratins Proteins 0.000 title claims abstract description 204
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 176
- 229920001184 polypeptide Polymers 0.000 title claims description 52
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 52
- 239000000203 mixture Substances 0.000 claims description 160
- 239000012636 effector Substances 0.000 claims description 80
- 210000004209 hair Anatomy 0.000 claims description 75
- 238000002360 preparation method Methods 0.000 claims description 60
- 239000002537 cosmetic Substances 0.000 claims description 57
- 230000002421 anti-septic effect Effects 0.000 claims description 56
- 239000003795 chemical substances by application Substances 0.000 claims description 55
- 239000003921 oil Substances 0.000 claims description 49
- 235000001014 amino acid Nutrition 0.000 claims description 31
- 150000001413 amino acids Chemical class 0.000 claims description 29
- 239000000975 dye Substances 0.000 claims description 23
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 125000000524 functional group Chemical group 0.000 claims description 18
- 241000282414 Homo sapiens Species 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- 210000004905 finger nail Anatomy 0.000 claims description 14
- 230000008878 coupling Effects 0.000 claims description 12
- 238000010168 coupling process Methods 0.000 claims description 12
- 238000005859 coupling reaction Methods 0.000 claims description 12
- 239000000049 pigment Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 210000004899 c-terminal region Anatomy 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 230000003078 antioxidant effect Effects 0.000 claims description 8
- 235000021466 carotenoid Nutrition 0.000 claims description 7
- 150000001747 carotenoids Chemical class 0.000 claims description 7
- 239000003605 opacifier Substances 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 239000004365 Protease Substances 0.000 claims description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 4
- 125000006850 spacer group Chemical group 0.000 claims description 4
- 108090000371 Esterases Proteins 0.000 claims description 3
- 108090001060 Lipase Proteins 0.000 claims description 3
- 239000004367 Lipase Substances 0.000 claims description 3
- 102000004882 Lipase Human genes 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 239000002917 insecticide Substances 0.000 claims description 3
- 235000019421 lipase Nutrition 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 2
- 230000009977 dual effect Effects 0.000 claims description 2
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003139 biocide Substances 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 229940056582 human hair preparation Drugs 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 229920005615 natural polymer Polymers 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 235000013599 spices Nutrition 0.000 claims 1
- 229920001059 synthetic polymer Polymers 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 239000013543 active substance Substances 0.000 abstract description 4
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- -1 inorganic acid salt Chemical class 0.000 description 198
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 104
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 83
- 239000007864 aqueous solution Substances 0.000 description 75
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 73
- 210000003491 skin Anatomy 0.000 description 72
- 238000003756 stirring Methods 0.000 description 61
- 235000002639 sodium chloride Nutrition 0.000 description 57
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 55
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 54
- 239000010692 aromatic oil Substances 0.000 description 54
- 239000012071 phase Substances 0.000 description 52
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical group CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 47
- 235000019198 oils Nutrition 0.000 description 46
- 108090000623 proteins and genes Proteins 0.000 description 42
- 241001597008 Nomeidae Species 0.000 description 39
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 39
- 229920001577 copolymer Polymers 0.000 description 38
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 36
- 150000003839 salts Chemical class 0.000 description 36
- 239000002253 acid Substances 0.000 description 33
- 239000004205 dimethyl polysiloxane Substances 0.000 description 33
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 33
- 150000002148 esters Chemical class 0.000 description 33
- 239000000463 material Substances 0.000 description 33
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 33
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 32
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 32
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 32
- 229940036350 bisabolol Drugs 0.000 description 32
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 32
- 239000003292 glue Substances 0.000 description 32
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 32
- 102000004169 proteins and genes Human genes 0.000 description 32
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 31
- 239000000194 fatty acid Substances 0.000 description 31
- 229920000642 polymer Polymers 0.000 description 31
- 235000018102 proteins Nutrition 0.000 description 31
- 150000001875 compounds Chemical class 0.000 description 30
- 229940008099 dimethicone Drugs 0.000 description 29
- 239000000047 product Substances 0.000 description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
- 235000014113 dietary fatty acids Nutrition 0.000 description 28
- 239000003995 emulsifying agent Substances 0.000 description 28
- 229930195729 fatty acid Natural products 0.000 description 28
- 235000011187 glycerol Nutrition 0.000 description 28
- 239000000839 emulsion Substances 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 26
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 25
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 25
- 239000007788 liquid Substances 0.000 description 24
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 23
- 244000060011 Cocos nucifera Species 0.000 description 22
- 235000013162 Cocos nucifera Nutrition 0.000 description 22
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 22
- 239000001294 propane Substances 0.000 description 22
- 238000011534 incubation Methods 0.000 description 21
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 21
- 229920001296 polysiloxane Polymers 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 239000002671 adjuvant Substances 0.000 description 20
- 125000000217 alkyl group Chemical group 0.000 description 20
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- 239000001273 butane Substances 0.000 description 19
- 239000006071 cream Substances 0.000 description 19
- 150000004665 fatty acids Chemical class 0.000 description 19
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 18
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 18
- 229940081733 cetearyl alcohol Drugs 0.000 description 17
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 17
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 16
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 239000002453 shampoo Substances 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229910019142 PO4 Inorganic materials 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 14
- 229940073639 ceteareth-6 Drugs 0.000 description 14
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 14
- 229930182478 glucoside Natural products 0.000 description 14
- 239000002480 mineral oil Substances 0.000 description 14
- 235000010446 mineral oil Nutrition 0.000 description 14
- 239000010452 phosphate Substances 0.000 description 14
- 239000002953 phosphate buffered saline Substances 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 14
- 229910052938 sodium sulfate Inorganic materials 0.000 description 14
- 235000011152 sodium sulphate Nutrition 0.000 description 14
- 238000005406 washing Methods 0.000 description 14
- 108091000074 Desmoplakin Proteins 0.000 description 13
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 13
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 13
- 230000009471 action Effects 0.000 description 13
- 239000002585 base Substances 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 235000015165 citric acid Nutrition 0.000 description 13
- BEGBSFPALGFMJI-UHFFFAOYSA-N ethene;sodium Chemical group [Na].C=C BEGBSFPALGFMJI-UHFFFAOYSA-N 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 235000021317 phosphate Nutrition 0.000 description 13
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 13
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 13
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 12
- 102000029792 Desmoplakin Human genes 0.000 description 12
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 12
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 12
- 239000006210 lotion Substances 0.000 description 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 12
- 239000007921 spray Substances 0.000 description 12
- 239000002562 thickening agent Substances 0.000 description 12
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 11
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 11
- 102000003992 Peroxidases Human genes 0.000 description 11
- 229920001213 Polysorbate 20 Polymers 0.000 description 11
- 230000000474 nursing effect Effects 0.000 description 11
- 108040007629 peroxidase activity proteins Proteins 0.000 description 11
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 11
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 11
- 238000000746 purification Methods 0.000 description 11
- 208000017520 skin disease Diseases 0.000 description 11
- 239000000344 soap Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000012177 spermaceti Substances 0.000 description 11
- 229940084106 spermaceti Drugs 0.000 description 11
- 239000004408 titanium dioxide Substances 0.000 description 11
- 235000010215 titanium dioxide Nutrition 0.000 description 11
- 229920001285 xanthan gum Polymers 0.000 description 11
- 239000000230 xanthan gum Substances 0.000 description 11
- 235000010493 xanthan gum Nutrition 0.000 description 11
- 229940082509 xanthan gum Drugs 0.000 description 11
- 206010048768 Dermatosis Diseases 0.000 description 10
- 102100032249 Dystonin Human genes 0.000 description 10
- 108010013976 Dystonin Proteins 0.000 description 10
- 241000235058 Komagataella pastoris Species 0.000 description 10
- 108091034117 Oligonucleotide Proteins 0.000 description 10
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 10
- 229940048053 acrylate Drugs 0.000 description 10
- 239000000443 aerosol Substances 0.000 description 10
- 150000003863 ammonium salts Chemical class 0.000 description 10
- 238000004140 cleaning Methods 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 159000000000 sodium salts Chemical class 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 9
- 239000004202 carbamide Substances 0.000 description 9
- 235000013877 carbamide Nutrition 0.000 description 9
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 9
- 239000006260 foam Substances 0.000 description 9
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 8
- 241000351920 Aspergillus nidulans Species 0.000 description 8
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 8
- 229920002125 Sokalan® Polymers 0.000 description 8
- 239000007983 Tris buffer Substances 0.000 description 8
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- GZFRSYFOWVTEHV-UHFFFAOYSA-N dimethylazanium;phosphate Chemical compound C[NH2+]C.C[NH2+]C.C[NH2+]C.[O-]P([O-])([O-])=O GZFRSYFOWVTEHV-UHFFFAOYSA-N 0.000 description 8
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 8
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 8
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 229960003742 phenol Drugs 0.000 description 8
- 239000003380 propellant Substances 0.000 description 8
- 229940047670 sodium acrylate Drugs 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 239000004577 thatch Substances 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 230000000996 additive effect Effects 0.000 description 7
- 239000002280 amphoteric surfactant Substances 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 239000012965 benzophenone Substances 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- 238000000502 dialysis Methods 0.000 description 7
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 7
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 7
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 7
- 238000013467 fragmentation Methods 0.000 description 7
- 238000006062 fragmentation reaction Methods 0.000 description 7
- FQEDESWDVHAQBG-UHFFFAOYSA-N hexyl 2-methoxy-3-phenylprop-2-enoate Chemical compound CCCCCCOC(=O)C(OC)=CC1=CC=CC=C1 FQEDESWDVHAQBG-UHFFFAOYSA-N 0.000 description 7
- 210000003000 inclusion body Anatomy 0.000 description 7
- 229960001679 octinoxate Drugs 0.000 description 7
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 description 7
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 235000020944 retinol Nutrition 0.000 description 7
- 239000011607 retinol Substances 0.000 description 7
- 229960003471 retinol Drugs 0.000 description 7
- 229920002545 silicone oil Polymers 0.000 description 7
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 7
- 229960000368 sulisobenzone Drugs 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 235000014692 zinc oxide Nutrition 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 125000005250 alkyl acrylate group Chemical group 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000010238 camphora Substances 0.000 description 6
- 229940025250 camphora Drugs 0.000 description 6
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 238000005352 clarification Methods 0.000 description 6
- 229920006037 cross link polymer Polymers 0.000 description 6
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 235000013980 iron oxide Nutrition 0.000 description 6
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 229960002216 methylparaben Drugs 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 6
- 239000003531 protein hydrolysate Substances 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 235000010384 tocopherol Nutrition 0.000 description 6
- 229930003799 tocopherol Natural products 0.000 description 6
- 229960001295 tocopherol Drugs 0.000 description 6
- 239000011732 tocopherol Substances 0.000 description 6
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 239000011787 zinc oxide Substances 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 5
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 5
- 241000194107 Bacillus megaterium Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 5
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 5
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 5
- 108010009736 Protein Hydrolysates Proteins 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 239000011543 agarose gel Substances 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 150000001447 alkali salts Chemical class 0.000 description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 5
- 125000003368 amide group Chemical group 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 5
- 235000012677 beetroot red Nutrition 0.000 description 5
- 239000001654 beetroot red Substances 0.000 description 5
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 5
- 239000011648 beta-carotene Substances 0.000 description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 5
- 229950011260 betanaphthol Drugs 0.000 description 5
- 235000002185 betanin Nutrition 0.000 description 5
- 239000004305 biphenyl Substances 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 229920006317 cationic polymer Polymers 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000008266 hair spray Substances 0.000 description 5
- 150000002460 imidazoles Chemical class 0.000 description 5
- 210000003963 intermediate filament Anatomy 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 229920000570 polyether Polymers 0.000 description 5
- 229920000223 polyglycerol Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 5
- 238000004153 renaturation Methods 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 5
- 239000001052 yellow pigment Substances 0.000 description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 5
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 4
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 4
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 4
- AKWFJQNBHYVIPY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO AKWFJQNBHYVIPY-UHFFFAOYSA-N 0.000 description 4
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 4
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 4
- 239000005662 Paraffin oil Substances 0.000 description 4
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 4
- 108010054050 Plectin Proteins 0.000 description 4
- 102000056300 Plectins Human genes 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 244000044822 Simmondsia californica Species 0.000 description 4
- 235000004433 Simmondsia californica Nutrition 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 239000006180 TBST buffer Substances 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003270 Vitamin B Natural products 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 229960004365 benzoic acid Drugs 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 4
- 238000005282 brightening Methods 0.000 description 4
- 159000000007 calcium salts Chemical class 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 4
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 229940100539 dibutyl adipate Drugs 0.000 description 4
- 150000005690 diesters Chemical class 0.000 description 4
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000010985 leather Substances 0.000 description 4
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 4
- 235000012661 lycopene Nutrition 0.000 description 4
- 239000001751 lycopene Substances 0.000 description 4
- 229960004999 lycopene Drugs 0.000 description 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 4
- QSQLTHHMFHEFIY-UHFFFAOYSA-N methyl behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OC QSQLTHHMFHEFIY-UHFFFAOYSA-N 0.000 description 4
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 4
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 4
- 239000004530 micro-emulsion Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- CBFCDTFDPHXCNY-UHFFFAOYSA-N octyldodecane Natural products CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 4
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 4
- CGIHFIDULQUVJG-VNTMZGSJSA-N phytantriol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(O)[C@H](O)CO CGIHFIDULQUVJG-VNTMZGSJSA-N 0.000 description 4
- 125000001453 quaternary ammonium group Chemical class 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 230000003248 secreting effect Effects 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 235000011008 sodium phosphates Nutrition 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 150000005846 sugar alcohols Chemical class 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 239000007762 w/o emulsion Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 239000002888 zwitterionic surfactant Substances 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 3
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 3
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 3
- UDNHDGAIYIWBCN-UHFFFAOYSA-N 1-butyl-2,3,4,5-tetramethylbenzene phenol Chemical compound C1(=CC=CC=C1)O.CC=1C(=C(C(=C(C1)CCCC)C)C)C UDNHDGAIYIWBCN-UHFFFAOYSA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 3
- IAIDZNVXRRXCHU-UHFFFAOYSA-N 3-ethyl-2-hexylphenol Chemical compound CCCCCCC1=C(O)C=CC=C1CC IAIDZNVXRRXCHU-UHFFFAOYSA-N 0.000 description 3
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-M 4-aminobenzoate Chemical compound NC1=CC=C(C([O-])=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-M 0.000 description 3
- VTQVLCXOOIFPBB-UHFFFAOYSA-N 4-ethyl-5-hexyl-1H-triazin-6-one Chemical compound C(C)C1=C(C(NN=N1)=O)CCCCCC VTQVLCXOOIFPBB-UHFFFAOYSA-N 0.000 description 3
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 244000017106 Bixa orellana Species 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 108010087806 Carnosine Proteins 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000001263 FEMA 3042 Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- HCZKYJDFEPMADG-TXEJJXNPSA-N Nordihydroguaiaretic acid Natural products C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 3
- 241000235648 Pichia Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 102000002933 Thioredoxin Human genes 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 3
- 229920006322 acrylamide copolymer Polymers 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 125000003282 alkyl amino group Chemical group 0.000 description 3
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 3
- 125000005376 alkyl siloxane group Chemical group 0.000 description 3
- 150000008051 alkyl sulfates Chemical class 0.000 description 3
- 150000008052 alkyl sulfonates Chemical class 0.000 description 3
- 239000002168 alkylating agent Substances 0.000 description 3
- 229940100198 alkylating agent Drugs 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- UBNYRXMKIIGMKK-UHFFFAOYSA-N amiloxate Chemical compound COC1=CC=C(C=CC(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000004873 anchoring Methods 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 235000012665 annatto Nutrition 0.000 description 3
- 239000010362 annatto Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000003287 bathing Methods 0.000 description 3
- 239000012964 benzotriazole Substances 0.000 description 3
- 235000010290 biphenyl Nutrition 0.000 description 3
- 235000012682 canthaxanthin Nutrition 0.000 description 3
- 239000001659 canthaxanthin Substances 0.000 description 3
- 229940008033 canthaxanthin Drugs 0.000 description 3
- 150000001718 carbodiimides Chemical class 0.000 description 3
- 150000007942 carboxylates Chemical group 0.000 description 3
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 3
- 239000004568 cement Substances 0.000 description 3
- 239000007766 cera flava Substances 0.000 description 3
- 229940114081 cinnamate Drugs 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 235000019244 cryptoxanthin Nutrition 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 3
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 3
- 229960000979 drometrizole Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 229960000655 ensulizole Drugs 0.000 description 3
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 239000000118 hair dye Substances 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000008176 lyophilized powder Substances 0.000 description 3
- 159000000003 magnesium salts Chemical class 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- NQNOMXXYKHWVKR-UHFFFAOYSA-N methylazanium;sulfate Chemical class NC.NC.OS(O)(=O)=O NQNOMXXYKHWVKR-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 150000003833 nucleoside derivatives Chemical class 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229960001173 oxybenzone Drugs 0.000 description 3
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 3
- 229940115458 pantolactone Drugs 0.000 description 3
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 3
- 229960000969 phenyl salicylate Drugs 0.000 description 3
- 239000004584 polyacrylic acid Substances 0.000 description 3
- 229920000867 polyelectrolyte Polymers 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 3
- 239000001054 red pigment Substances 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N salicylic acid phenyl ester Natural products OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 3
- 229940071089 sarcosinate Drugs 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 235000010378 sodium ascorbate Nutrition 0.000 description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 3
- 229960005055 sodium ascorbate Drugs 0.000 description 3
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 3
- 235000010334 sodium propionate Nutrition 0.000 description 3
- 239000004324 sodium propionate Substances 0.000 description 3
- 229960003212 sodium propionate Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 3
- 229920002258 tannic acid Polymers 0.000 description 3
- 229940033123 tannic acid Drugs 0.000 description 3
- 235000015523 tannic acid Nutrition 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 229940094937 thioredoxin Drugs 0.000 description 3
- 108060008226 thioredoxin Proteins 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 150000003918 triazines Chemical class 0.000 description 3
- 229960003500 triclosan Drugs 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 2
- GVOIABOMXKDDGU-XRODXAHISA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Chemical compound O=C([C@@]1(C)C(C[C@H](O)C1)(C)C)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C GVOIABOMXKDDGU-XRODXAHISA-N 0.000 description 2
- GVOIABOMXKDDGU-LOFNIBRQSA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)C1(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C GVOIABOMXKDDGU-LOFNIBRQSA-N 0.000 description 2
- ATCICVFRSJQYDV-UHFFFAOYSA-N (6E,8E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,26,30-dodecaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C ATCICVFRSJQYDV-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- KBKGPMDADJLBEM-UHFFFAOYSA-N 1-(4-pentylphenyl)ethanone Chemical compound CCCCCC1=CC=C(C(C)=O)C=C1 KBKGPMDADJLBEM-UHFFFAOYSA-N 0.000 description 2
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 2
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical class C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 2
- MBDUIEKYVPVZJH-UHFFFAOYSA-N 1-ethylsulfonylethane Chemical compound CCS(=O)(=O)CC MBDUIEKYVPVZJH-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- BYQPMKXSZDJZAW-UHFFFAOYSA-N 1-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OC(CCC)OC(=O)CCCCCCC BYQPMKXSZDJZAW-UHFFFAOYSA-N 0.000 description 2
- KDBTVTJXYASRRV-UHFFFAOYSA-N 1-trimethoxysilyldecan-1-one Chemical compound CCCCCCCCCC(=O)[Si](OC)(OC)OC KDBTVTJXYASRRV-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 2
- WSRCOZWDQPJAQT-UHFFFAOYSA-N 18-methylicosanoic acid Chemical compound CCC(C)CCCCCCCCCCCCCCCCC(O)=O WSRCOZWDQPJAQT-UHFFFAOYSA-N 0.000 description 2
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 2
- KAWVQDRRFHLAPC-UHFFFAOYSA-N 2-(2,3-dimethoxyphenyl)-2-oxoacetic acid Chemical compound COC1=CC=CC(C(=O)C(O)=O)=C1OC KAWVQDRRFHLAPC-UHFFFAOYSA-N 0.000 description 2
- ZUVDVLYXIZFDRM-UHFFFAOYSA-N 2-(hydroxymethyl)-4-methylphenol Chemical compound CC1=CC=C(O)C(CO)=C1 ZUVDVLYXIZFDRM-UHFFFAOYSA-N 0.000 description 2
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- 229940086681 4-aminobenzoate Drugs 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- QXNWZXMBUKUYMD-ITUXNECMSA-N 4-keto-beta-carotene Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C QXNWZXMBUKUYMD-ITUXNECMSA-N 0.000 description 2
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 2
- SEEJXAIRWOAGDV-UHFFFAOYSA-N 5-hexyl-1H-triazin-6-one Chemical compound C(CCCCC)C=1C(NN=NC=1)=O SEEJXAIRWOAGDV-UHFFFAOYSA-N 0.000 description 2
- VVZCFQPOPYXQBM-UHFFFAOYSA-N 6-amino-3-methyl-6-propan-2-ylcyclohexa-2,4-diene-1-carboxylic acid Chemical compound CC(C)C1(N)C=CC(C)=CC1C(O)=O VVZCFQPOPYXQBM-UHFFFAOYSA-N 0.000 description 2
- DFMMVLFMMAQXHZ-DOKBYWHISA-N 8'-apo-beta,psi-caroten-8'-al Chemical compound O=CC(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C DFMMVLFMMAQXHZ-DOKBYWHISA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 101710145634 Antigen 1 Proteins 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 101000798396 Bacillus licheniformis Phenylalanine racemase [ATP hydrolyzing] Proteins 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VLOQYUSEMICXEZ-UHFFFAOYSA-N COC1=CC=C(C=CC(=O)OC(C)C(C)C)C=C1 Chemical compound COC1=CC=C(C=CC(=O)OC(C)C(C)C)C=C1 VLOQYUSEMICXEZ-UHFFFAOYSA-N 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- GVOIABOMXKDDGU-SUKXYCKUSA-N Capsorubin Natural products O=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C(=O)[C@@]1(C)C(C)(C)C[C@H](O)C1)\C)/C)\C)/C)[C@@]1(C)C(C)(C)C[C@H](O)C1 GVOIABOMXKDDGU-SUKXYCKUSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 102100035882 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 244000293323 Cosmos caudatus Species 0.000 description 2
- 235000005956 Cosmos caudatus Nutrition 0.000 description 2
- 239000004212 Cryptoxanthin Substances 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000011703 D-panthenol Substances 0.000 description 2
- 235000004866 D-panthenol Nutrition 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004348 Glyceryl diacetate Substances 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 2
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical group COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- GFPJSSAOISEBQL-FZKBJVJCSA-N Mutatochrome Chemical compound O1C2(C)CCCC(C)(C)C2=CC1C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C GFPJSSAOISEBQL-FZKBJVJCSA-N 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 2
- 206010034277 Pemphigoid Diseases 0.000 description 2
- 244000025272 Persea americana Species 0.000 description 2
- 235000008673 Persea americana Nutrition 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- BKDZVPVJIXZYBH-UHFFFAOYSA-N [Na].C(C)(=O)O.NC(=N)N Chemical compound [Na].C(C)(=O)O.NC(=N)N BKDZVPVJIXZYBH-UHFFFAOYSA-N 0.000 description 2
- ROUVVBLYVOSGLH-UHFFFAOYSA-N [Na].COC1=CC=C(C(=O)C(O)=O)C=C1OC Chemical compound [Na].COC1=CC=C(C(=O)C(O)=O)C=C1OC ROUVVBLYVOSGLH-UHFFFAOYSA-N 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 2
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 125000005157 alkyl carboxy group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 239000005030 aluminium foil Substances 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 2
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000006229 amino acid addition Effects 0.000 description 2
- 229940064734 aminobenzoate Drugs 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 2
- 229960005193 avobenzone Drugs 0.000 description 2
- CESHKJCQQFFQQQ-UHFFFAOYSA-N azane 2-dodecyl-2-sulfobutanedioic acid Chemical compound N.CCCCCCCCCCCCC(S(O)(=O)=O)(C(O)=O)CC(O)=O CESHKJCQQFFQQQ-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 2
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- JHUWODOJJBBFNF-UHFFFAOYSA-N bis(2,3-dihydroxyphenyl)methanone Chemical compound OC1=CC=CC(C(=O)C=2C(=C(O)C=CC=2)O)=C1O JHUWODOJJBBFNF-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical class O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000009132 capsorubin Nutrition 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 229940105657 catalase Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000002742 combinatorial mutagenesis Methods 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 210000004292 cytoskeleton Anatomy 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229960003949 dexpanthenol Drugs 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 229910000071 diazene Inorganic materials 0.000 description 2
- 229960005215 dichloroacetic acid Drugs 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 2
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 2
- 239000000555 dodecyl gallate Substances 0.000 description 2
- 235000010386 dodecyl gallate Nutrition 0.000 description 2
- 229940080643 dodecyl gallate Drugs 0.000 description 2
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- FPVGTPBMTFTMRT-NSKUCRDLSA-L fast yellow Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 FPVGTPBMTFTMRT-NSKUCRDLSA-L 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000019443 glyceryl diacetate Nutrition 0.000 description 2
- 150000002333 glycines Chemical class 0.000 description 2
- 229940100608 glycol distearate Drugs 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- JGIDSJGZGFYYNX-YUAHOQAQSA-N indian yellow Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC=C(OC=2C(=C(O)C=CC=2)C2=O)C2=C1 JGIDSJGZGFYYNX-YUAHOQAQSA-N 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 229910000462 iron(III) oxide hydroxide Inorganic materials 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000035984 keratolysis Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 229960003951 masoprocol Drugs 0.000 description 2
- BPDGKTMMBDRVHQ-UNVLYCKESA-M methanesulfonate;trimethyl-[4-[(z)-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]phenyl]azanium Chemical compound CS([O-])(=O)=O.CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=C([N+](C)(C)C)C=C1 BPDGKTMMBDRVHQ-UNVLYCKESA-M 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Substances CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 229950000999 mexenone Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 2
- JMXROTHPANUTOJ-UHFFFAOYSA-H naphthol green b Chemical compound [Na+].[Na+].[Na+].[Fe+3].C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21.C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21.C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21 JMXROTHPANUTOJ-UHFFFAOYSA-H 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N noncarboxylic acid Natural products CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- RAFYDKXYXRZODZ-UHFFFAOYSA-N octanoyl octanoate Chemical class CCCCCCCC(=O)OC(=O)CCCCCCC RAFYDKXYXRZODZ-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 235000012658 paprika extract Nutrition 0.000 description 2
- 239000001688 paprika extract Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229940059574 pentaerithrityl Drugs 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000000985 reactive dye Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 150000004492 retinoid derivatives Chemical class 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- LUPNKHXLFSSUGS-UHFFFAOYSA-M sodium;2,2-dichloroacetate Chemical compound [Na+].[O-]C(=O)C(Cl)Cl LUPNKHXLFSSUGS-UHFFFAOYSA-M 0.000 description 2
- JHJUUEHSAZXEEO-UHFFFAOYSA-M sodium;4-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 JHJUUEHSAZXEEO-UHFFFAOYSA-M 0.000 description 2
- NHZIBLPDGIARQC-UHFFFAOYSA-M sodium;4-hydroxy-5-(2-hydroxy-4-methoxybenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].OC1=CC(OC)=CC=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O NHZIBLPDGIARQC-UHFFFAOYSA-M 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 238000005987 sulfurization reaction Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000007970 thio esters Chemical class 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 150000003573 thiols Chemical group 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- AIBOHNYYKWYQMM-MXBSLTGDSA-N torulene Chemical compound CC(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C AIBOHNYYKWYQMM-MXBSLTGDSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000001069 triethyl citrate Substances 0.000 description 2
- 235000013769 triethyl citrate Nutrition 0.000 description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 2
- 229940100530 zinc ricinoleate Drugs 0.000 description 2
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 2
- HSVDGMYRFLHPMS-UHFFFAOYSA-N (2-benzylidene-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl)methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC1=CC=CC=C1 HSVDGMYRFLHPMS-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- AFDFUQMUEYLSSW-UHFFFAOYSA-N (2-hydroxy-3-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O AFDFUQMUEYLSSW-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- NESPPCWGYRQEJQ-VATUXEBJSA-N (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e)-2,6,10,14,19,23-hexamethyl-25-(2,6,6-trimethylcyclohexen-1-yl)pentacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaenoic acid Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C NESPPCWGYRQEJQ-VATUXEBJSA-N 0.000 description 1
- XSYUPRQVAHJETO-WPMUBMLPSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidaz Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 XSYUPRQVAHJETO-WPMUBMLPSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NSSALFVIQPAIQK-FPLPWBNLSA-N (Z)-2-Nonen-1-ol Chemical compound CCCCCC\C=C/CO NSSALFVIQPAIQK-FPLPWBNLSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 1
- AHFMSNDOYCFEPH-UHFFFAOYSA-N 1,2-difluoroethane Chemical compound FCCF AHFMSNDOYCFEPH-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical class OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- IYOLBFFHPZOQGW-UHFFFAOYSA-N 2,4-dichloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=C(Cl)C(C)=C1Cl IYOLBFFHPZOQGW-UHFFFAOYSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 description 1
- DXPQDAHFCMBFMM-UHFFFAOYSA-N 2-benzoylbenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 DXPQDAHFCMBFMM-UHFFFAOYSA-N 0.000 description 1
- OVUDIKNHEYJSMX-UHFFFAOYSA-N 2-bromo-2-(bromomethyl)pentanedinitrile 2,3-dibromo-2,3-dimethylbutanedinitrile Chemical compound BrC(C#N)(CCC#N)CBr.BrC(C(C)(C#N)Br)(C)C#N OVUDIKNHEYJSMX-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- QUTGXAIWZAMYEM-UHFFFAOYSA-N 2-cyclopentyloxyethanamine Chemical compound NCCOC1CCCC1 QUTGXAIWZAMYEM-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- 125000003816 2-hydroxybenzoyl group Chemical group OC1=C(C(=O)*)C=CC=C1 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- XXUNIGZDNWWYED-UHFFFAOYSA-N 2-methylbenzamide Chemical compound CC1=CC=CC=C1C(N)=O XXUNIGZDNWWYED-UHFFFAOYSA-N 0.000 description 1
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 description 1
- BHVJSLPLFOAMEV-UHIFYLTQSA-M 20-Epibryonolic acid Natural products C([C@H]1[C@]2(C)CC3)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@]2(C)C1=C3[C@@]2(C)CC[C@H](O)C(C)(C)[C@@H]2CC1 BHVJSLPLFOAMEV-UHIFYLTQSA-M 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 150000003042 3-dehydroretinol derivatives Chemical class 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- OCFMAQIVFZVNGM-UHFFFAOYSA-N 3-hydroxy-4-[(2-sulfonaphthalen-1-yl)diazenyl]naphthalene-2-carboxylic acid Chemical compound C1=CC=C2C(N=NC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(S(O)(=O)=O)C=CC2=C1 OCFMAQIVFZVNGM-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- FHYNZKLNCPUNEU-UHFFFAOYSA-N 4-[(3,4-dihydroxyphenyl)methyl]-3-[(4-hydroxyphenyl)methyl]oxolan-2-one Chemical compound C1=CC(O)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(O)=C1 FHYNZKLNCPUNEU-UHFFFAOYSA-N 0.000 description 1
- JSEYDVLGSMLKDL-UHFFFAOYSA-N 4-[(4-ethoxyphenyl)diazenyl]naphthalen-1-ol Chemical compound C1=CC(OCC)=CC=C1N=NC1=CC=C(O)C2=CC=CC=C12 JSEYDVLGSMLKDL-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 150000005418 4-aminobenzoic acid derivatives Chemical class 0.000 description 1
- QPQKUYVSJWQSDY-UHFFFAOYSA-N 4-phenyldiazenylaniline Chemical compound C1=CC(N)=CC=C1N=NC1=CC=CC=C1 QPQKUYVSJWQSDY-UHFFFAOYSA-N 0.000 description 1
- NSISJFFVIMQBRN-UHFFFAOYSA-N 5-(hydroxymethyl)oxolan-2-one Chemical compound OCC1CCC(=O)O1 NSISJFFVIMQBRN-UHFFFAOYSA-N 0.000 description 1
- DMYYPSLMFSEFCK-UHFFFAOYSA-N 5-amino-n-[2-methyl-5-(1,2-oxazol-3-ylcarbamoyl)phenyl]-1-phenylpyrazole-4-carboxamide Chemical compound CC1=CC=C(C(=O)NC2=NOC=C2)C=C1NC(=O)C(=C1N)C=NN1C1=CC=CC=C1 DMYYPSLMFSEFCK-UHFFFAOYSA-N 0.000 description 1
- XCKGFJPFEHHHQA-UHFFFAOYSA-N 5-methyl-2-phenyl-4-phenyldiazenyl-4h-pyrazol-3-one Chemical compound CC1=NN(C=2C=CC=CC=2)C(=O)C1N=NC1=CC=CC=C1 XCKGFJPFEHHHQA-UHFFFAOYSA-N 0.000 description 1
- MSLKMRUEVOYOOZ-VBYMZDBQSA-L 519-62-0 Chemical compound [Mg+2].[N-]1C2=C(C=3[C@H]([C@H](C)C(=CC=4C(=C(C=C)C(=C5)N=4)C)N=3)CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@@H](C(=O)OC)C([O-])=C2C(C)=C1C=C1C(CC)=C(C=O)C5=N1 MSLKMRUEVOYOOZ-VBYMZDBQSA-L 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical class CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- 241001119624 Aesculus chinensis Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 1
- 241001136782 Alca Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- AOMZHDJXSYHPKS-DROYEMJCSA-L Amido Black 10B Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=C(\N=N\C=3C=CC=CC=3)C(O)=C2C(N)=C1\N=N\C1=CC=C(N(=O)=O)C=C1 AOMZHDJXSYHPKS-DROYEMJCSA-L 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- QCWJKJLNCFEVPQ-WHFBIAKZSA-N Asn-Gln Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O QCWJKJLNCFEVPQ-WHFBIAKZSA-N 0.000 description 1
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 1
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 208000036641 Aspergillus infections Diseases 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 1
- BHVJSLPLFOAMEV-UHFFFAOYSA-N Bryonolic acid Natural products C1CC2(C)C3CC(C)(C(O)=O)CCC3(C)CCC2(C)C2=C1C1(C)CCC(O)C(C)(C)C1CC2 BHVJSLPLFOAMEV-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- QADPCIDWEVVLSR-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC)[N+](OCC)(C)C Chemical compound C(CCCCCCCCCCCCCCC)[N+](OCC)(C)C QADPCIDWEVVLSR-UHFFFAOYSA-N 0.000 description 1
- AHCDZZIXAMDCBJ-UHFFFAOYSA-N CCC[Na] Chemical compound CCC[Na] AHCDZZIXAMDCBJ-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 241001597062 Channa argus Species 0.000 description 1
- 239000004217 Citranaxanthin Substances 0.000 description 1
- SLQHGWZKKZPZEK-JKEZLOPUSA-N Citranaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)C)C=CC=C(/C)C=CC1=C(C)CCCC1(C)C SLQHGWZKKZPZEK-JKEZLOPUSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- YXQDRIRSAHTJKM-IMJSIDKUSA-N Cys-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YXQDRIRSAHTJKM-IMJSIDKUSA-N 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108010046331 Deoxyribodipyrimidine photo-lyase Proteins 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- DFMMVLFMMAQXHZ-IZEVWJMWSA-N E 160e Natural products CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)/C)C=O DFMMVLFMMAQXHZ-IZEVWJMWSA-N 0.000 description 1
- 108091065810 E family Proteins 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 108091072036 F family Proteins 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- DXJZITDUDUPINW-WHFBIAKZSA-N Gln-Asn Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O DXJZITDUDUPINW-WHFBIAKZSA-N 0.000 description 1
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 1
- 201000002563 Histoplasmosis Diseases 0.000 description 1
- 241000384507 Hoplostethus Species 0.000 description 1
- 101710091977 Hydrophobin Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 244000162475 Juniperus rigida Species 0.000 description 1
- 235000009069 Juniperus rigida Nutrition 0.000 description 1
- 241001446187 Kermes Species 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- KJQFBVYMGADDTQ-CVSPRKDYSA-N L-buthionine-(S,R)-sulfoximine Chemical compound CCCCS(=N)(=O)CC[C@H](N)C(O)=O KJQFBVYMGADDTQ-CVSPRKDYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 102100032241 Lactotransferrin Human genes 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 208000034493 Mucous membrane disease Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- IYNZALIBZCUUFA-UHFFFAOYSA-N N(=O)OC(C)CCCCCC.C(C1=CC=CC=C1)=C(C(=O)O)C(=O)O Chemical compound N(=O)OC(C)CCCCCC.C(C1=CC=CC=C1)=C(C(=O)O)C(=O)O IYNZALIBZCUUFA-UHFFFAOYSA-N 0.000 description 1
- GWPZQWJNTQGLFJ-UHFFFAOYSA-N N(=O)OC(C)CCCCCC.CN(C1=CC=C(C(=O)O)C=C1)C Chemical compound N(=O)OC(C)CCCCCC.CN(C1=CC=C(C(=O)O)C=C1)C GWPZQWJNTQGLFJ-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- MLMIWLRSYWEPEL-UHFFFAOYSA-N NCC1=CC=C(C=C1)NC1=CC=CC=2C(C3=CC=CC=C3C(C12)=O)=O Chemical compound NCC1=CC=C(C=C1)NC1=CC=CC=2C(C3=CC=CC=C3C(C12)=O)=O MLMIWLRSYWEPEL-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- ATCICVFRSJQYDV-DDRHJXQASA-N Neurosporene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C ATCICVFRSJQYDV-DDRHJXQASA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- SLCXKUHUSINOCU-UHFFFAOYSA-N OC1=CC=C(C=2C(C3=CC=CC=C3C(C12)=O)=O)NC1=CC=C(C=C1)CN Chemical compound OC1=CC=C(C=2C(C3=CC=CC=C3C(C12)=O)=O)NC1=CC=C(C=C1)CN SLCXKUHUSINOCU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- PYOHODCEOHCZBM-RYUDHWBXSA-N Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 PYOHODCEOHCZBM-RYUDHWBXSA-N 0.000 description 1
- OOUTWVMJGMVRQF-NWYYEFBESA-N Phoenicoxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C OOUTWVMJGMVRQF-NWYYEFBESA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- 235000011568 Pinus mugo Nutrition 0.000 description 1
- 241001136577 Pinus mugo Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 101710183548 Pyridoxal 5'-phosphate synthase subunit PdxS Proteins 0.000 description 1
- 102100035459 Pyruvate dehydrogenase protein X component, mitochondrial Human genes 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 1
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 1
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- NESPPCWGYRQEJQ-AGUCYFRTSA-N Torularhodin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC=C(/C)C=CC=C(/C)C(=O)O NESPPCWGYRQEJQ-AGUCYFRTSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- TYYLDKGBCJGJGW-WMZOPIPTSA-N Trp-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 TYYLDKGBCJGJGW-WMZOPIPTSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- BMPPMAOOKQJYIP-WMZOPIPTSA-N Tyr-Trp Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C([O-])=O)C1=CC=C(O)C=C1 BMPPMAOOKQJYIP-WMZOPIPTSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- ZVNYJIZDIRKMBF-UHFFFAOYSA-N Vesnarinone Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)N1CCN(C=2C=C3CCC(=O)NC3=CC=2)CC1 ZVNYJIZDIRKMBF-UHFFFAOYSA-N 0.000 description 1
- 239000004213 Violaxanthin Substances 0.000 description 1
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 206010061418 Zygomycosis Diseases 0.000 description 1
- AZFNGPAYDKGCRB-XCPIVNJJSA-M [(1s,2s)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1-methyl-4-propan-2-ylbenzene Chemical compound [Ru+]Cl.CC(C)C1=CC=C(C)C=C1.C1=CC(C)=CC=C1S(=O)(=O)[N-][C@@H](C=1C=CC=CC=1)[C@@H](N)C1=CC=CC=C1 AZFNGPAYDKGCRB-XCPIVNJJSA-M 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- ULGYAEQHFNJYML-UHFFFAOYSA-N [AlH3].[Ca] Chemical compound [AlH3].[Ca] ULGYAEQHFNJYML-UHFFFAOYSA-N 0.000 description 1
- IAEVWHUMVCQYTK-UHFFFAOYSA-N [Cl-].C(C=C)(=O)NOCCC[N+](C)(C)C Chemical compound [Cl-].C(C=C)(=O)NOCCC[N+](C)(C)C IAEVWHUMVCQYTK-UHFFFAOYSA-N 0.000 description 1
- BCLSJBCAXDSCPG-UHFFFAOYSA-N [O+]1=C(C=CC2=C1C=CC=C2)C=O Chemical class [O+]1=C(C=CC2=C1C=CC=C2)C=O BCLSJBCAXDSCPG-UHFFFAOYSA-N 0.000 description 1
- ORQFFSCMRVMJHS-UHFFFAOYSA-N [S].C(C1=CC=CC=C1)N Chemical compound [S].C(C1=CC=CC=C1)N ORQFFSCMRVMJHS-UHFFFAOYSA-N 0.000 description 1
- AHIBWURJLGCHAY-UHFFFAOYSA-N [S].C1=CC=CC=C1 Chemical compound [S].C1=CC=CC=C1 AHIBWURJLGCHAY-UHFFFAOYSA-N 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical group 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229940067621 aminobutyrate Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- BOMINLBVYNPVIK-UHFFFAOYSA-N azane;manganese(2+) Chemical compound N.[Mn+2] BOMINLBVYNPVIK-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical compound C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- KUCISDUQDQAGRU-UHFFFAOYSA-N benzene;azide Chemical class [N-]=[N+]=[N-].C1=CC=CC=C1 KUCISDUQDQAGRU-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 229940024874 benzophenone Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 1
- 239000001652 beta-apo-8'-carotenal Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- LVGQIQHJMRUCRM-UHFFFAOYSA-L calcium bisulfite Chemical compound [Ca+2].OS([O-])=O.OS([O-])=O LVGQIQHJMRUCRM-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 235000010260 calcium hydrogen sulphite Nutrition 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- GBAOBIBJACZTNA-UHFFFAOYSA-L calcium sulfite Chemical compound [Ca+2].[O-]S([O-])=O GBAOBIBJACZTNA-UHFFFAOYSA-L 0.000 description 1
- 235000010261 calcium sulphite Nutrition 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- DYMRMULFWJUGDJ-UHFFFAOYSA-N chembl1976469 Chemical compound OC=1C(C(=O)O)=CC2=CC=CC=C2C=1N=NC1=CC=CC=C1 DYMRMULFWJUGDJ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000019247 citranaxanthin Nutrition 0.000 description 1
- PRDJTOVRIHGKNU-ZWERVMMHSA-N citranaxanthin Chemical compound CC(=O)\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-ZWERVMMHSA-N 0.000 description 1
- PRDJTOVRIHGKNU-UHFFFAOYSA-N citranaxanthine Natural products CC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-UHFFFAOYSA-N 0.000 description 1
- 108010087236 cobra venom endonuclease Proteins 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical class C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 239000004064 cosurfactant Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 230000022811 deglycosylation Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical compound OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- AOMZHDJXSYHPKS-UHFFFAOYSA-L disodium 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 AOMZHDJXSYHPKS-UHFFFAOYSA-L 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- FPVGTPBMTFTMRT-UHFFFAOYSA-L disodium;2-amino-5-[(4-sulfonatophenyl)diazenyl]benzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 FPVGTPBMTFTMRT-UHFFFAOYSA-L 0.000 description 1
- UHXQPQCJDDSMCB-UHFFFAOYSA-L disodium;3-[[9,10-dioxo-4-(2,4,6-trimethyl-3-sulfonatoanilino)anthracen-1-yl]amino]-2,4,6-trimethylbenzenesulfonate Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C(C)=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=C(C)C=C(C)C(S([O-])(=O)=O)=C1C UHXQPQCJDDSMCB-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000006932 echinenone Nutrition 0.000 description 1
- YXPMCBGFLULSGQ-YHEDCBSUSA-N echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(=O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C YXPMCBGFLULSGQ-YHEDCBSUSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- ROBXZHNBBCHEIQ-UHFFFAOYSA-N ethyl 2-aminopropanoate Chemical compound CCOC(=O)C(C)N ROBXZHNBBCHEIQ-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 235000019233 fast yellow AB Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000013360 fish flour Nutrition 0.000 description 1
- FCQJEPASRCXVCB-UHFFFAOYSA-N flavianic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FCQJEPASRCXVCB-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- KZNQNBZMBZJQJO-YFKPBYRVSA-N glyclproline Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 239000003722 gum benzoin Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 210000000301 hemidesmosome Anatomy 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- AVIYEYCFMVPYST-UHFFFAOYSA-N hexane-1,3-diol Chemical compound CCCC(O)CCO AVIYEYCFMVPYST-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- CPSYWNLKRDURMG-UHFFFAOYSA-L hydron;manganese(2+);phosphate Chemical compound [Mn+2].OP([O-])([O-])=O CPSYWNLKRDURMG-UHFFFAOYSA-L 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- KQSBZNJFKWOQQK-UHFFFAOYSA-N hystazarin Natural products O=C1C2=CC=CC=C2C(=O)C2=C1C=C(O)C(O)=C2 KQSBZNJFKWOQQK-UHFFFAOYSA-N 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 229910000765 intermetallic Inorganic materials 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 235000010213 iron oxides and hydroxides Nutrition 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- CXORMDKZEUMQHX-UHFFFAOYSA-N kermesic acid Chemical compound O=C1C2=C(O)C(O)=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C CXORMDKZEUMQHX-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940105082 medicinal charcoal Drugs 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229940063557 methacrylate Drugs 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000013586 microbial product Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 201000007524 mucormycosis Diseases 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- AJUXDFHPVZQOGF-UHFFFAOYSA-N n,n-dimethyl-1-naphthylamine Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1 AJUXDFHPVZQOGF-UHFFFAOYSA-N 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- KWUZCAVKPCRJPO-UHFFFAOYSA-N n-ethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline Chemical compound C1=CC(NCC)=CC=C1C1=NC2=CC=C(C)C=C2S1 KWUZCAVKPCRJPO-UHFFFAOYSA-N 0.000 description 1
- DNOYBZQNDHJASH-UHFFFAOYSA-N n-ethyl-n-trityloxyethanamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(ON(CC)CC)C1=CC=CC=C1 DNOYBZQNDHJASH-UHFFFAOYSA-N 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 235000008665 neurosporene Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical class CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 1
- WQDGUYZIAJKLAB-UHFFFAOYSA-N octan-2-yl nitrite Chemical compound CCCCCCC(C)ON=O WQDGUYZIAJKLAB-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- RDUQEQWTZYCTJZ-UHFFFAOYSA-N octyl 16-methylheptadecanoate Chemical compound CCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C RDUQEQWTZYCTJZ-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- HSXUHWZMNJHFRV-QIKYXUGXSA-L orange G Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1\N=N\C1=CC=CC=C1 HSXUHWZMNJHFRV-QIKYXUGXSA-L 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229940032067 peg-20 stearate Drugs 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- BKOHCPVMXFUECE-UHFFFAOYSA-N phenoxybenzene;sodium;tetrahydrate Chemical compound O.O.O.O.[Na].C=1C=CC=CC=1OC1=CC=CC=C1 BKOHCPVMXFUECE-UHFFFAOYSA-N 0.000 description 1
- RDBMUARQWLPMNW-UHFFFAOYSA-N phosphanylmethanol Chemical compound OCP RDBMUARQWLPMNW-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010289 potassium nitrite Nutrition 0.000 description 1
- 239000004304 potassium nitrite Substances 0.000 description 1
- BWILYWWHXDGKQA-UHFFFAOYSA-M potassium propanoate Chemical compound [K+].CCC([O-])=O BWILYWWHXDGKQA-UHFFFAOYSA-M 0.000 description 1
- 235000010332 potassium propionate Nutrition 0.000 description 1
- 239000004331 potassium propionate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229940115476 ppg-1 trideceth-6 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical compound ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 description 1
- 229960002026 pyrithione Drugs 0.000 description 1
- 229960001141 pyrithione zinc Drugs 0.000 description 1
- 150000003921 pyrrolotriazines Chemical class 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000004508 retinoic acid derivatives Chemical class 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical group CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- SRRKNRDXURUMPP-UHFFFAOYSA-N sodium disulfide Chemical compound [Na+].[Na+].[S-][S-] SRRKNRDXURUMPP-UHFFFAOYSA-N 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- AXMCIYLNKNGNOT-UHFFFAOYSA-N sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 AXMCIYLNKNGNOT-UHFFFAOYSA-N 0.000 description 1
- FTUYQIPAPWPHNC-UHFFFAOYSA-M sodium;4-[[4-[benzyl(ethyl)amino]phenyl]-[4-[benzyl(ethyl)azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzene-1,3-disulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=CC=CC=2)C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC=C1 FTUYQIPAPWPHNC-UHFFFAOYSA-M 0.000 description 1
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 description 1
- 239000000992 solvent dye Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000271 synthetic detergent Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 238000009492 tablet coating Methods 0.000 description 1
- 239000002700 tablet coating Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- ZRTORXKSPTUTCN-BENRWUELSA-N tetradecyl (Z)-tetradec-9-enoate Chemical compound C(CCCCCCC\C=C/CCCC)(=O)OCCCCCCCCCCCCCC ZRTORXKSPTUTCN-BENRWUELSA-N 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- RSPCKAHMRANGJZ-UHFFFAOYSA-N thiohydroxylamine Chemical compound SN RSPCKAHMRANGJZ-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229940093633 tricaprin Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- UGCDBQWJXSAYIL-UHFFFAOYSA-N vat blue 6 Chemical compound O=C1C2=CC=CC=C2C(=O)C(C=C2Cl)=C1C1=C2NC2=C(C(=O)C=3C(=CC=CC=3)C3=O)C3=CC(Cl)=C2N1 UGCDBQWJXSAYIL-UHFFFAOYSA-N 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019245 violaxanthin Nutrition 0.000 description 1
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 150000003732 xanthenes Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to novel keratin-binding protein active substances, and also to the production and use thereof.
Description
Prior art
Vertebrate cells comprises fibril, i.e. the material be made up of keratin of a class.These keratin also are present in hair, among skin and the fingernail, and specific protein such as the desmoplakin special sequence motif by being referred to as the keratin binding structural domain is with it in conjunction with (Fontao L, Favre B, RiouS, Geerts D, Jaunin F, Saurat JH, Green KJ, Sonnenberg A, Borradori L., Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakinwith intermediate filaments is mediated by distinct sequences within theirCOOH terminus, Mol Biol Cell.2003 May; 14 (5): 1978-92, on January 26th, 2003, electronics was open; Hopkinson SB, Jones JC., The N terminus of thetransmembrane protein BP180 interacts with the N-terminal domain ofBP230, thereby mediating keratin eytoskeleton anchorage to the cellsurface at the site of the hemidesmosome, Mol Biol Cell.2000 January; 11 (1): 277-86).
Goal of the invention
One object of the present invention is to provide to keratin or contains the new polypeptide that keratin thing such as skin or hair have high-affinity.Such polypeptide is suitable for containing the cosmetic and the drug treating of keratin structure (particularly hair and skin).
Summary of the invention
The present invention relates to be used to handle the make-up composition that contains the keratin thing, comprise at least a keratin-binding polypeptides sequence (i) in the cosmetic compatible media.
Peptide sequence (i)
Peptide sequence (i) has binding affinity to keratin.Peptide sequence (i) can be analyzed under the condition described in embodiment 8,9 and 10 with keratic the combination.
Particularly Shi Yi keratin-binding polypeptides is the sequence that is present in people's desmoplakin, or by modifying people's desmoplakin peptide sequence for example aminoacid insertion, replacement or disappearance and by it deutero-sequence.
The peptide sequence of people's desmoplakin is shown in SEQ ID NO:1.Suitable keratin binding structural domain (domain B) is the 2193rd to 2481 and the function equivalent of peptide sequence SEQ ID NO:1.Other keratin binding structural domain (domain C) is the 2606th to 2871 of peptide sequence SEQ ID NO:1 and function equivalent thereof.
The keratin binding structural domain is shown in Fig. 1.
Preferred peptide sequence (i) comprises the aminoacid sequence shown in SEQ ID NO:1.
According to the present invention, equally also comprise described concrete openly " function equivalent " and the purposes in the methods of the invention thereof of peptide sequence (i).
Be purpose meter of the present invention, " function equivalent " of described concrete openly polypeptide (i) or analog be different with it and the biological activity that additionally has an expectation for example keratin in conjunction with active polypeptide.Thereby, for instance, " function equivalent " is meant such peptide sequence, it demonstrates following combination (activity) in one of embodiment 9 or 10 described binding assays, be embodiment 9 or 10 described in conjunction with shown in the polypeptide of domain B that has SEQ ID NO:1 in measuring or domain C in conjunction with (activity) at least 10%, preferably at least 50%, especially preferred 75%, extremely preferred 90%.
The example of suitable aminoacid replacement can see the following form:
Original residue replaces example
Ala Ser
Arg Lys
Asn Gln;His
Asp Glu
Cys Ser
Gln Asn
Glu Asp
Gly Pro
His Asn;Gln
Ile Leu;Val
Leu Ile;Val
Lys Arg;Gln;Glu
Met Leu;Ile
Phe Met;Leu;Tyr
Ser Thr
Thr Ser
Trp Tyr
Tyr Trp;Phe
Val Ile;Leu
For example, as everyone knows, the serine that the natural SEQ of being present in ID NO:1 is the 2849th can be replaced by glycine, to avoid this locational phosphorylation (Fontao L, Favre B, Riou S, Geerts D, Jaunin F, Saurat JH, Green KJ, Sonnenberg A, Borradori L., Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakinwith intermediate filaments is mediated by distinct sequences within theirCOOH terminus, Mol Biol Cell.2003 May; 14 (5): 1978-92, on January 26th, 2003, electronics was open).
According to the present invention, " function equivalent " also means to have the mutein that is different from the aminoacid of specifically mentioning but still has one of above-mentioned biological activity especially at least one sequence location of above-mentioned aminoacid sequence.Therefore, " function equivalent " comprises the mutein that can obtain by one or more aminoacid addition, replacement, disappearance and/or inversion, wherein said being modified with may be present on any sequence location, as long as can obtain having the mutein of character type of the present invention.
" function equivalent " of above-mentioned implication comprises that also " precursor " of described polypeptide, " functional deriv " of polypeptide reach " salt ".
Thus, " precursor " is for being with or without the bioactive natural or synthetic polypeptide precursor of expectation.
Term " salt " refers to the carboxylic salts and the amino acid addition salt of protein molecule of the present invention.Carboxylic salts can prepare according to himself known mode, and comprises inorganic salt for example sodium salt, calcium salt, ammonium salt, iron salt and zinc salt, and organic alkali salt, amine for example, and as triethanolamine, arginine, lysine, piperidines, or the like.The present invention relates to acid addition salt equally, inorganic acid salt for example, and example hydrochloric acid salt or sulfate, and acylate are as acetate and oxalates.
" functional deriv " of polypeptide of the present invention can prepare at the functional amino side-chain radical or on its N-terminal or C-terminal by known technology equally.For example, such derivant comprises carboxyl ester or thioesters, Carboxylamide (can by obtaining with ammonia or primary amine or secondary amine reaction); The N-acyl derivative of free amine group (by preparing) with acylation reaction; The N-alkyl derivative of free amine group (by with the alkylating agent prepared in reaction); The S-acyl derivative of free mercaptan (by preparing) with acylation reaction; The thioether of free mercaptan (by the alkylating agent prepared in reaction); Disulphide (by the reaction of free mercaptan) with for example mercaptan; The O-acyl derivative of free hydroxyl group (by preparing) with acylation reaction; Or ether (by the reaction of free hydroxyl group and alkylating agent).
" function equivalent " also comprises polypeptide and the naturally occurring variant that obtains from other organism naturally.For example, might relatively set up the homologous sequence area scope, and determine enzyme of equal value based on specific requirement of the present invention by sequence.
For example, " function equivalent " comprises the fragment of the polypeptide of the present invention with expectation biological function equally, preferred single structure territory or sequence motifs.
In addition, " function equivalent " can be fusion rotein, comprise one of aforementioned polypeptides sequence or by its deutero-function equivalent, and another different heterologous sequence on function with it at least, described heterologous sequence is functional N-terminal with it or C-terminal connects (that is, fusion rotein partly being had the mutual function damage of ignoring).For example, the limiting examples of such heterologous sequence has signal peptide or enzyme.
" function equivalent " included equally in the present invention is the described proteinic homologue that specifically discloses.According to Pearson and Lipman algorithm (Proc.Natl.Acad, Sci. (USA) 85 (8), 1988, calculating 2444-2448), these homologues and described concrete disclosed aminoacid sequence have at least 50%, preferably at least 75%, particularly at least 85%, 90%, 95% or 99% homology for example.The percent homology of homology polypeptide of the present invention is meant the homogeneity percentage ratio based on the amino acid residue of the total length of one of specifically described aminoacid sequence of this paper especially.
With regard to possible protein glycosylation, " function equivalent " of the present invention comprises the protein type of deglycosylation defined above or glycosylation form, and by changing the modified forms that the glycosylation pattern obtains.
With regard to possible protein phosphorylation effect, " function equivalent " of the present invention comprises the protein type of dephosphorylation defined above or phosphorylation form, and by changing the modified forms that the phosphorylation pattern obtains.
The homologue of polypeptide of the present invention (i) can produce by mutation, as point mutation or protein truncate.
The homologue of polypeptide of the present invention can be by for example combinatorial library evaluation of truncated mutant of screening mutant.For example, the protein variants library can be by the preparation of combinatorial mutagenesis on nucleic acid level, and for example enzymatic connects synthetic oligonucleotide mixture.There are a lot of methods to can be used for preparing potential homologue library from degenerate oligonucleotide sequence.In automatic dna synthesizer, can carry out the chemosynthesis of degeneracy gene order, then synthetic gene is connected in the suitable expression vector.Use one group of degeneracy gene, all sequences of the potential protein sequence of one group of expectation of codified might be provided in a kind of mixture.The method that is used for synthetic degenerate oligonucleotide be the technical staff known (as Narang, S.A. (1983) Tetrahedron 39:3; Itakura etc., (1984) Annu.Rev.Biochem.53:323; Itakura etc., (1984) Science 198:1056; Ike etc., (1983) Nucleic Acids Res.11:477).
Several Methods known in the art is used in by screening-gene product in the prepared combinatorial library of point mutation or truncate, and the gene outcome that has selected character at the cDNA library screening.These technology can be suitable for the gene library that the combinatorial mutagenesis of rapid screening by homologue of the present invention produces.Be used to screen the technology of normal use of a large amount of gene libraries of pending high throughput analysis, comprise gene library is cloned in the replication form expression vector, vector library with gained transforms suitable cell, and under such condition, express combination gene, expect under the described conditions that wherein active detection can promote the separation of carrier, and the gene of the described detection product of described vector encoded.Recurrence assemblage mutation (REM), a kind of technology that improves functional mutants frequency in the library can be united with screening test and is used to identify homologue (Arkin and Yourvan (1992) PNAS 89:7811-7815; Delgrave etc., (1993) Protein Engineering 6 (3): 327-331).
The particularly advantageous embodiment of the present invention is the peptide sequence (i) that comprises at least a following peptide sequence:
A) the 2193rd to 248 peptide sequence (domain B) among the SEQ ID NO:1;
B) the 2606th to 2871 peptide sequence (domain C) among the SEQ ID NO:1;
C) compare with (a), go up to the adorned peptide sequence of 60% aminoacid;
D) compare with (b), go up to the adorned peptide sequence of 50% aminoacid;
Condition be peptide sequence (c) or keratin (d) in conjunction with reach the peptide sequence (a) in the test of embodiment 9 or 10, surveyed or (b) institute's indicating value at least 10%.In this connection, domain B or C refer to the keratin binding structural domain of above-mentioned people's desmoplakin (SEQ ID NO:1).Thus, amino acid modified finger aminoacid replacement, insertion and disappearance or this three kinds of possible combination in any.
The preferred peptide sequence (i) that uses is that the organism of expecting is had the sequence of high specific affinity.Correspondingly, use for cosmetics for skin, the preferred peptide sequence (i) that adopts is the sequence that the application on human skin keratin is had special high-affinity.Use for hair cosmetic composition, preferred peptide sequence is the sequence that human hair keratin is had special high-affinity.
Correspondingly, for the application of house pet aspect, except that described peptide sequence (SEQ ID NO:1), preferred peptide sequence (i) is that corresponding keratin (for example Canis animals keratin or felid keratin) is had the sequence of special high-affinity.
Yet, in effector molecule of the present invention, also might use more than one peptide sequence (i), for example the application on human skin keratin is had the sequence (i) of high binding affinity, together with the sequence (i) that human hair keratin is had high-affinity.For example, same peptide sequence (i) that also might sequential connection multicopy is to realize higher combination.
Suitable keratin-binding polypeptides sequence (i) is known.For example, the desmoplakin and plectin (the Fontao L that comprise the keratin binding structural domain, Favre B, Riou S, Geerts D, Jaunin F, Saurat JH, Green KJ, Sonnenberg A, Borradori L., Interaction of thebullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediatefilaments is mediated by distinct sequences within their COOH terminus, Mol Biol Cell.2003 May; 14 (5): 1978-92.2003 electronics on January 26 is open; Hopkinson SB, Jones JC., The N terminus of the transmembrane proteinBP180 interacts with the N-terminal domain of BP230, thereby mediatingkeratin cytoskeleton anchorage to the cell surface at the site of thehemidesmosome, Mol Biol Cell.2000 January; 11 (1): 277-86).
For example, the Vector NTI 8 (2002 year JIUYUE 25 day version) of the program that uses a computer as being provided by InforMax Inc by comparing this class known protein matter sequence, might draw and identify such zone.
Other the suitable peptide sequence (i) that human keratin is had good combination is to show the sequence area of high homology or sequence homogeneity in comparison, and can be considered the consensus sequence of keratin binding structural domain.
Preferred especially following sequence area:
Domain B (KBD-B): among the peptide sequence SEQ ID NO:1 the 2193rd to 2448;
Domain B (KBD-B): among the peptide sequence SEQ ID NO:1 the 2209th to 2448;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2606th to 2871;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2616th to 2871;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2616th to 2811;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2606th to 2871.
For example, the 2849th serine can be replaced by glycine among the known natural SEQ of the being present in ID NO:1, to avoid this locational phosphorylation, thereby guarantee that domain C is bonded to corresponding keratin (Fontao L, Favre B, Riou S, Geerts D, Jaunin F, Saurat JH, Green KJ, Sonnenberg A, Borradori L., Interaction of the bullouspemphigoid antigen 1 (BP230) and desmoplakin with intermediatefilaments is mediated by distinct sequences within their COOH terminus, Mol Biol Cell.2003 May; 14 (5): 1978-92, on January 26th, 2003, electronics was open).
If expectation peptide sequence (i) has special good binding to the keratin that comes from non-human being's body, selected suitable sequence motifs is preferably from the sequence of keratin conjugated protein (as the desmoplakin or the plectin of suitable organism).
Fig. 2 has shown the comparison of keratin binding molecule.
If expectation also can easily separate from keratin according to keratin-binding polypeptides of the present invention (i) once more.For this purpose, what might adopt is: for example, washing keratin, by this with keratin-binding polypeptides (i) from its with keratic existing the combination cement out, and carry out saturated with the keratin in the cleaning mixture.Perhaps, also might be used to wash off keratin-binding polypeptides (i) with high-load detergent (as SDS) washing.
In people's cosmetics (particularly skin, fingernail and hair-care), animal care, leather nursing and leather processing, has application fields according to keratin-binding polypeptides of the present invention (i).
(i) is preferred for cosmetics for skin according to keratin-binding polypeptides of the present invention.They allow the high concentration and the long-acting time of skin nursing or skin care effector.
The suitable adjuvant and the additive that are used to produce hair cosmetic product, fingernail cosmetic product or skin cosmetic product are well known to those skilled in the art, and can be referring to the cosmetics handbook, Schrader for example, the ultimate principle and the preparation of Grundlagen und Rezepturen der Kosmetika[cosmetics], H ü thig Verlag, Heidelberg, 1989, ISBN 3-7785-1491-1.
According to make-up composition of the present invention can be cutization composition for cosmetics, fingernail make-up composition, hair make-up composition, dermatosis compositions, health compositions or pharmaceutical composition.
Preferably, the compositions according to the present invention form that is gel, foam, spray, unguentum, cream, Emulsion, suspensoid, lotion, emulsion or paste.If expectation also can be used liposome or microsphere.
Can additionally comprise cosmetic and/or dermatosis active component and adjuvant according to cosmetic of the present invention or pharmaceutically active compositions.
Preferably, cosmetic composition according to the present invention comprises at least a keratin-binding polypeptides sequence (i) and at least a different with it component as hereinbefore defined, and wherein said component is selected from the cosmetic active component, emulsifying agent, surfactant, antiseptic, aromatic oil, thickening agent, polymeric hair, hair and skin conditioner, graft polymers, the polymer that contains water solublity or dispersibility silicones, light protective agent, brightening agent, gelatinizing agent, nursing agent, coloring agent, stain, tanning agent, dyestuff, pigment, concentration regulator, humidizer, fatting agent (re-fatting agents), collagen, protolysate, lipid, antioxidant, antifoaming agent, antistatic additive, emollient and softening agent.The keratin-binding polypeptides active component also can be present in the cosmetic product with capsule formulation.
Antioxidant preferably is selected from aminoacid (as glycine, histidine, tyrosine, tryptophan) and derivant, imidazoles (as urocanic acid) and derivant thereof, peptide such as D, the L-carnosine, the D-carnosine, L-carnosine and their derivant (as anserine), carotenoid, carotene is (as beta-carotene, lycopene) and their derivant, chlorogenic acid and derivant thereof, thioctic acid and derivant thereof (as dihydrolipoic acid), aurothioglucose, propylthiouracil and other mercaptan are (as thioredoxin, glutathion, cysteine, cystine, cystamine and glycosyl ester thereof, the N-acetonyl ester, methyl ester, ethyl ester, propyl ester, pentyl ester, butyl ester and lauryl, the palmityl ester, grease, γ-Ya oleoyl ester, cholesteryl ester and glyceride) and their salt, dilauryl thiodipropionate, distearyl thiodipropionate, thio-2 acid and their derivant (ester, ether, peptide, lipid, nucleotide, nucleoside and salt), and sulfoxide amine (sulfoximine) chemical compound of extremely low tolerance dose (as pmol to μ mol/kg) is (as buthionine sulfoximine, homocysteine sulfoxide amine, fourth methyllanthionine sulfone, five thionine sulfoxide amine, six thionine sulfoxide amine, seven thionine sulfoxide amine), also has (metal) chelating agen (as alpha-hydroxy fatty acid, Palmic acid, phytic acid, lactotransferrin), alpha-hydroxy acid is (as citric acid, lactic acid, malic acid), humic acid, bile acid, bile extract, bilirubin, biliverdin, EDTA and their derivant, unsaturated fatty acid and derivant thereof are (as gamma-Linolenic acid, linoleic acid, oleic acid), folic acid and derivant thereof, ubiquinone and pantothenylol and their derivant, vitamin C and derivant thereof are (as sodium ascorbate, ascorbyl palmitate, magnesium ascorbyl phosphate, the ascorbic acid acetate), tocopherol and derivant thereof are (as Vitamin E acetate, tocotrienol), vitamin A and derivant thereof (vitamin A palmitate), and the coniferyl benzoate of benzoin resin, rutinic acid and their derivant, the a-glycosyl rutin, ferulic acid, the furfurylidene glucitol, carnosine, butylated hydroxytoluene, Butylated hydroxyanisole, nor-dihydroguaiaretic acid phenolic acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivant thereof, mannose and derivant thereof, zinc and derivant thereof are (as ZnO, ZnSO
4), selenium and derivant (as selenomethionine), stilbene and derivant thereof (as stilbene oxide, trans-stilbene oxide).
In such preparation, common thickening agent is crosslinked polyacrylic acid and derivant thereof, polysaccharide and derivant thereof, as xanthan gum, agar, alginate or methylcellulose, cellulose derivative is as carboxymethyl cellulose or hydroxyl carboxymethyl cellulose, aliphatic alcohol, monoglyceride and fatty acid, polyvinyl alcohol and polyvinylpyrrolidone.The preferred nonionic thickener that uses.
For example, suitable cosmetic and/or dermatosis active component are painted active component, the skin and hair pigment agent, stain, tanning agent, brightening agent, the keratin hardening material, the antimicrobial acivity composition, lightscreening agent (photofilter) active component, the repellant active component, material with congested effect, material with keratolysis and ceratoplasty effect, dandruff removing agent active component, antiinflammatory, material with keratinization effect, active component with effect of antioxidation or removing free radical, increase the material of moisture of skin or maintenance skin wet, the stuffing active component, anti-erythema or anti-allergy active component, branched chain fatty acid such as 18-methyl arachic acid, and their mixture.
For example, artificial tanning and be suitable for needn't be with ultraviolet rays nature or manually irradiation and the active component of tanning has dihydroxyacetone, alloxan and Endocarpium Juglandis extract.Suitable keratin hardening material normally also can be used as the active component of antiperspirant, for example aluminium potassium sulfate, polymeric aluminum chloride, aluctyl. or the like.
The antimicrobial acivity composition is used for the elimination of micro-organisms or suppresses its growth, also can be used as the deodorization material that reduces body odor formation or intensity thereby both can be used as antiseptic.For example, they comprise and well known to a person skilled in the art conventional preservatives, for example para hydroxybenzene methyl ester, imidazolinyl carbamide, formaldehyde, sorbic acid, benzoic acid, salicylic acid or the like.For example, such deodorization material has zinc ricinoleate, triclosan (triclosan), endecatylene alkylolamides (undecylenic alkylolamides), triethyl citrate, chlorhexidine or the like
Following table is listed suitable antiseptic and the E coding thereof that preferably uses according to the present invention.
E?200 | Sorbic acid | E?227 | Calcium bisulfite |
E?201 | Sodium sorbate | E?228 | Potassium acid sulfite |
E?202 | Potassium sorbate | E?230 | Biphenyl (diphenyl) |
E?203 | Calcium sorbate | E?231 | O-phenyl phenol |
E?210 | Benzoic acid | E?232 | O-Phenylphenol Sodium salt tetrahydrate |
E?211 | Sodium benzoate | E?233 | Thiabendazole |
E?212 | Potassium Benzoate | E?235 | Natamycin |
E?213 | Calcium benzoate | E?236 | Formic acid |
E?214 | Ethylparaben | E?237 | Sodium formate |
E?215 | Nipagin A sodium | E?238 | Calcium formate |
E?216 | The p-hydroxybenzoic acid n-propyl | E?239 | Hexamethylenetetramine |
E?217 | P-hydroxybenzoic acid n-propyl sodium | E?249 | Potassium nitrite |
E?218 | Methyl parahydroxybenzoate | E?250 | Sodium nitrite |
E?219 | Sodium Methyl Hydroxybenzoate | E?251 | Chile saltpeter |
E?220 | Sulfur dioxide | E?252 | Potassium nitrate |
E?221 | Sodium sulfite | E?280 | Propanoic acid |
E?222 | Sodium sulfite | E?281 | Sodium propionate |
E?223 | Sodium disulfide | E?282 | Calcium propionate |
E?224 | Curing potassium | E?283 | Potassium propionate |
E?226 | Calcium sulfite | E?290 | Carbon dioxide |
According to the present invention same be suitable for antiseptic or the antiseptic adjuvant that is generally used for cosmetics arranged, for example dibromo dicyanobutane (2-bromo-2-bromomethyl glutaronitrile), 3-iodo-2-propynyl butyl carbamate, 2-bromo-2-nitropropane-1,3 glycol, imidazolinyl carbamide, 5-chloro-2-methyl-4-isothiazoline-3-ketone, 2-chloroacetamide, Benzalkonii Chloridum and benzyl alcohol+formaldehyde donor.
Be suitable for equally as antiseptic the phenyl hydroxyalkyl ether arranged, particularly because many microorganisms are killed antibacterial and fungicidal effect and the well-known chemical compound that is referred to as phenoxyethanol.
Other antimicrobial is suitable for being incorporated in the article according to the invention equally.For example, useful material has 2,4,4 '-three chloro-2 '-xenol ether (triclosan), 1,6-two (4-chlorobenzene biguanide) hexane (chlorhexidine), 3,4,4 '-Amolden MCM 400, quaternary ammonium compound, Oleum Caryophylli, Oleum menthae, thyme oil, triethyl citrate, farnesol (3,7,11-trimethyl-2,6,10-12 carbon triolefin-1-alcohol), and active component of describing in following patent disclosure description or active component combination: DE-37 40186, DE-39 38 140, DE-42 04 321, DE-42 29 707, DE-43 09 372, DE-4411 664, DE-195 41 967, DE-195 43 695, DE-195 43 696, DE-195 47 160, DE-196 02 108, DE-196 02 110, DE-196 02 111, DE-196 31 003, DE-196 31004 and DE-196 34 019, and patent specification DE-42 29 737, DE-42 37 081, DE-4324 219, DE-44 29 467, DE-44 23 410 and DE-195 16 705.Also be preferably to use sodium bicarbonate.Similarly also can use antimicrobial polypeptide.
Suitable lightscreening agent active component is the material that absorbs the ultraviolet rays in UV-B and/or the ultraviolet light,long wave district.For example, suitable ultraviolet filter agent is 2,4,6-triaryl-1,3, the 5-triazine, at least one substituent group of aryl portability in either case wherein, preferred substituents is selected from hydroxyl, alkoxyl, methoxyl group particularly, alkoxy carbonyl group, particularly methoxycarbonyl group and ethoxycarbonyl and their mixture.Same suitable have p-aminobenzoate, cinnamate, benzophenone, camphor derivatives and the pigment that can stop ultraviolet rays, for example titanium dioxide, Talcum and zinc oxide.
Suitable ultraviolet filter material is any ultraviolet light,long wave and UV-B ray filtering material.That can mention has a following example:
Numbering | Material | CAS numbers (=acid) |
1 | The 4-amino benzoic Acid | 150-13-0 |
2 | 3-(4 '-trimethylamine) benzal thatch alkane-2-ketone methylsulfuric acid ester | 52793-97-2 |
3 | 3,3,5-trimethylcyclohexyl salicylate (homosaligenin) | 118-56-9 |
4 | 2-hydroxyl-4-methoxyl group-benzophenone (oxybenzone) | 131-57-7 |
5 | 2-Phenylbenzimidazole-5-sulfonic acid and potassium salt, sodium salt and triethanolamine salt | 27503-81-7 |
6 | 3,3 '-(1, the 4-phenylenedimethylidyne) two (7,7-dimethyl-2-oxo dicyclo [2.2.1] heptane-1-methane-sulfonic acid) and salt thereof | 90457-82-2 |
7 | Poly-ethoxyethyl-4-two (poly-ethoxy) Aminobenzoate | 113010-52-9 |
8 | 2-ethylhexyl 4-dimethylaminobenzoic acid ester | 21245-02-3 |
9 | The 2-Ethylhexyl salicylate | 118-60-5 |
10 | 2-isopentyl 4-Methoxycinnamate | 71617-10-2 |
11 | 2-ethylhexyl 4-Methoxycinnamate | 5466-77-3 |
12 | 2-hydroxyl-4-methoxyl group benzophenone-5-sulfonic acid (sulisobenzone) and sodium salt thereof | 4065-45-6 |
13 | 3-(4 '-sulfo-benzal) thatch alkane-2-ketone and salt thereof | 58030-58-6 |
14 | 3-benzal thatch alkane-2-ketone | 16087-24-8 |
15 | 1-(4 '-isopropyl phenyl)-3-phenyl-propane-1, the 3-diketone | 63260-25-9 |
16 | 4-isopropyl phenyl salicylate | 94134-93-7 |
17 | 3-imidazol-4 yl acrylic acid and ethyl ester thereof | 104-98-3 |
18 | 2-cyano-3,3-diphenyl ethyl acrylate | 5232-99-5 |
19 | 2 '-ethylhexyl 2-cyano group-3,3-diphenylacrylate ester | 6197-30-4 |
20 | Methyl 2-aminobenzoate or 5-methyl-2-(1-Methylethyl)-2-Aminobenzoate | 134-09-8 |
21 | Para-amino benzoic acid glyceride or 1-glyceryl 4-Aminobenzoate | 136-44-7 |
22 | 2,2 '-dihydroxy-4-methoxyl group benzophenone (dihydroxyphenyl ketone) | 131-53-3 |
23 | 2-hydroxyl-4-methoxyl group-4-methyldiphenyl ketone (mexenone) | 1641-17-4 |
24 | The triethanolamine Salicylate | 2174-16-5 |
25 | Dimethoxyphenyl glyoxalic acid or 3,4-Dimethoxyphenyl glyoxalic acid sodium | 4732-70-1 |
26 | 3-(4 '-sulfo-) benzal thatch alkane-2-ketone and salt thereof | 56039-58-8 |
27 | The 4-tert-butyl group-4 '-methoxy dibenzoyl methane | 70356-09-1 |
28 | 2,2 ', 4,4 '-tetrahydroxybenzophenone | 131-55-5 |
29 | 2,2 '-di-2-ethylhexylphosphine oxide [6-(2H-benzotriazole-2-yl)-4-(1,1,3, the 3-tetramethyl butyl) phenol] | 103597-45-1 |
30 | 2,2 '-(1, the 4-phenylene) is two-1H-benzimidazole-4,6-disulfonic acid, sodium salt | 180898-37-7 |
31 | 2, two [4-(2-ethyl hexyl oxy)-2-hydroxyl] phenyl-6-(4-methoxyl group-phenyl) of 4--(1,3,5) triazine | 187393-00-6 |
32 | 3-(4 '-methyl benzal) Camphora | 36861-47-9 |
33 | Poly-ethoxyethyl-4-two (poly-ethoxy) p-aminobenzoate | 113010-52-9 |
34 | 2,4 dihydroxy benzophenone | 131-56-6 |
35 | 2,2 '-dihydroxy-4,4 '-dimethoxy-benzophenone-5,5 '-sodium disulfonate | 3121-60-6 |
36 | 2-[4-(diethylamino)-2-hydroxy benzoyl]-benzoic acid hexyl ester | 302776-68-7 |
37 | 2-(2H-2-benzotriazole-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethyl silyl) the oxygen base]-the disiloxane base] propyl group]-phenol | 155633-54-8 |
38 | 1,1-[(2,2 '-diformazan propoxyl group) carbonyl]-4,4-hexichol-1,3-butadiene | 363602-15-7 |
Can preferably additionally contain according to cosmetic of the present invention and dermatosis goods and to stop ultravioletly, and can be selected from zinc oxide (ZnO), titanium oxide (TiO based on the insoluble or water-soluble slightly metal-oxide and/or the inorganic pigment of other metallic compound
2), iron oxides is (as Fe
2O
3), Zirconium oxide (ZrO
2), Si oxide (SiO
2), Mn oxide (as MnO), aluminum oxide (Al
2O
3), cerium oxide is (as Ce
2O
3), the mixed oxide of respective metal and the mixture of this type oxide.
The inorganic pigment of this paper can be a coating form, promptly through surface treatment.For example, this surface treatment can comprise with itself known method form hydrophobic thin film on pigment, as described in DE-A-33 14 742
Suitable repellant active component is or to drive the particularly chemical compound of insecticide of some animal away from the human body expeling.For example, these comprise 2-ethyl-1, the 3-hexanediol, and N, toluamide between the N-diethyl, or the like.Stimulate blood for example essential oil to be arranged by the mobile suitable congested material of skin, for example Pinus mugo extract, Garden lavender extract, Herba Rosmarini Officinalis extract, Juniperus rigida Sieb.et Zucc. extract, Aesculus chinensis Bunge extract, birch leaf extract, Radix Glycyrrhizae flower extract, ethyl acetate, Camphora, menthol, Oleum menthae, Herba Rosmarini Officinalis extract, Eucalyptus oil, or the like.For example, the suitable keratolysis and the material of ceratoplasty have salicylic acid, mercaptan calcium acetate, mercaptan acetic acid and salt thereof, sulfur, or the like.For example, suitable dandruff removing agent active component has sulfur, sulfuration Polyethylene Glycol sorbitan mono-oleic acid ester, sulfuration Semen Ricini alcohol polyethoxylate, pyrithione zinc, pyrithione aluminum, or the like.For example, reducing skin irritant suitable antiinflammatory has allantoin, Bisabolol terpene alcohol, bisabolol, Flos Chrysanthemi extract, pantothenylol, or the like.
Can contain as making up and/or (and if also suitable also as adjuvant) at least a cosmetic or pharmaceutically acceptable polymer of active constituents of medicine according to make-up composition of the present invention, wherein said polymer is different from the polymer that can generate the used polyelectrolyte complex compound of the present invention.Normally, these comprise cation, both sexes and neutral polymer.
For example, suitable polymers has the polyquaternary ammonium salt cationic polymer of INCI name, as copolymer (Luviquat FC, Luviquat HM, LuviquatMS, the Luviquat﹠amp of vinylpyrrolidone/N-vinyl imidazole salt; Commat, Care), with dithyl sulfate quaternised N-vinylpyrrolidone/dimethylaminoethyl methacrylate copolymer (Luviquat PQ 11), N-ethylene caprolactam/N-vinylpyrrolidone/N-vinyl imidazole salt copolymer (Luviquat E Hold), cationic cellulose derivative (polyquaternary ammonium salt-4 and polyquaternary ammonium salt-10), acrylamide copolymer (polyquaternary ammonium salt-7) and chitosan.
Suitable cationic polymers (quaternised) also has Merquat (based on the muriatic polymer of dimethyldiallylammonium), Gafquat (reacting the quadripolymer that produces by polyvinylpyrrolidone and quaternary ammonium compound), polymer JR (hydroxyethyl-cellulose with cation group), and based on the cationic polymer of plant, as guar polymer, for example from the guar polymer of the Jaguar grade series of Rhodia (Luo Diya).
Other suitable polymers also has neutral polymer, polyvinylpyrrolidone for example, the copolymer of N-vinyl pyrrolidone and vinyl acetate and/or propionate, polysiloxanes, polyethylene caprolactam and other have N-vinylpyrrolidone copolymers, polymine and salt thereof, polyvinylamine and salt thereof, cellulose derivative, polyaspartic acid salts and derivant.For example, these comprise Luviflex 0 Swing (the saponified copolymer of polyvinyl acetate and polyalkylene glycol moiety, BASF).
Suitable polymers also has non-ionic water-soluble or water-dispersible polymer or oligomer, polyethylene caprolactam (as Luviskol 0 Plus (BASF)) for example, or polyvinylpyrrolidone and copolymer thereof, the copolymer that particularly has vinyl acetate, vinyl acetate (Luviskol 0 VA 37 (BASF)) for example, and for example based on the polyamide of methylene succinic acid and aliphatic diamine, for example, as described in the DE-A-4333238.
Suitable polymers also has both sexes or amphoteric ion polymer, octyl acrylamide/methyl methacrylate/tert-butyl group aminoethyl methacrylate/Hydroxypropyl methacrylate the copolymer that for example can trade name Amphomer (National Starch) obtains, and in German patent application DE39 29 973, DE21 50 557, DE28 17 369 and DE37 08 451 disclosed amphoteric ion polymer.Acrylamido oxypropyl trimethyl ammonium chloride/acrylic or methacrylic acid copolymer and alkali metal salt thereof and ammonium salt are preferred amphoteric ion polymers.Other suitable amphoteric ion polymer have can the commercial acquisition of trade name Amersette (AMERCHOL) the methylpropenyl ethyl in ammonium ester (methacroylethylbetaine)/methacrylate copolymer, and hydroxyethyl meth acrylate, methyl methacrylate, methacrylic acid N, N-dimethylaminoethyl and acrylic acid copolymer (Jordapon (D)).
Suitable polymers also has nonionic to contain the water solublity or the water-dispersible polymers of siloxanes, as polyether silicone, and for example Tegopren 0 (Goldschmidt) or Besi﹠amp; Commat (Wacker).
Preparation matrix optimization according to pharmaceutical composition of the present invention comprises pharmaceutically acceptable adjuvant.Pharmaceutically acceptable adjuvant is because of use well-known adjuvant in pharmaceutical field, Food technology and association area, those listed adjuvant in relevant pharmacopeia (as DAB Ph.Eur.BP NF) particularly, with and the character adjuvant that do not hinder the physiology to use.
Suitable adjuvant can be: lubricant, wetting agent, emulsifying agent and suspending agent, antiseptic, antioxidant, counter-stimulus, chelating agen, emulsion stabilizer, film former, gelatinizing agent, odor masking agent, resin, hydrocolloid, solvent, solubilizing agent, nertralizer, penetration enhancer, pigment agent, quaternary ammonium compound, fatting agent and superfatting agent, unguentum, cream or oily matter, silicone derivative, stabilizing agent, antibacterial, propellant, desiccant, opacifier, thickening agent, wax, softening agent, white oil.In this respect, prescription is benchmark with the expertise, for example, as Fiedler, H.P (Lexikon der Hilfsstoffe f ü rPharmazie, the adjuvant dictionary of Kosmetik und angrenzende Gebiete[pharmacy, cosmetic and association area], the 4th edition, Aulendorf:ECV-Editio-Kantor-Verlag, 1996) knowledge that is provided in.
In order to prepare according to dermatosis compositions of the present invention, available suitable adjuvant (excipient) mixes or the dilution active component.Excipient can be solid, semisolid or the liquid charging stock of the carrier, carrier or the medium that can be used as active component.If expectation can add other adjuvant in the manner known to persons skilled in the art.In addition, polymer and dispersion are suitable for as adjuvant in pharmacy, preferably as or be used for the coating or the binding agent of solid pharmaceutical dosage formulation.They can also be used for cream and as tablet coating and tablet binder.
According to embodiment preferred, compositions of the present invention is a skin cleansing compositions.
Preferred skin cleansing compositions is the liquid soap of gluey concentration, for example transparent soap, high-grade fancy soap, deodorant soap, cream soap, baby's soap, skin-protection soap, abrasive soap and synthetic detergent, pasty state soap (pastysoaps), soft soap and cleaning paste, exfoliation soap (exfoliation soaps), preserve moisture and wipe paper, liquid scrubbing thing, shower and bathing goods, for example washing liquid, shower lotion, shower glue, bath foam, oil bath and scrub goods, shaving foam glue, washing liquid and cream.
According to another preferred embodiment, compositions of the present invention is make-up composition, the manicure compositions of nursing and protection skin and hair or the goods that are used for ornamental cosmetic.
For example, the suitable skin make-up composition is facial cosmetic water (tonic), facial film, deodorizer and other astringent.For example, the compositions that is used for decorative cosmetic product having comprises: concealer (concealingstick), stage cosmetics (stage makeup), mascara and eye shadow cream, lipstick, cosmetic pencil, eyeliner, kermes, face powder and eyebrow pencil.
In addition, peptide sequence (i) can be used for the subsides of pore cleaning nose, anti-acne composition, repellant, Shave composition, behind the care composition before and after shaving, Exposure to Sunlight among care composition, Depilatory composition, hair dye, privates care composition, foodcare compositions, the Baby Care compositions.
Particularly, skin care compositions according to the present invention be water-in-oil type or oil-in-water type protective skin cream, day cream and night frost, eye cream, facial cream, crease-proof cream, sunscreen cream, moisturiser, fair complexion cream, self-service U.S. black frost, vitamin cream, skin care liquid, conditioning liquid and moisture retention liquid.
Skin cosmetic and dermatosis compositions display based on above-mentioned polyelectrolyte complex compound go out superior effect.Wherein, polymer helps preserving moisture and conditioning skin, and improves the skin feel.Polymer also can be used as the thickening agent of preparation.By adding, in some preparation, can realize the improvement that the skin adaptability is considerable according to polymer of the present invention.
Skin is made up and the dermatosis compositions preferably comprises at least a about by weight 0.001% to 30%, preferred about by weight 0.01% to 20%, the extremely preferred peptide sequence (i) of about by weight 0.1% to 12% weight based on composition total weight.
Especially, compare, have the performance of the holdup time of improving the uv absorption composition based on the photoprotection compositions of peptide sequence (i) with the adjuvant such as the polyvinylpyrrolidone of routine.
According to the use field, compositions according to the present invention is used with the form that is suitable for skin protection, for example, and as cream, foam, gel, stick (stick), mousse, emulsion, fog-like body (atomizing pump or contain the spray of propellant) or lotion.
Except that peptide sequence (i) and suitable carriers, the skin cosmetic product also can comprise other active component and the conventional adjuvant in the aforesaid cosmetics for skin.They preferably include emulsifying agent, antiseptic, aromatic oil, cosmetic active component (for example phytantriol, vitamin A, vitamin E and vitamin C, retinol, Bisabolol terpene alcohol, pantothenylol), light protective agent, brightening agent, coloring agent, stain, tanning agent, collagen, protein hydrolysate, stabilizing agent, pH regulator agent, dyestuff, salt, thickening agent, gelatinizing agent, concentration regulator, silicone, humidizer, fatting agent and other conventional additive.
Skin is made up and the preferred lubricant component of dermatosis compositions is above-mentioned mineral oil and artificial oil, for example paraffin, silicone oil and more than the aliphatic hydrocarbon of 8 carbon atoms; Vegetable and animals oils, for example Oleum helianthi, coconut oil, American Avocado Tree oil, olive oil, lanoline or wax; Fatty acid or fatty acid ester, the triglyceride of C6-C30 fatty acid for example, wax ester, for example Simmondsia chinensis oil, aliphatic alcohol, vaseline, hydrogenated lanolin and acetylated lanolin, and their mixture.
If the establishment special performances also can be mixed with conventional polymer according to peptide sequence of the present invention (i).
In order to create some performance, for example improve the water-resistance and/or the combination of sense of touch, spreading property and active component and adjuvant (for example pigment), described skin cosmetic and skin goods can also comprise the conditioning material based on silicone compounds in addition.
For example, suitable silicone compounds has poly-alkylsiloxane, poly-aryl siloxanes, poly-aryl alkyl siloxanes, polyether siloxane or silicone resin.
Cosmetic or dermatosis goods can prepare according to conventional method well known by persons skilled in the art.
Preferably, cosmetic and dermatosis compositions are Emulsion form, particularly water-in-oil type (W/O) or oil-in-water type (O/W) Emulsion.
But, can also select other dosage form, example gel agent, oil preparation, oleogel, multiple Emulsion be W/O/W or the form of O/W/O type Emulsion, anhydrous unguentum or paste substrate for example, or the like.The dosage form of emulsifier-free also is superior embodiment, for example water dispersant (hydrodispersion), hydrogel or Pickering Emulsion.
Emulsion prepares by known method.Except that at least a peptide sequence (i), Emulsion comprises conventional component usually, particularly fatty acid triglyceride, fatty acid, lanoline and derivant thereof, natural or synthetic oil or wax of aliphatic alcohol, fatty acid ester for example, and be present in emulsifying agent among the water.For example, Schrader, the ultimate principle and the preparation of Grundlagen und Rezepturen der Kosmetika[cosmetics], H ü thig Buch Verlag, Heidelberg, second edition, 1989, third part clearly is incorporated herein by reference hereby) additive that is specific to the Emulsion kind and the preparation of suitable Emulsion described.
Usually comprise by suitable emulsifier system as the suitable Emulsion of water-in-oil emulsion (as protective skin cream etc.) and to carry out emulsive water in mutually at oil phase or fat.For water is provided, can use polyelectrolyte complex compound.
Being present in the Emulsion fat fat constituent among mutually preferably has: Hydrocarbon oil preparation, for example the microwax solution in paraffin oil, purcellin oil, perhydro-squalene and these oil; Animal or plant oil, for example Semen pruni armeniacae oil, American Avocado Tree oil, Caulis et folium euphorbiae milii (calophylum) oil, lanoline and derivant thereof, Oleum Ricini, Oleum sesami, olive oil, Simmondsia chinensis oil, cream wood fruit (karit é) oil, breast sour jujube Channa argus (hoplostethus) oil; Normal pressure down about 250 ℃ and distillation end point of distillation starting point is 410 ℃ a mineral oil, for example vaseline oil; Saturated or unsaturated fatty acid ester, alkyl myristinate for example, as isopropyl myristate, butyl myristate or myristic acid spermaceti alcohol ester, hexadecyl stearate, ethyl palmitate or isopropyl palmitate, Trivent OCG or tricaprin and cetyl ricinoleate.
Be dissolved in other oily silicone oil fatty also can comprising mutually, for example dimethicone, toluene polysiloxanes and silicone glycol copolymer, fatty acid and aliphatic alcohol.
Except that peptide sequence (i), also might use wax, for example Brazil wax, candelilla wax, Cera Flava, microwax, ceresine, and the oleate of Ca, Mg and Al, myristate, linoleate and stearate.
In addition, can be the oil-in-water emulsion form according to Emulsion of the present invention.Such Emulsion comprises oil phase usually, makes oil phase at aqueous phase stable emulsifying agent and water, and it exists with dense thick form usually.Suitable emulsifying agent is oil-in-water emulsifiers preferably, for example the glyceride of polyglycerin ester, sorbitan ester or partial esterification.
According to another preferred embodiment, compositions of the present invention is shower lotion, hair washing preparation or bath goods.
Such preparation comprises at least a peptide sequence (i) and as the conventional anion surfactant of surface of base activating agent and as the both sexes and/or the nonionic surfactant of cosurfactant.Active component that other is suitable and/or adjuvant are selected from lipid, aromatic oil, dyestuff, organic acid, antiseptic and antioxidant and thickening agent/gelatinizing agent, skin conditioning agent and humidizer usually.
These preparations preferably comprise about by weight 2% to 50%, preferred about by weight 5% to 40%, preferred especially about by weight 8% to 30% the surfactant based on total formulation weight.
In washing, shower and bathing goods, might use all aniones, neutrality, both sexes or cationic surfactant among the compositions that is generally used for cleaning health.
For example; suitable anion surfactant has alkyl sulfate, alkyl ether sulfate, alkylsulfonate, alkylaryl sulfonates, alkyl succinate, alkyl sulfo succinate, N-alkoxyl sarcosinate, acyl taurine salt, acyl-hydroxyethyl sulfonate, alkylphosphonic, alkyl ether phosphate, alkyl ether carboxy acid salt, alpha-alkene sulfonate; particularly alkali metal salt and alkali salt are as sodium salt, potassium salt, magnesium salt, calcium salt, ammonium salt and triethanolamine salt.Alkyl ether sulfate, alkyl ether phosphate and alkyl ether carboxy acid salt can have 1 to 10 oxirane or expoxy propane unit in molecule, preferred 1 to 3 ethylene oxide unit(s).
For example, these comprise sodium lauryl sulphate, tauryl ammonium sulfate, dodecyl ether sodium sulfate, ammonium dodecyl ether sulfate, sarcosyl, oily octenyl succinate sodium, dodecyl 2-Sulfosuccinic acid ammonium, dodecylbenzene sodium sulfonate, triethanolamine dodecylbenzene sodium sulfonate.
For example, suitable amphoteric surfactant has alkyl betaine, alkyl amino CAB, alkyl sulfobetaines, p dialkylaminobenzoic acid salt, alkyl carboxyl Glycinates, alkyl both sexes acetate or both sexes propionate, alkyl both sexes diacetin or both sexes dipropionate.
For example, can use coco dimethyl sulfopropyl betaine (cocodimethylsulfopropylbetaine), empgen BB, cocamidopropyl betaine (cocamidopropylbetaine) or cocos nucifera oil both sexes sodium propionate (sodiumcocamphopropionate).
For example, suitable nonionic surfactant is the product that has aliphatic alcohol or alkyl phenol and the oxirane and/or the expoxy propane of 6 to 20 carbon atoms in the straight or branched hydrocarbon chain.The amount of epoxyalkane is about 6 to 60 moles of every mol of alcohol.In addition, fatty acid ester, ethoxylated fatty acid amide, alkyl poly glucoside or the sorbitan ether-ether of alkyl amine oxide, an alkyl alkanolamine or dialkyl group alkanolamine, Polyethylene Glycol are fit to.
In addition, washing, shower and bathing goods can comprise conventional cationic surfactant, and quaternary ammonium compound for example is as hexadecyltrimethylammonium chloride.
In addition, shower lotion/hair washing preparation can comprise thickening agent, for example sodium chloride, PEG-55, propylene glycol oleate, PEG-120, methyl glucoside dioleate etc., and antiseptic, other active component and adjuvant and water.
According to another preferred embodiment, compositions of the present invention is a Hiar treatment compositions.
The peptide sequence (i) that preferably comprises at least a about by weight 0.01% to 30% based on composition total weight, preferred about by weight amount of 0.5% to 20% according to Hiar treatment compositions of the present invention.
Preferably, Hiar treatment compositions according to the present invention is following form: typing foamed glue, hair mousse, hair jelly, shampoo, hair spray, hair foamed glue, hydrojet agent (spitzenfluid) are used for nertralizer, hair dye and brightening agent or the hot oil processing agent of lasting hair-waving.According to the use field, the hair cosmetic product can be used as (aerosol) spray, (aerosol) foamed glue, hair jelly, hair jelly spray, hair ointment, hair conditioner or pomade and uses.The hair spray of this paper comprises the pump formula spray of aerosol spray agent and no propelling gas.The hair foamed glue comprises the pump formula foamed glue of aerosol foam glue and no propelling gas.Hair spray and hair foamed glue preferably comprise water solublity or water-dispersible composition highlightedly or exclusively.If it is water-dispersible being used for the chemical compound of the present invention of agent and hair foamed glue, they are that the form of a water differential prose style free from parallelism of 1 to 350nm, preferred 1 to 250nm is used with particle diameter usually.The solid content of these goods is usually in about scope of 0.5% to 20% by weight herein.Usually these differential prose style free from parallelisms do not need emulsifying agent or surfactant to its stabilisation in addition.
In preferred embodiments, hair make-up preparation according to the present invention comprises: a) be 0.01% to 30% at least a peptide sequence (i) by weight; B) be 20% to 99.95% water and/or alcohol by weight; C) be 0 to 50% at least a gaseous propellant by weight; D) be 0 to 5% at least a emulsifying agent by weight; E) be 0 to 3% at least a thickening agent by weight; Go up by weight other component to 25%.
Alcohol refers to the alcohol of all routines in the cosmetics, as ethanol, isopropyl alcohol, normal propyl alcohol.
Other component refers to additive conventional in the cosmetics, and for example propellant, defoamer, interfacial activity chemical compound are surfactant, emulsifying agent, foam agent and solubilizing agent.The interfacial activity chemical compound that uses can be anion, cation, both sexes or neutral compound.For example, other conventional component also can be an antiseptic, aromatic oil, opacifier, active component, ultraviolet filter agent, care substance, for example pantothenylol, collagen, vitamin, protein hydrolysate, α and β hydroxy carboxylic acid, stabilizing agent, the pH regulator agent, dyestuff, viscosity modifier, gelatinizing agent, salt, humidizer, fatting agent, chelating agent and other conventional additive.
If create very special performances, these also comprise all known hair styles and the conditioner polymer in cosmetic field that can unite use with peptide sequence of the present invention (i).
For example, suitable conventional hair cosmetic polymer is above-mentioned cationic polymer, anionic polymer, neutral polymer, non-ionic polymers and amphiphilic polymers, at this it is incorporated herein by reference.
In order to create some performance, goods also can comprise the conditioning material based on silicone compounds in addition.For example, suitable silicone compounds has poly-alkylsiloxane, poly-aryl siloxanes, poly-aryl alkyl siloxanes, polyether silicone, silicone resin or dimethicone copolyol (CTFA) and amido functional group silicone compounds, for example amino polydimethylsiloxane (CTFA).
Polymer according to the present invention is particularly suitable as setting agent, particularly hair spray (the pump formula spray of aerosol spray agent and no propelling gas) and the hair foamed glue (the pump formula foamed glue of aerosol foam glue and no propelling gas) in the hair style goods.
In preferred embodiments, the spray goods comprise: a) be 0.01% to 30% at least a peptide sequence (i) by weight; B) be 20% to 99.9% water and/or alcohol by weight; C) be 0 to 70% at least a propellant by weight; D) be other composition of 0 to 20% by weight.
Propellant is the propellant that is generally used for hair spray or aerosol foam glue.Preferably propane/butane mix, pentane, dimethyl ether, 1, the 1-Difluoroethane (HFC-152 a), carbon dioxide, nitrogen or compressed air.
The preparation that is used for aerosol hair foamed glue of the present invention preferably includes: a) be 0.01% to 30% at least a peptide sequence (i) by weight; B) be 55% to 99.8% water and/or alcohol by weight; C) be 5% to 20% propellant by weight; D) be 0.1% to 5% emulsifying agent by weight; E) be other component of 0 to 10% by weight.
Employed emulsifying agent is all emulsifying agents that are generally used for the hair foamed glue.Suitable emulsifying agent is nonionic, cation or anion or amphoteric emulsifier.
The example of nonionic emulsifier (INCI name) has lauryl alcohol (laureth), as lauryl alcohol-4; Spermaceti alcohol ether (ceteth) is as spermaceti alcohol ether-1; The Polyethylene Glycol cetyl ether, ceteareth (ceteareth) is as ceteareth-25; Polyethylene glycol fatty acid glyceride, hydroxylated lecithin, fatty acid lactoyl ester, alkyl poly glucoside.
The example of cationic emulsifier has cetyl dimethyl-2-ethoxy Ammonium biphosphate, cetyl trimethyl ammonium chloride, cetyl trimethylammonium bromide, cocos nucifera oil trimethyl sulfate methyl ammonium, quaternary ammonium salt-1 to x (INCI).
For example; anion emulsifier can be selected from alkyl sulfate, alkyl ether sulfate, alkylsulfonate, alkylaryl sulfonates, alkyl succinate, alkyl sulfo succinate, N-alkoxyl sarcosinate, acyl taurine salt, acyl-hydroxyethyl sulfonate, alkylphosphonic, alkyl ether phosphate, alkyl ether carboxy acid salt, alpha-alkene sulfonate; particularly alkali metal salt and alkali salt are as sodium salt, potassium salt, magnesium salt, calcium salt, ammonium salt and triethanolamine salt.Alkyl ether sulfate, alkyl ether phosphate and alkyl ether carboxy acid salt can have 1 to 10 oxirane or expoxy propane unit in molecule, preferred 1 to 3 ethylene oxide unit(s).
For example, the suitable goods of the present invention that are applicable to hair style glue can have following compositions: a) be 0.01% to 30% at least a peptide sequence (i) by weight; B) be 80% to 99.85% water and/or alcohol by weight; C) be 0 to 3% by weight, preferably be 0.05% to 2% gelatinizing agent by weight; D) be other component of 0 to 20% by weight.
Usually, peptide sequence used according to the invention (i) has " thickening automatically " effect, means when the preparation gel, can exempt the use of gelatinizing agent as a rule.Yet for special flow degeneration or other application performance of creating gel, the use of gelatinizing agent may be best.Available gelatinizing agent has all conventional gelatinizing agents in the cosmetics.These comprise lightly crosslinked polyacrylic acid, carbomer (INCI) for example, cellulose derivative, as hydroxypropyl cellulose, hydroxyethyl-cellulose, cation modified cellulose, polysaccharide such as xanthan gum, caprylic/capric triglyceride, sodium acrylate copolymer, polyquaternium-32 (with) paraffin oil (INCI), sodium acrylate copolymer (with) paraffin oil (with) PPG-1 polyoxyethylene tridecyl-6 (PPG-1 trideceth-6), acrylamido oxypropyl trimethyl ammonium chloride/acrylamide copolymer, stearic alcohol ether-10 (steareth), allyl ether, acrylic copolymer, polyquaternary ammonium salt-37 (with) paraffin oil (with) PPG-1 polyoxyethylene tridecyl ether-6, polyquaternary ammonium salt 37 (with) propylene glycol dicaprate/dicaprylate (with) PPG-1 polyoxyethylene tridecyl ether-6, polyquaternary ammonium salt-7, polyquaternary ammonium salt-44.
Can be used as conditioner in the cosmetic product according to peptide sequence of the present invention (i).
The goods that comprise peptide sequence of the present invention (i) preferably are used among the shampoo preparation as setting agent and/or conditioner.Preferred shampoo preparation comprises: a) be 0.01% to 30% at least a peptide sequence (i) by weight; B) be 20% to 94.95% water by weight; C) be 5% to 50% surfactant by weight; C) be other conditioner of 0 to 5% by weight; D) be other cosmetic components of 0 to 10% by weight.
In the shampoo preparation, might use all aniones, neutrality, both sexes or the cationic surfactant that are generally used for shampoo.
For example; suitable anion surfactant has alkyl sulfate, alkyl ether sulfate, alkylsulfonate, alkylaryl sulfonates, alkyl succinate, alkyl sulfo succinate, N-alkoxyl sarcosinate, acyl taurine salt, acyl-hydroxyethyl sulfonate, alkylphosphonic, alkyl ether phosphate, alkyl ether carboxy acid salt, alpha-alkene sulfonate; particularly alkali metal salt and alkali salt are as sodium salt, potassium salt, magnesium salt, calcium salt, ammonium salt and triethanolamine salt.Alkyl ether sulfate, alkyl ether phosphate and alkyl ether carboxy acid salt can have 1 to 10 oxirane or expoxy propane unit in molecule, preferred 1 to 3 ethylene oxide unit(s)
What for example, be fit to has sodium lauryl sulphate, ammonium lauryl sulfate, dodecyl ether sodium sulfate, ammonium dodecyl ether sulfate, sarcosyl, oily octenyl succinate sodium, dodecyl 2-Sulfosuccinic acid ammonium, dodecylbenzene sodium sulfonate, a triethanolamine dodecylbenzene sodium sulfonate.
For example, suitable amphoteric surfactant has alkyl betaine, alkyl amino CAB, alkyl sulfobetaines, p dialkylaminobenzoic acid salt, alkyl carboxyl Glycinates, alkyl both sexes acetate or both sexes propionate, alkyl both sexes diacetin or both sexes dipropionate.
For example, can use coco dimethyl sulfopropyl betaine, empgen BB, cocamidopropyl betaine or cocos nucifera oil both sexes sodium propionate.
For example, suitable nonionic surfactant is the product that has aliphatic alcohol or alkyl phenol and the oxirane and/or the expoxy propane of 6 to 20 carbon atoms in the straight or branched hydrocarbon chain.The amount of epoxyalkane is about 6 to 60 moles of every mol of alcohol.In addition, fatty acid ester, alkyl poly glucoside or the sorbitan ether-ether of alkyl amine oxide, an alkyl alkanolamine or dialkyl group alkanolamine, Polyethylene Glycol are fit to.
In addition, the shampoo preparation can comprise conventional cationic surfactant, and quaternary ammonium compound for example is as hexadecyltrimethylammonium chloride.
In the shampoo preparation, conventional conditioner can be united use with peptide sequence (i), to realize some effect.
For example, these comprise copolymer (Luviquat FC, Luviquat HM, Luviquat MS, the Luviquat﹠amp of cationic polymer, the particularly vinylpyrrolidone/N-vinyl imidazole salt of the polyquaternary ammonium salt that the above-mentioned INCI of having names; Commat, Care), with dithyl sulfate quaternised N-vinylpyrrolidone/dimethylaminoethyl methacrylate copolymer (Luviquat D PQ 11), N-ethylene caprolactam/N-vinylpyrrolidone/N-vinyl imidazole salt copolymer (Luviquat D Hold), cationic cellulose derivative (polyquaternary ammonium salt-4 and-10), acrylamide copolymer (polyquaternary ammonium salt-7).In addition, can use protein hydrolysate and, for example poly-alkylsiloxane, poly-aryl siloxanes, poly-aryl alkyl siloxanes, polyether silicone or silicone resin based on the adjusting material of silicone compounds.Other suitable silicone compounds has dimethicone copolyol (CTFA) and amido functional group silicone compounds, for example amino polydimethylsiloxane (CTFA).In addition, can use cationic guar derivative, for example guar gum hydroxypropyl-trimethyl ammonium chloride (INCI).
The invention still further relates to keratin-binding effector molecules, comprising:
(i) at least a have the peptide sequence of binding affinity to keratin,
The (ii) effector molecule that is connected with peptide sequence (i) and non-natural.
Suitable peptide sequence (i) as mentioned above.
The particularly advantageous embodiment of the present invention is the peptide sequence (i) that comprises at least a following peptide sequence:
I. peptide sequence (domain B)
Ii. peptide sequence (domain C)
Iii. compare with (a), go up to the adorned peptide sequence of 70% aminoacid.
Iv. compare with (b), go up to the adorned peptide sequence of 70% aminoacid.
Condition be peptide sequence (c) or keratin (d) in conjunction with reach the peptide sequence (a) in the test of embodiment 9 or 10, surveyed or (b) institute's indicating value at least 10%.In this connection, domain B or C refer to the keratin binding structural domain of above-mentioned people's desmoplakin (SEQ ID NO:1).Thus, amino acid modified finger aminoacid replacement, insertion and disappearance or this three kinds of possible combination in any.
The preferred peptide sequence (i) that uses is that the organism of expecting is had the sequence of high specific affinity.Correspondingly, use for cosmetics for skin, the preferred peptide sequence (i) that adopts is the sequence that the application on human skin keratin is had special high-affinity.Use for hair cosmetic composition, preferred peptide sequence is the sequence that human hair keratin is had special high-affinity.
Correspondingly, for the application of house pet aspect, preferred peptide sequence (i) is that corresponding keratin (for example Canis animals keratin or felid keratin) is had the sequence of special high-affinity.
Yet, in effector molecule of the present invention, also might use more than one peptide sequence (i), for example the application on human skin keratin is had the sequence (i) of high binding affinity, together with the sequence (i) that human hair keratin is had high-affinity.For example, same peptide sequence (i) that also might sequential connection multicopy is to realize higher combination.
Suitable keratin-binding polypeptides sequence (i) is known.For example, the desmoplakin and plectin (the Fontao L that comprise the keratin binding structural domain, Favre B, Riou S, Geerts D, Jaunin F, Saurat JH, Green KJ, Sonnenberg A, Borradori L., Interaction of thebullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediatefilaments is mediated by distinct sequences within their COOH terminus, Mol Biol Cell.2003 May; 14 (5): 1978-92.2003 electronics on January 26 is open; Hopkinson SB, Jones JC., The N terminus of the transmembrane proteinBP180 interacts with the N-terminal domain of BP230, thereby mediatingkeratin cytoskeleton anchorage to the cell surface at the site of thehemidesmosome, Mol Biol Cell.2000 January; 11 (1): 277-86).
For example, the Vector NTI 8 (2002 year JIUYUE 25 day version) of the program that uses a computer as being provided by InforMax Inc by comparing this class known protein matter sequence, might draw and identify such zone.
Other the suitable peptide sequence (i) that human keratin is had good combination is to show the sequence area of high homology or sequence homogeneity in comparison, and can be considered the consensus sequence of keratin binding structural domain.
Preferred especially following sequence area:
Domain B (KBD-B): among the peptide sequence SEQ ID NO:1 the 2193rd to 2448;
Domain B (KBD-B): among the peptide sequence SEQ ID NO:1 the 2209th to 2448;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2606th to 2871;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2616th to 2871;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2616th to 2811;
Domain C (KBD-C): among the peptide sequence SEQ ID NO:1 the 2606th to 2871.
If expectation peptide sequence (i) has special good binding to the keratin that comes from non-human being's body, selected suitable sequence motifs is preferably from the sequence of keratin conjugated protein (as the desmoplakin or the plectin of suitable organism).
Fig. 2 has shown the comparison of keratin binding molecule.
Effector molecule (ii)
Effector molecule (ii) is meant the molecule with specific measurable effect hereinafter.They can be protein molecule such as enzyme, perhaps also can be the molecule of non-proteinogen such as the chemical compound of dyestuff, opacifier, vitamin, provitamin, antioxidant and fatty acid, conditioner or metal ion.
Among the protein effector molecule, preferably surely belong to enzyme and antibody.
Among enzyme, preferred following action effect molecule (ii): oxidase, peroxidase, protease, glucanase, mutant enzyme, tryrosinase, laccase, melts combine enzyme, lactoperoxidase, lysozyme, starch glycosidase, glucoseoxidase, superoxide dismutase, photolyase, T4 Cobra venom endonuclease, catalase, thioredoxin, thioredoxin reductase.
Following be preferred action effect molecule non-enzymatic activity protein effector molecule (ii) (ii): antibacterial peptide, silk protein, hydrophobin, collagen (collaten), carotenoid is conjugated protein, heavy metal is conjugated protein, OBP.
Be suitable as equally very much the protein effector molecule (ii) be the protein hydrolysate in plant and animal source, for example protein hydrolysate in marine products source or silk hydrolysate.
The nonprotein effector molecule (ii) among, preferably surely belong to dyestuff, for example food coloring, impermanency dyestuff or chemically-reactive dyes or oxidation dye.With regard to oxidation dye, preferably with a kind of component and keratin-binding polypeptides sequence (i) coupling (ii) of action effect molecule, subsequently at (after being attached on the hair) on the action site and the second dye component oxidative coupling.Also, implement the coupling of colour component by oxidation dye preferably being connected to peptide sequence (i) before.
Also can preferably chemically-reactive dyes action effect molecule a kind of component (ii) be connected on the keratin-binding polypeptides sequence (i), it is attached on the hair.In addition, might be in decorative cosmetic product having use the action effect molecule (ii) to be connected to such dyestuff on the keratin-binding polypeptides sequence (i) by being incorporated into fingernail or skin.
The suitable dye that is used for molecule of the present invention is all conventional hair dyess.According to the cosmetics handbook, suitable dyestuff is known for the technical staff, Schrader for example, Grundlagen undRezepturen " der Kosmetika, H ü thig Verlag, Heidelberg, 1989, ISBN3-7785-1491-1 ".
Particularly advantageous dyestuff is the dyestuff of listing in following table.Color index number (CIN) is selected from " RoweColour Index, the 3rd edition, Society of Dyers and Colourists, Bradford, England, 1971 ".
Chemical name or other title | ?CIN | Color |
Phthalocyanine green | ?10006 | Green |
Acid green 1 | ?10020 | Green |
2,4-dinitro hydroxyl naphthalene-7-sulfonic acid | ?10316 | Yellow |
Pigment yellow 1 | ?11680 | Yellow |
Pigment yellow 3 | ?11710 | |
Pigment orange | ||
1 | ?11725 | |
2,4-dihydroxy diphenyl diimide | ?11920 | Orange |
Solvent red 3 | ?12010 | Red |
1-(2 '-chloro-4 '-nitro-1 '-phenylazo)-2 hydroxy naphthalene | ?12085 | Red |
Pigment red 3 | ?12120 | Red |
Solvent red; Tonyred; Oil red G | ?12150 | Red |
Pigment red 112 | 12370 | Red |
Paratonere 7 | 12420 | Red |
Pigment brown 1 | 12480 | Palm fibre |
4-(2 '-methoxyl group-5 '-sulfo group lignocaine-1 '-phenylazo)-3-hydroxyl-5 "-chloro-2 ", 4 "-dimethoxy-2-naphthanilide | 12490 | Red |
Disperse yellow 16 | 12700 | Yellow |
1-(4-sulfo--1-phenylazo)-4-aminobenzene-5-sulfonic acid | 13015 | Yellow |
2,4-dihydroxy diphenyl diimide-4 '-sulfonic acid | 14270 | Orange |
2-(2,4-xylene azoic base-5-sulfo group)-1-hydroxyl naphthalene-4-sulfonic acid | 14700 | Red |
2-(4-sulfo--1-naphthylazo)-Neville acid | 14720 | Red |
2-(6-sulfo--2,4-xylene azoic)-1-naphthol-5-sulfonic acid | 14815 | Red |
1-(4 '-sulfophenyl azo)-2 hydroxy naphthalene | 15510 | Orange |
1-(2-sulfo--4-chloro-5-carboxyl-1-phenylazo)-2 hydroxy naphthalene | 15525 | Red |
1-(3-methylbenzene azo-4-sulfo group)-2 hydroxy naphthalene | 15580 | Red |
1-(4 ', (8 ')-sulfonic acid benzeneazo)-2 hydroxy naphthalene | 15620 | Red |
2-hydroxyl-1,2 '-azonaphthalene-1 '-sulfonic acid | 15630 | Red |
3-hydroxyl-4-phenylazo-2-naphthalene-carboxylic acid | 15800 | Red |
1-(2-sulfo--4-methyl isophthalic acid-phenylazo)-2-naphthalene-carboxylic acid | 15850 | Red |
1-(2-sulfo--4-methyl-5-chloro-1-phenylazo)-2 hydroxy naphthalene-3-carboxylic acid | 15865 | Red |
1-(2-sulfo--1-naphthylazo)-2 hydroxy naphthalene-3-carboxylic acid | 15880 | Red |
1-(3-sulfo--1-phenylazo)-beta naphthal-6-sulfonic acid | 15980 | Orange |
1-(4-sulfo--1-phenylazo)-beta naphthal-6-sulfonic acid | 15985 | Yellow |
Lure red | 16035 | Red |
1-(4-sulfo--1-naphthylazo)-beta naphthal-3, the 6-disulfonic acid | 16185 | Red |
Acid orange 10 | 16230 | Orange |
1-(4-sulfo--1-naphthylazo)-beta naphthal-6, the 8-disulfonic acid | 16255 | Red |
1-(4-sulfo--1-naphthylazo)-beta naphthal-3,6, the 8-trisulfonic acid | 16290 | Red |
8-amino-2-benzeneazo-1-naphthols-3, the 6-disulfonic acid | ?17200 | Red |
Azogeramine | ?18050 | Red |
Azogeramine 55 | ?18130 | Red |
Indian yellow 121 | ?18690 | Yellow |
Acid red 18 0 | ?18736 | Red |
Acid yellow 11 | ?18820 | Yellow |
Indian yellow 17 | ?18965 | Yellow |
4-(4-sulfo--1-benzeneazo)-1-(4-sulfophenyl)-5-hydroxypyrazoles quinoline ketone-3-carboxylic acid | ?19140 | Yellow |
Pigment yellow 16 | ?20040 | Yellow |
2,6-(4 '-sulfo--2 ", 4 "-dimethyl) two benzeneazos)-1, the 3-hydroquinone | ?20170 | Orange |
Acid black 1 | ?20470 | Black |
Pigment yellow 13 | ?21100 | Yellow |
Pigment yellow 83 | ?21108 | Yellow |
Solvent yellow | ?21230 | Yellow |
Azogeramine 63 | ?24790 | Red |
Xylene Red 73 | ?27290 | Red |
2-[4 '-(4 "-sulfo--1 "-benzeneazo)-7 '-sulfo--1 '-naphthylazo]-1-hydroxyl-7-amino naphthalenes-3, the 6-disulfonic acid | ?27755 | Black |
4 '-[4 "-sulfo--1 "-benzeneazo)-7 '-sulfo--1 '-naphthylazo]-1-hydroxyl-8-acetyl-amino naphthalenes-3, the 5-disulfonic acid | ?28440 | Black |
Direct orange 34,39,44,46,60 | ?40215 | Orange |
Edible yellow | ?40800 | Orange |
Trans-β-apo--8 '-carotenal (C30) | ?40820 | Orange |
Trans-apo--8 '-daucic acid (C30) ethyl ester | ?40820 | Orange |
Canthaxanthin | ?40850 | Orange |
Blue VRS | ?42045 | Blue |
2,4-two sulfur-5-hydroxyl-4 ', 4 "-two (diethyl amino) triphenylcarbinol | 42051 | Blue |
The 4-[(4-N-ethyl-to sulfophenyl (amino) phenyl-(4-hydroxyl-2-sulfophenyl) (methylene-1-(N-ethyl-N-is to sulfophenyl)-2,5-cyclohexyl diimine] | 42053 | Green |
Acid Blue 7 | 42080 | Blue |
(the N-ethyl-to the sulphur benzylamine) phenyl-(2-sulfophenyl) methylene-(N-ethyl-N-is to sulfophenyl)-δ 2,5-cyclohexyl diimine | 42090 | Blue |
Acid green 9 | 42100 | Green |
Diethyl two sulfur benzyls two-4-amino-2-chloro two-2-methyl fuchsonimmonium | 42170 | Green |
Basis purple 14 | 42510 | Purple |
Basis purple 2 | 42520 | Purple |
2 '-methyl-4 '-(sulfophenyl between N-ethyl-N-) amino-4 "-(N-diethyl) amino-2-methyl-N-ethyl-N-between sulphur benzene fuchsonimmonium | 42735 | Blue |
4 '-(N-dimethyl) amino-4 "-(N-phenyl) amino naphthalenes-N-dimethyl fuchsonimmonium | 44045 | Blue |
2-hydroxyl-3,6-two sulfur-4,4 '-two dimethylamino naphthalene fuchsonimmonium | 44090 | Green |
Xylene Red 52 | 45100 | Red |
3-(2 '-amino toluene)-6-(2 '-methyl-4 '-sulfur phenylamino)-9-(2 "-carboxyl benzene) xanthene Salt | 45190 | Purple |
Xylene Red 50 | 45220 | Red |
Phenyl-2-oxygen base fluorone-2-carboxylic acid | 45350 | Yellow |
4, the 5-dibromofluorescein | 45370 | Orange |
2,4,5, the 7-eosin | 45380 | Red |
Solvent dye | 45396 | Orange |
Xylene Red 98 | 45405 | Red |
3 ', 4 ', 5 ', 6 '-tetrachloro-2,4,5,7-eosin | 45410 | Red |
4, the 5-diiodofluorescein | ?45425 | Red |
2,4,5, the 7-tetraiodofluorescein | ?45430 | Red |
Quinophthalone (Quinophthalone) | ?47000 | Yellow |
The quinophthalone disulfonic acid | ?47005 | Yellow |
Acid violet 50 | ?50325 | Purple |
Acid black 2 | ?50420 | Black |
Pigment Violet 23 | ?51319 | Purple |
1,2-dihydroxyanthraquinone, calcium-aluminum complex | ?58000 | Red |
3-hydroxyl pyrene-5,8,10-sulfonic acid | ?59040 | Green |
1-hydroxyl-4-N-phenyl amino anthraquinone | ?60724 | Purple |
1-hydroxyl-4-(4 '-aminomethyl phenyl amino) anthraquinone | ?60725 | Purple |
Acid violet 23 | ?60730 | Purple |
1,4-two (4 '-aminomethyl phenyl amino) anthraquinone | ?61565 | Green |
1, two (adjacent sulfo group-para-totuidine base) anthraquinones of 4- | ?61570 | Green |
Acid blue 80 | ?61585 | Blue |
Acid blue 62 | ?62045 | Blue |
N, N '-dihydro-1,2,1 ', 2 '-anthraquinone azine | ?69800 | Blue |
Vat blue 6; Alizarol saphirol 64 | ?69825 | Blue |
Urn orange 7 | ?71105 | Orange |
Indigo | ?73000 | Blue |
Indigo disulfonic acid | ?73015 | Blue |
4,4 '-dimethyl-6,6 '-dichloro thioindigo | ?73360 | Red |
5,5 '-two chloro-7,7 '-dimethyl thioindigo | ?73385 | Purple |
Quinacridone violet 19 | ?73900 | Purple |
Pigment red 122 | ?73915 | Red |
Pigment blue 16 | ?74100 | Blue |
Phthalocyanine | ?74160 | Blue |
Sun blue 86 | 74180 | Blue |
The chlorination phthalocyanine | 74260 | Green |
Naturally yellow 6,19; Naturally red 1 | 75100 | Yellow |
Annatto falls in annatto | 75120 | Orange |
Lycopene | 75125 | Yellow |
Trans-α-, β-or gamma carotene | 75130 | Orange |
The ketone of carotene and/or hydroxy derivatives | 75135 | Yellow |
Guanine or pearling agent | 75170 | In |
1, two (the 4-hydroxy 3-methoxybenzene bases)-1 of 7-, 6-heptadiene-3,5-diketone | 75300 | Yellow |
The complex salt of axinic acid (Na, Al, Ca) | 75470 | Red |
Chlorophyll a and b; The copper compound of chlorophyll and CHLOROPHYLLINE | 75810 | Green |
Aluminum | 77000 | In vain |
Hydrated alumina | 77002 | In vain |
Hydrated aluminium silicate | 77004 | In vain |
Ultramarine | 77007 | Blue |
Paratonere 101 and 102 | 77015 | Red |
Barium sulfate | 77120 | In vain |
The bismuth oxychloride and with micaceous mixture | 77163 | In vain |
Calcium carbonate | 77220 | In vain |
Calcium sulfate | 77231 | In vain |
Carbon black | 77266 | Black |
Pigment black 9 | 77267 | Black |
Medicinal charcoal, plant carbon | 77268 | Black |
Chromated oxide | 77288 | Green |
The chromated oxide hydrate | 77289 | Green |
Alizarol saphirol 28, naphthol green 14 | 77346 | |
Pigment metal | ||
2 | 77400 | Palm fibre |
Gold | 77480 | Palm fibre |
Iron oxides and hydroxide | 77489 | Orange |
Iron oxides | 77491 | Red |
The iron oxides hydrate | 77492 | Yellow |
Iron oxides | 77499 | Black |
Six cyano group ferric acid ferrum (II) and six cyano group ferric acid ferrum (III) mixture | 77510 | Blue |
Pigment white 18 | 77713 | In vain |
Diphosphonic acid manganese ammonium salt | 77742 | Purple |
Manganese phosphate, Mn 3(PO 4) 2·7H 2O | 77745 | Red |
Silver | 77820 | In vain |
Titanium dioxide and composition thereof | 77891 | In vain |
Zinc oxide | 77947 | In |
6,7-dimethyl-9-(1 '-D-ribityl) isoalloxazine, riboflavin | ? | Yellow |
Caramel | ? | Palm fibre |
Capsorubin, capsorubin | ? | Orange |
Betanin | ? | Red |
Benzopyralium salt, anthocyanidin | ? | Red |
Bromocresol green | ? | Green |
Aluminium stearate, zinc stearate, magnesium stearate and calcium stearate | ? | In vain |
Bromophenol blue | ? | Blue |
Azogeramine 95 | ? | Red |
Food coloring is suitable as hair dyes equally very much.
Above-mentioned dyestuff can also be used as in conjunction with the effector molecule of peptide sequence (i) (ii), and is painted to (for example in tatooing) skin or fingernail.
If expectation, also can be easy in the keratin from skin, hair or fingernail to separate once more be connected in keratin-binding polypeptides sequence (i) effector molecule (ii).For this purpose, what might adopt is: for example, washing keratin, the effector molecule that will be connected in keratin-binding polypeptides (i) by this (ii) from its with keratic existing the combination cement out, and carry out saturated with the keratin in the cleaning mixture.Perhaps, also might be used to wash effector molecule off (ii) with high-load detergent (as SDS) washing.
Other preferred effector molecule (ii) is a fatty acid, the satisfied fatty acid that particularly has alkyl branches, preferred especially side chain arachidic acid, for example 18-methyl arachic acid.
Other preferred effector molecule (ii) is a carotenoid.According to the present invention, carotenoid is interpreted as being meant following one or as chemical compound and the esterification or the glycosylated derivative of mixture: beta-carotene, lycopene, phylloxanthin, astaxanthin, cryptoxanthin, kryptoxanthin, citroxanthin (citranaxanthin), canthaxanthin, annatto, β-apo--4-Radix Dauci Sativae aldehyde, β-apo--8-Radix Dauci Sativae aldehyde, β-apo--8-Radix Dauci Sativae ester, neurosporene, echinenone, adonirubin, violaxanthin, torulin (torulene), torularhodin.The preferred carotenoid that uses has beta-carotene, lycopene, phylloxanthin, astaxanthin, cryptoxanthin, citroxanthin and canthaxanthin.
Other preferred effector molecule (ii) is vitamin, particularly vitamin A and ester thereof.
For the object of the invention, retinoid refers to retinol (retinol) and derivant thereof, for example axerophthal (retinal), retinoic acid (tretinoin) and Davitin A (as acetic acid retinyl ester, Vitamin A propionate and retinyl palmitate).Thus, the term tretinoin comprises all trans retinoic acids and 13-cis-retinoic acid.Term retinol and retinal preferably include all trans-compounds.The retinoid that is preferred for suspension of the present invention is an alltrans retinol, hereinafter is referred to as retinol.
Other preferred effector molecule (ii) has from the vitamin of A, C, E and F family, provitamin and previtamin thing, and particularly 3, the two dehydroretinols of 4-, beta-carotene (provitamin of vitamin A); The cetylate of ascorbic acid (vitamin C) and ascorbic acid or glucosides or phosphate; Tocopherol, particularly alpha-tocopherol and ester thereof are as acetate, nicotinate, phosphate ester and succinate; The vitaminF, particularly linoleic acid, linolenic acid and the arachidonic acid that belong to essential fatty acid in addition in addition.
The vitamin of vitamin B group preferably used according to the invention, provitamin or previtamin or derivatives thereof, and 2-furanone derivatives comprise:
Vitamin B
1, popular name thiamine, chemical name 3-[(4 '-amino-2 '-methyl-5 ' pyrimidine radicals) and methyl]-5-(2-ethoxy)-4-methylthiazol hydrochlorate;
Vitamin B
2, popular name riboflavin, chemical name 7,8-dimethyl-10-(1-D-ribityl)-benzo [g] pteridine-2,4 (3H, 10H)-diketone.For example, riboflavin is present in the milk surum with free form, and can separate other from antibacterial and yeast and examine horizontal plain derivant.Being suitable for riboflavin stereoisomer of the present invention equally is lyxoflavin (lyxoflavin), and it can separate and have the D-arabinose alcohol radical that replaces the D-ribityl from fish flour or liver.
Vitamin B
3, chemical compound nicotinic acid and nicotiamide (niacin amide) be so name often.According to the present invention, preferred nicotiamide.
Vitamin B
5(pantothenic acid and pantothenylol).The preferred pantothenylol that adopts.Especially, adoptable pantothenylol derivant is a pantothenylol according to the present invention ester and ether, and the cationic derivative of pantothenylol.In another embodiment preferred of the present invention, except that pantothenic acid or pantothenylol, also might adopt the 2-furanone derivatives.Particularly preferred derivant is commercially available material, as dihydro-3-hydroxyl-4,4-dimethyl-2 (3H)-furanone, popular name pantolactone (pantolactone) (Merck), 4-methylol-gamma-butyrolacton (Merck), 3,3-dimethyl-2-hydroxyl-gamma-butyrolacton (Aldrich) and 2,5-dihydro-5-methoxyl group-2-furanone (Merck) is wherein particularly including all stereoisomers.
These chemical compounds can advantageously be given the performance of preserving moisture with skin lubrication to keratin-binding effector molecules of the present invention.
Vitamin B
6Be not the same material, and be meant 5-methylol-2-picoline-3-01 derivatives, it is famous because of popular name pyridoxol, pyridoxamine and 2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine..
Vitamin B
7(biotin) also is referred to as biotin or " skin vitamin ".Biotin be (3aS, 4S, 6aR)-2-oxo six hydrogen thiophene [3,4-d] imidazoles-4-valeric acid.
According to the present invention, extremely preferred pantothenylol, pantolactone, nicotiamide and biotin.
According to the present invention, might use suitable derivant (salt, ester, sugar, nucleotide, nucleoside, peptide and lipid).Preferred lipotropy oil-soluble inhibitor is tocopherol and derivant thereof in this family, gallium ester (gallic ester), flavonoid and carotenoid, and butylated hydroxy-methylbenzene/methoxybenzene.Preferred water soluble antioxidant is an aminoacid, as tyrosine and cysteine and their derivant, and the tannic acid tannic acid of plant origin particularly.
Triterpenoid compound, particularly triterpenic acid, for example ursolic acid, rosmarinic acid, belulinic acid Betulinic acid, boswellic acid and bryonolic acid.
Other preferred effector molecule is thioctic acid and suitable derivant (salt, ester, sugar, nucleotide, nucleoside, peptide and lipid) thereof.
Other preferred effector molecule (ii) is the ultraviolet filter agent, is meant the organic substance that can absorb ultraviolet and can radiate the energy that is absorbed with the form of long-wave radiation (as heat radiation) once more.Organic substance can be oil-soluble or water miscible.
The example of operable oil-soluble UV-B lightscreening agent has following material:
3-benzylidene camphor and derivant thereof are as 3-(4-methyl benzal) Camphora;
The 4-aminobenzoic acid derivative, preferred 4-(dimethylamino) benzoic acid 2-Octyl Nitrite, 4-(dimethylamino) benzoic acid 2-monooctyl ester and 4-(dimethylamino) amyl benzoate;
Cinnamate, preferred 4-methoxy cinnamic acid 2-Octyl Nitrite, 4-methoxy cinnamic acid propyl ester, 4-methoxy cinnamic acid isopentyl ester, 4-methoxy cinnamic acid isopentyl ester, 2-cyanogen-3-phenyl-cinnamic acid 2-Octyl Nitrite (1-Octyl acrylate);
Salicylate, preferred 2-Ethylhexyl salicylate, 4-isopropyl phenyl salicylate, 3,5,5-cyclonol salicylate (homomenthyl salicylate);
The derivant of benzophenone, preferred 2-hydroxyl-methoxy benzophenone, 2-hydroxyl-4-methoxyl group-4 '-methyldiphenyl ketone, 2,2 '-dihydroxy-4-methoxy benzophenone;
The benzylidene malonic acid ester, preferred 4-methoxyl group benzal malonic acid 2-Octyl Nitrite;
Pyrrolotriazine derivatives, for example 2,4,6-triphen amido-(to carbonyl-2 '-ethyl-1 '-hexyloxy)-1,3,5-triazines (octyl triazone) and dioctyl fourth ammonia triazinone (Uvasorb
HEB)
Propane-1,3-diketone, 1-(4-2-methyl-2-phenylpropane)-3-(4 '-methoxyphenyl) propane-1 for example, 3-diketone.
Suitable water-soluble substances has:
2-Phenylbenzimidazole-5-sulfonic acid and alkali metal salt, alkali salt, ammonium salt, alkylammonium salt, alkanol ammonium salt and glutamic acid ammonium salt.
The benzophenone sulfonic acid, preferred 2-hydroxyl-4-methoxy benzophenone-5-sulfonic acid and salt thereof;
3-benzylidene camphor sulfonic acid, for example 4-(2-oxo-3-borneol diene methyl) benzenesulfonic acid and 2-methyl-5-(2-oxo-3-borneol diene) sulfonic acid and salt thereof.
Especially preferably use cinnamate, preferred 4-methoxy cinnamic acid 2-Octyl Nitrite, 4-methoxy cinnamic acid isopentyl ester, 2-cyanogen-3-phenyl-cinnamic acid-2 Octyl Nitrite (1-Octyl acrylate);
Also preferably use benzophenone derivates, particularly 2-hydroxyl-4-methoxy benzophenone, 2-hydroxyl-4-methoxyl group-4 '-methyldiphenyl ketone, 2,2 '-dihydroxy-4-methoxy benzophenone; And use propane-1,3-diketone, 1-(4-2-methyl-2-phenylpropane)-3-(4 '-anisyl) propane-1 for example, 3-diketone.
Suitable typical ultraviolet light,long wave lightscreening agent has:
The benzoyl methane Derivatives, 1-(4 '-2-methyl-2-phenylpropane)-3-(4 '-methoxyphenyl) propane-1 for example, 3-diketone, the 4-tert-butyl group-4 '-methoxy dibenzoyl methane or 1-phenyl-3-(4 '-isopropyl phenyl) propane-1,3-diketone;
The hydroxy amino substitutive derivative of benzophenone, N for example, N-diethylamino (2-hydroxybenzoyl)-positive hexyl phenenyl formic acid esters.
Certainly also can adopt the mixture of ultraviolet light,long wave and UV-B lightscreening agent.
Following table provides other suitable ultraviolet filtering agent material.
Numbering | Material | CAS numbers (=acid) |
1 | The 4-amino benzoic Acid | 150-13-0 |
2 | 3-(4 '-trimethylamine) benzal thatch alkane-2-ketone methylsulfuric acid ester | 52793-97-2 |
3 | 3,3,5-trimethylcyclohexyl salicylate (homosaligenin) | 118-56-9 |
4 | 2-hydroxyl-4-methoxyl group-benzophenone (oxybenzone) | 131-57-7 |
5 | 2-Phenylbenzimidazole-5-sulfonic acid and potassium salt, sodium salt and triethanolamine salt | 27503-81-7 |
6 | 3,3 '-(1, the 4-phenylenedimethylidyne) two (7,7-dimethyl-2-oxo dicyclo [2.2.1] heptane-1-methane-sulfonic acid) and salt thereof | 90457-82-2 |
7 | Poly-ethoxyethyl 4-two (poly-ethoxy) Aminobenzoate | 113010-52-9 |
8 | 2-ethylhexyl 4-dimethylaminobenzoic acid ester | 21245-02-3 |
9 | The 2-Ethylhexyl salicylate | 118-60-5 |
10 | 2-isopentyl 4-Methoxycinnamate | 71617-10-2 |
11 | 2-ethylhexyl 4-Methoxycinnamate | 5466-77-3 |
12 | 2-hydroxyl-4-methoxyl group benzophenone-5-sulfonic acid (sulisobenzone) and sodium salt thereof | 4065-45-6 |
13 | 3-(4 '-sulfo-benzal) thatch alkane-2-ketone and salt thereof | 58030-58-6 |
14 | 3-benzal thatch alkane-2-ketone | 16087-24-8 |
15 | 1-(4 '-isopropyl phenyl)-3-phenyl-propane-1, the 3-diketone | 63260-25-9 |
16 | 4-isopropyl phenyl salicylate | 94134-93-7 |
17 | 3-imidazol-4 yl acrylic acid and ethyl ester thereof | 104-98-3 |
18 | 2-cyano-3,3-diphenyl ethyl acrylate | 5232-99-5 |
19 | 2 '-ethylhexyl 2-cyano group-3,3-diphenylacrylate ester | 6197-30-4 |
20 | Methyl 2-aminobenzoate or 5-methyl-2-(1-Methylethyl)-2-Aminobenzoate | 134-09-8 |
21 | Para-amino benzoic acid glyceride or 1-glyceryl 4-Aminobenzoate | 136-44-7 |
22 | 2,2 '-dihydroxy-4-methoxyl group benzophenone (dihydroxyphenyl ketone) | 131-53-3 |
23 | 2-hydroxyl-4-methoxyl group-4-methyldiphenyl ketone (mexenone) | 1641-17-4 |
24 | The triethanolamine Salicylate | 2174-16-5 |
25 | Dimethoxyphenyl glyoxalic acid or 3,4-Dimethoxyphenyl glyoxalic acid sodium | 4732-70-1 |
26 | 3-(4 '-sulfo-) benzal thatch alkane-2-ketone and salt thereof | 56039-58-8 |
27 | The 4-tert-butyl group-4 '-methoxy dibenzoyl methane | 70356-09-1 |
28 | 2,2 ', 4,4 '-tetrahydroxybenzophenone | 131-55-5 |
29 | 2,2 '-di-2-ethylhexylphosphine oxide [6-(2H-benzotriazole-2-yl)-4-(1,1,3, the 3-tetramethyl butyl) phenol] | 103597-45-1 |
30 | 2,2 '-(1, the 4-phenylene) is two-1H-benzimidazole-4,6-disulfonic acid, sodium salt | 180898-37-7 |
31 | 2, two [4-(2-ethyl hexyl oxy)-2-hydroxyl] phenyl-6-(4-methoxyl group-phenyl) of 4--(1,3,5) triazine | 187393-00-6 |
32 | 3-(4 '-methyl benzal) Camphora | 36861-47-9 |
33 | Poly-ethoxyethyl-4-two (poly-ethoxy) p-aminobenzoate | 113010-52-9 |
34 | 2,4 dihydroxy benzophenone | 131-56-6 |
35 | 2,2 '-dihydroxy-4,4 '-dimethoxy-benzophenone-5,5 '-sodium disulfonate | 3121-60-6 |
36 | 2-[4-(diethylamino)-2-hydroxy benzoyl]-benzoic acid hexyl ester | 302776-68-7 |
37 | 2-(2H-2-benzotriazole-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethyl silyl) the oxygen base]-the disiloxane base] propyl group]-phenol | 155633-54-8 |
Except that the main photoprotection material of two above-mentioned classes, also might adopt the secondary opacifier of antioxidation dosage form, described opacifier can interrupt when ultraviolet runs through skin and inductive chain type photochemical reaction.Its representative instance has superoxide dismutase, catalase, tocopherol (vitamin E) and ascorbic acid (vitamin C).
Other class has the skin of pair ultraviolet damage to have the counter-stimulus of antiinflammatory action.The example of this class material is Bisabolol terpene alcohol, phytol and phytantriol.
Effector molecule (ii) with being connected of keratin-binding polypeptides sequence (i)
Effector molecule (ii) is connected on the peptide sequence (i) with keratin binding affinity.(i) and the connection (ii) both can be covalent bond, also can be based on the interaction of ion or Van der Waals force.
The preferably covalently key.For example, this can be undertaken by the side chain of peptide sequence (i), particularly by amido functional group or hydroxy functional group or carboxylate functional group or thiol functionalities.Preferably the amido functional group by one or more lysine residues, the mercaptan by one or more cysteine residues or N-terminal or C-terminal functional group by polypeptide (i) connect.The amino acid functional group in being present in peptide sequence (i), also the aminoacid (as cysteine, lysine, aspartic acid, glutamic acid) with appropriate functional group might be connected in peptide sequence (i), or the aminoacid of peptide sequence (i) is replaced by such amino acid functional group.
Can directly carry out effector molecule (ii) with being connected of peptide sequence (i), promptly as be present in already (i) and (ii) among two kinds of chemical functional groups covalently bound, for example the amido functional group of (i) is connected in (ii) carboxylate functional group with the generation amide.But, also can connect by so-called joint (promptly being at least dual functional molecule), described joint is connected with (i) by a kind of functional group, and is connected in (ii) by one or more other functional groups.
If effector molecule (ii) is made up of peptide sequence equally, then (i) with (ii) can be connected the i.e. continuous peptide sequence of forming by two parts (i) and sequence (ii) by the mode of so-called fusion rotein.
Also so-called spacer element might be inserted in (i) and (ii) between, the peptide sequence that for example has the potential cracking site of protease, lipase, esterase, phosphatase, hydrolytic enzyme, perhaps make the oligopeptide sequence or the peptide sequence of the easy purification of fusion rotein, for example so-called histidine-tagged, i.e. oligo-histidine residue.
Spacer element can be made up of alkyl chain, ethylene glycol and Polyethylene Glycol in addition.
Particularly preferably, joint and/or spacer element have the potential cracking site of protease, lipase, esterase, phosphatase, hydrolytic enzyme, promptly are the enzyme cleavables.
For example, disclose the example of the joint of the enzyme cleavable that can be used for molecule of the present invention among the WO98/01406, clearly its full content has been quoted as a reference at this.
Particularly preferred joint and sept are hot cleavable, light cleavable.
Corresponding chemical constitution is well known to a person skilled in the art, and can be incorporated into molecular moiety (i) and (ii) between.
Under nonprotein effector molecule and situation that peptide sequence (i) is connected, preferably by polypeptide (i) but the residue (side-chain radical, C or N-terminal) of going up functional groupization carry out, it is covalently attached to the chemical functional group of effector molecule.
In this case, preferably amino, mercaptan or the hydroxy functional group by polypeptide (i) connects, and for example, under suitable situation, after they are activated, can carry out corresponding amide, thioesters or ester with effector molecule carboxyl functional group (ii) and be connected.
Other preferred peptide sequence (i) and the effector molecule use that is connected customization (tailored) joint that is (ii).Such joint has two or more so-called anchoring groups, and it can (ii) couple together peptide sequence (i) and one or more effector molecules.For example, the anchoring group that is used for peptide sequence (i) can be a thiol functionalities, and by means of this mercaptan, joint carries out disulfide bond with the cysteine residues of polypeptide (i) and is connected.For example, being used for effector molecule anchoring group (ii) can be carboxyl functional group, and by means of this carboxyl, joint can carry out ester bond with effector molecule hydroxy functional group (ii) and be connected.
Use such customization joint, make connection can mate the effector molecule of expectation exactly.Thus, also the mode of a large amount of effector molecules with regulation might be connected on the peptide sequence (i) in addition.
Used joint depends on treats link coupled functional group.For example, suitable example has by following sulfydryl reactive group and polypeptide (i) coupling: maleimide, pyridyl disulfide, alpha-halogen acetyl, vinyl sulfone(Remzaol, sulfato alkyl sulfone (the preferably sulfuric acid root closes ethyl sulfone), and by following groups and the (ii) link coupled molecule of effector molecule:
-sulfydryl reactive group is (as maleimide, pyridyl disulfide, a-halo acetyl, vinyl sulfone(Remzaol, sulfato alkyl sulfone (the preferably sulfuric acid root closes ethyl sulfone);
-amine reactive group (as succinimide ester, carbodiimide, methylol phosphine, imino-ester, PFP ester or the like);
-sugar or oxosugar reactive group (as hydrazides or the like);
-carboxyl reactive group (as carbodiimide or the like);
-hydroxyl reaction base (as isocyanates or the like);
-thymus pyrimidine reactive group (as psoralen or the like);
-non-selectivity group (as aromatic yl azide or the like);
-light reaction group (as full-fluorinated benzene azide or the like);
-metal complex group (as EDTA, six histidine (hexahis), ferritin);
-antibody and fragment thereof (as F (ab) fragment, the catalytic antibody of single-chain antibody, antibody).
Alternative possibilities is directly to put together between active substance/effector molecule and keratin binding structural domain, as being the known cross-linking agent of technical staff by carbodiimide, glutaraldehyde, above-mentioned cross-linking agent or other.
If expectation also can be easy to separate once more keratin-binding effector molecules of the present invention from keratin.For this purpose, what might adopt is: for example, washing keratin, by this with keratin-binding effector molecules from its with keratic existing the combination cement out, and carry out saturated with the keratin in the cleaning mixture.Therefore, might carry out a large amount of effector molecules to keratic reversible adhering to.Perhaps, also might be used to wash off effector molecule with high-load detergent (as SDS) washing.
Keratin-binding effector molecules according to the present invention particularly is with a wide range of applications in skin and hair-care, animal care, leather nursing and the leather processing at people's cosmetics.
Keratin-binding effector molecules of the present invention is preferred for skin, fingernail and hair cosmetic composition.They allow the high concentration and the long-acting time of skin, fingernail and hair nursing or skin, fingernail and hair protective effect thing.
Be used to produce that hair is made up or the suitable adjuvant of skin cosmetic product is well known to those skilled in the art, and can be referring to the cosmetic handbook, Schrader for example, Grundlagen und Rezepturen, derKosmetika, H ü thig Verlag, Heidelberg, 1989, ISBN 3-7785-1491-1.
In another embodiment, described hair is made up or the skin cosmetic product is used for nursing or protection skin or hair, and can be following form: Emulsion; dispersion, suspension, aqueous tenside goods; emulsion, lotion, cream; face cream, unguentum, gel; granule, face powder, the stick product is lipstick for example; foamed glue, aerosol or spray.Such dosage form is very suitable for local goods.Suitable Emulsion is oil-in-water emulsion and water-in-oil emulsion or microemulsion.
Hair cosmetic or skin cosmetic product are applied to skin (part) or hair usually.Thus, local goods refer to be suitable for the active substance FINE DISTRIBUTION to skin and be preferably the goods that can see through the skin absorbs form.The example that is suitable for this purpose has aqueous and alcohol-water solution, spray, foamed glue, foam aerosol, unguentum, aqueous gel, oil-in-water or water-in-oil emulsion, microemulsion or cosmetic stick product.
In the preferred embodiment of make-up composition of the present invention, compositions comprises carrier.Preferred carrier is water, gas, the liquid based on water, oil, gel, Emulsion or microemulsion, dispersion or their mixture.Described carrier is that skin is well tolerable.Good especially local goods are hydrogel adhesive, Emulsion or microemulsion.
Spendable emulsifying agent is nonionic surfactant, zwitterionic surfactant, amphoteric surfactant or anion emulsifier.Emulsifier based in compositions be 0.1% to 10% by weight, preferred 1% to 5% amount is present among the compositions of the present invention.
For example, can use and be selected from following at least a surfactant and be used as nonionic surfactant:
2 to 30mol oxirane and/or 0 to 5mol expoxy propane and straight-chain fatty alcohol with 8 to 22 C atoms, with the adduct that has the fatty acid of 12 to 22 C atoms and in alkyl, have the alkyl phenol of 8 to 15 C atoms;
The C of the adduct of 1 to 30mol oxirane and glycerol
12/18Fatty-acid monoester and diester;
Have the saturated and unsaturated fatty acid of 6 to 22 carbon atoms and glycerol monoesters and diester and the sorbitan monoester and the diester of ethylene oxide adduct thereof;
The alkyl monoglycosides and oligosaccharide glycosides and the ethoxylation analog thereof that in alkyl, have 8 to 22 carbon atoms;
The adduct of 15 to 60mol oxirane and Oleum Ricini and/or hardened castor oil;
Polyol ester, particularly polyglycerin ester, for example poly-ricinoleate of polyglycerol, the poly-12-hydroxy stearic acid ester of polyglycerol or polyglycerol dimer.Compound mixture from a large amount of these class materials equally also is suitable;
The adduct of 2 to 15mol oxirane and Oleum Ricini and/or hardened castor oil;
With the unsaturated or saturated C of straight or branched
6/22Fatty acid, ricinoleic acid and 12-hydroxy stearic acid and glycerol, polyglycerol, tetramethylolmethane, dipentaerythritol, sugar alcohol (as Sorbitol), alkyl polyglucoside (as methylglycoside, butyl glycoside, dodecyl glucosides) and polyglycosides (as cellulose) are the partial ester on basis.
Mono alkyl phosphate, phosphate dialkyl ester and trialkylphosphate and PEG-mono alkyl phosphate, PEG-phosphate dialkyl ester and/or PEG-trialkylphosphate and their salt;
Wool wax alcohol;
Polysiloxanes-poly-alkane copolyether and corresponding derivant;
As the mixed ester of disclosed tetramethylolmethane, fatty acid, citric acid and aliphatic alcohol among the DE1165574, and/or have fatty acid, methyl glucoside and the polyhydric alcohol of 6 to 22 carbon atoms, the mixed ester of preferred glycerol or polyglycerol, and
Polyglycols;
Betanin.
Also can use zwitterionic surfactant as emulsifying agent.The surfactant that is referred to as zwitterionic surfactant is the surfactant that has at least one quaternary ammonium group and at least one carboxylate or a sulfonate group in molecule.Specially suitable zwitterionic surfactant is so-called betanin; as N-alkyl-N; N-dimethylglycine ammonium; cocos nucifera oil alkyl dimethyl glycine ammonium for example; N-amidopropyl-N; N-dimethylglycine ammonium for example has the cocamidopropyl propyl-dimethyl glycine ammonium and the 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazole quinoline of 8 to 18 carbon atoms and cocamidopropyl ethyl-hydroxyethyl carboxymethyl glycinate respectively in alkyl or acyl group.Particularly preferred fat amide derivant is well-known derivant with CTFA name cocamidopropyl betaine.
Same suitable emulsifying agent is an amphoteric surfactant.Amphoteric surfactant refers to except C
8,18Beyond alkyl or the acyl group, in molecule, comprise at least one free amine group and at least one COOH or SO
3The H group also can form the surface active cpd of inner salt.Suitable examples of amphoteric surfactants is N-alkyl glycinate, N-alkyl propionate, N-alkyl amino butyrate, N-alkyl imido malonate, N-ethoxy-N-alkyl amino propyl group glycinate, N-alkyltaurate, N-alkyl sarcosine salt, 2-alkyl aminopropionic acid salt and the alkyl glycinate that has about 8 to 18 carbon atoms in alkyl respectively.
Particularly preferred amphoteric surfactant is N-coco alkyl amino propionic acid salt, coconut oleoyl amine ethylamino propionate and C12/18-acyl sarcosinates.Except that amphoteric emulsifier, same suitable emulsifying agent also has the quaternary emulsifying agent, the emulsifying agent of preferred especially four esters types, preferred tetramethylated difatty acid triethanolamine ester salts.Also spendable anion emulsifier is alkyl ether sulphate, sulphuric acid monoglyceride, fatty acid sulfate, sulfosuccinate and/or ether carboxylic acid.
Suitable oily matter is based on the Guerbet alcohol of the aliphatic alcohol with individual, preferred 8-10 the carbon atom of 6-18, straight chain C
6-C
22Fatty acid and straight chain C
6-C
22The ester of aliphatic alcohol, side chain C
6-C
13Carboxylic acid and straight chain C
6-C
22The ester of aliphatic alcohol, straight chain C
6-C
22The ester of fatty acid and branched-chain alcoho (particularly 2-Ethylhexyl Alcohol), the ester and/or the guerbet alcohol of straight chain and/or branched chain fatty acid and polyhydroxy-alcohol (for example propylene glycol, dimer diol or trimer triol) are based on C
6-C
10The triglyceride of fatty acid is based on C
6-C
18Liquid glycerin monoesters/the diester of fatty acid, three ester admixtures, C
6-C
22Aliphatic alcohol and/or guerbet alcohol and aromatic carboxylic acid's's (particularly benzoic acid) ester, C
2-C
12The ester of dicarboxylic acids and straight or branched alcohol with 1 to 22 carbon atom or with the ester of polyhydric alcohol, vegetable oil, branched-chain primary alcohol, the cyclohexane extraction of replacement, straight chain C with 2 to 10 carbon atoms and 2 to 6 hydroxyls
6-C
22The aliphatic alcohol carbonic ester, guerbet carbonic ester, benzoic acid and straight chain and/or side chain C
6-C
22Alcohol is (as FinsoIv
TN) ester, dialkyl ethers, the open-loop products of epoxidized fatty acid ester and polyhydric alcohol, silicone oil and/or aliphatic series or cycloalkane.Adoptable other oily matter is a silicone compounds, for example dimethicone, methyl phenyl silicone, ring silicone, and the silicone compounds of amino, fatty acid, alcohol, polyethers, epoxy radicals, fluorine, alkyl and/or glucosides modification, the silicone compounds of described modification at room temperature both can be that liquid state also can be a resin form.Oily matter based on compositions be by weight 1% to 90%, preferred 5% to 80% and preferred especially 10% to 50% amount be present among the compositions of the present invention.
By suitable compound being coupled to the continuous action that can prolong significantly on the keratin-binding polypeptides (i) to skin.Carry out coupling as mentioned above, and prepare and use by method known to those skilled in the art.The effector molecule that is particularly suitable for doing deodorizer (ii) is aromatic oil, cyclodextrin, ion-exchanger, zinc ricinoleate, antibiotic/bacteriostatic compound (as DCMX, Irgasan DP 300, TCC).
What be applicable to antiperspirant is: tannic acid and zinc/aluminum salt.
The Another Application field of material of the present invention is the treatment or the preventive use of some skin and mucous membrane disorder.The active substance that is used for the treatment of/prevents preferably is combined in more by force and for more time particularly in oral cavity, pharyngeal and nasal septum film by the keratin binding structural domain.Its concrete range of application is:
-viral disease (as herpes, Coxsackie virus, varicella zoster, cytomegalovirus etc.);
-bacterial disease (as tuberculosis, syphilis etc.);
-fungal disease (as Candida disease, Cryptococcus disease, histoplasmosis, aspergillosis, mucormycosis etc.);
-neoplastic disease (as melanoma, adenoma etc.);
-autoimmune disease (as chronic pemphigus, large blister quasi-Pemphigus, systemic lupus erythematosus etc.);
-sunburn;
-parasitic infection (as tick, demodicid mite, flea etc.);
-insecticide contact (as the blood sucking insect, for example malarial mosquito etc.).
Can will be suitable for treating or the material (as corticoid, immunosuppressant compounds, antibiotic, anti-mildew material, antiviral compound, insect repellent or the like) that prevents is coupled on the keratin-binding polypeptides (i) by means of above-mentioned joint (according to the joint for the treatment of that link coupled functional group is optimized).
Embodiment 1: expression vector and production strain
Multiple expression vector is carried out the test of express keratin binding structural domain (KBD).For this purpose, can use multiple promoter (as IPTG induction type, rhamnose induction type, arabinose induction type, methanol evoked, constitutive promoter, or the like).Same tested K BD as fusion rotein (as with the fusion [B.subtilis, SWISS-PROT:P37527, PDX1] of thioredoxin or eGFP or YaaD) construct of expressing.Use multiple expression system to express the combination of described KBD-B (keratin binding structural domain B) and KBD-C (keratin binding structural domain C) and these two kinds of domain KBD-BC herein.The vector construction body of mentioning is for claims and nonrestrictive.
Explanation is the carrier collection of illustrative plates of IPTG induction type carrier pQE30-KBD-B (Fig. 3), methanol evoked carrier pLib15 (Fig. 4) and pLib16 (Fig. 5) and induction type carrier pLib19 (Fig. 6) as an example.The method that is used for KBD-C also can be similar to the structure and the expression of described carrier.
For example, for expressing K BD, use multiple production host, for example escherichia coli (E.coli) bacterial strain is (referring to embodiment 2; As XL10-Gold[Stratagene], BL21-CodonPlus[Stratagene], or the like).But, also can use other antibacterial to produce host, for example bacillus megaterium (Bacillus megaterium) or bacillus subtilis (Bacillus subtilis).With regard to the expression in the bacillus megaterium, method is similar to Barg, H., Malten, M. and Jahn, D. (2005) .Proteinand vitamin production in Bacillus megaterium.In Methods inBiotechnology-Microbial Products and Biotransformations (Barredo, J.-L. edits).
The fungus production strain of using is that pichia pastoris phaff (Pichia pastoris) is (referring to embodiment 3; As GS115 and KM71[all from Invitrogen]; Or the like) and aspergillus nidulans (Aspergillusnidulans) (referring to embodiment 4; As RMS011[Stringer, MA, Dean, RA, Sewall, TC, Timberlake, WE (1991), Rodletless, a new Aspergillus developmentalmutant induced by direct gene activation.Genes Dev 5:1161-1171] and SRF200[Karos, M, Fischer, R (1999), Molecular characterization ofHymA, an evolutionarily highly conserved and highly expressed protein ofAspergillus nidulans.Mol Genet Genomics 260:510-521], or the like).But, also might use other fungus to produce the host, for example be used for the aspergillus niger (Aspergillus niger) (KBD expresses and is similar to EP0635574A1 and/or WO98/46772) that KBD expresses.
Embodiment 2: by IPTG inducible promoter such as expression plasmid pQE30-KBD-B at expression in escherichia coli KBD
In order to express, use multiple production host, for example multiple e. coli strains (as XL10-Gold[Stratagene], BL21-CodonPlus [Stratagene], or the like), bacillus megaterium, bacillus subtilis or the like.
Explanation as an example, what describe in the literary composition is by cloning and expressing K BD-B with the pQE30-KBD-B transformed into escherichia coli:
The clone of pQE30-KBD-B
-prepare λ-MaxiDNA (λ DNA Maxi test kit, Qiagen) (BD Bioscience, Clontech, human keratinocyte cDNA, foreskin, the primary culture of logarithmic (log) phase, carrier: λ gt11) from human keratinocyte cDNA library.
PCR uses following oligonucleotide to carry out:
Bag 43 (5 '-GGTCAGTTACGTGCAGCTGAAGG-3 ') and
Bag?44(5′GCTGAGGCTGCCGGATCG-3’)。
-from agarose gel, downcut the PCR product of about 1102 bp of resulting size, and carry out purification.
The PCR product of-use purification carries out the PCR second time then as template:
Use following oligonucleotide:
Bag 53:(5 '-CGCGCCTCGAGCCACATACTGGTCTGC-3 ') and
Bag?51(5′-GCTTAGCTGAGGCTGCCGGATCG-3’)。
-from the PCR product of the about 1073bp of the resulting size of agarose gel cutting-out, purification also is cloned in the following carrier: pCR2.1-TOPO (Invitrogen).
-then with carrier pCR2.1-TOPO+KBD-B (5027bp) transformed into escherichia coli that obtains and increase, use xhoI and EcoRI enzyme action then, and with the KBD-B fragment cloning that obtains to pBAD/HisA (Invitrogen; Same with xhoI and EcoRI enzyme action) in.
-with SacI and the StuI new carrier pBAD/HisA+KBD-B (5171bp) that forms of enzyme action once more, and with the KBD-B fragment cloning that obtains to pQE30 (Qiagen; With SacI and SmaI enzyme action) in.With the expression vector pQE30-KBD-B (4321bp that obtains; See Fig. 3) be used for following KBD-B and express.
By the KBD-B of carrier pQE30-KBD-B, in peptide sequence SEQ ID NO:1, the 2193-2481 position, comprise the aminoacid MRGSHHHHHHGSACEL of N-terminal and the aminoacid GVDLQPSLIS of C-terminal in addition at expression in escherichia coli.
By pQE30-KBD-B at expression in escherichia coli KBD-B
-inoculate pre-culture from the plate or the glycerol culture of the e. coli strains that transformed by pQE30-KBD-B (as XL10-Gold[Stratagene]).According to the size of master culture, in test tube or little flask, inoculate with LB culture medium (about 1: 100).
-use antibiotic (for pQE30-KBD-B, ampicillin is 100 μ g/ml) according to used bacterial strain.
-carry out incubation 250rpm and 37 ℃.
-with pre-culture with about 1: 100 the inoculation master culture (master culture: contain corresponding antibiotic LB culture medium or suitable minimal medium).Carry out incubation in 250rpm and 37 ℃.
-surpass at 0.5 o'clock in OD (600nm) value, induce with 1mM IPTG.
-induce 4h after, centrifuge cell.
Method is similarly in fermentation tank, though might when higher OD value, induce, thus cell and protein output improved in a large number.
Embodiment 3: use methanol inducible promoters, as expression plasmid pLib 15 and pLib 16, carry out cell inner expression and the secreting, expressing (shaking bottle) of KBD by the pichia pastoris phaff bacterial strain
For the expression of KBD, use multiple pichia pastoris phaff strain, for example GS115 and KM71 (Pichia Expression test kit, Version M; Invitrogen LifeTechnologies).
Explanation as an example, what describe in the literary composition is to come expressing K BD-B with the pichia pastoris phaff that pLib15 (cell inner expression, carrier is seen Fig. 4) or pLib16 (secreting, expressing, carrier is seen Fig. 5) transform.
-in order to make up pLib15, (embodiment 2 with carrier pQE30-KBD-B, Fig. 3) as template, use following oligonucleotide by PCR the increase dna fragmentation of encoded K BD-B of the about 930bp of size: Lib148 (5 '-GCTAAGGAATTCACCATGCATCACCATCACCATCACGAGCCA CATACTGGTCTGCT-3 ') and Lib149 (5 '-GCTGGAGAATTCTCAGCTAATTAAGCTTGGCTGCA-3 ').All introduced the EcoRI restriction enzyme site at the two ends of PCR product herein.
-in order to make up pLib16, (embodiment 2 with carrier pQE30-KBD-B, Fig. 3) as template, use following oligonucleotide by PCR the increase dna fragmentation of encoded K BD-B of the about 930bp of size: Lib149 (5 '-GCTGGAGAATTCTCAGCTAATTAAGCTTGGCTGCA-3 ') and Lib150 (5 '-GCTAAGGAATTCCATCACCATCACCATCACGAGCCACATACTGGTCTGCT-3 ').All introduced the EcoRI restriction enzyme site at the two ends of PCR product herein.
-digest by EcoRI with oligonucleotide Lib148/Lib149 amplification PCR products, and be connected to the EcoRI enzyme action carrier pPIC3.5 (Pichia Expression test kit, Version M, Invitrogen) in.Check order by the carrier pLib15 (Fig. 4) that connection is obtained, verify correct KBD-B amplification.
-digest by EcoRI with oligonucleotide Lib149/Lib150 amplification PCR products, and be connected to the EcoRI enzyme action carrier pPIC9 (Pichia Expression test kit, Version M, Invitrogen) in.Check order by the carrier plib16 (Fig. 5) that connection is obtained, verify correct KBD-B amplification.
-use ring-type and the linearizing carrier pLib15 of StuI and pLib16 to transform the electroporation competent cell and the spheroplast of pichia pastoris phaff.
-carry out Southern engram analysis transformant by PCR and use chromosomal DNA.
-for pre-culture, the pichia pastoris phaff transformant of inoculation expressing K BD-B from flat board or glycerol culture.According to the size of master culture, (the Pichia-Expression-test kit, Version M Invitrogen) inoculates to use MGY, BMG or BMGY culture medium (about 1: 100) in test tube or little flask.
-with culture in 250-300rpm and 30 ℃ of incubations until OD
600=2-6.
-at room temperature came collecting cell in centrifugal 5 minutes by 1500-3000 * g.
-for master culture, with the cell precipitation collected with OD
600=1 be dispersed in the mM, the BMM that contain methanol or BMMY culture medium (the Pichia-Expression-test kit, Version M, Invitrogen) in so that abduction delivering.
-with master culture in 250-300rpm and 30 ℃ of incubation 1-96h.
-add 100% methanol by every 24h to keep until 0.5% methanol final concentration and induce.
-under the situation of cell inner expression, after main cultivation finishes, collect and smudge cells by the Menton-Gaulin method.
-under the situation of secreting, expressing, collect the culture supernatant, and direct purification KBD-B therefrom.
-in peptide sequence SEQ ID NO:1 the 2193-2481 position, the KBD-B of cell inner expression comprises the aminoacid MHHHHHH of N-terminal and the aminoacid GVDLQPSLIS of C-terminal in addition in pichia pastoris phaff (pLib15).
-in peptide sequence SEQ ID NO:1 the 2193-2481 position, the KBD-B of secreting, expressing comprises the aminoacid MRFPSIFTAVLFAASSALAAPVNTTTEDETAQIPAEAVIGYSDLEGDFDVAVLPFS NSTNNGLLFINTTIASIAAKEEGVSLEKREAEAYVEFHHHHHH of N-terminal and the aminoacid GVDLQPSLIS of C-terminal in addition in pichia pastoris phaff (pLib16).
In peptide sequence SEQ ID NO:1, the 2193-2481 position, comprise the aminoacid YVEFHHHHHH of N-terminal and the aminoacid GVDLQPSLIS of C-terminal in addition by pichia pastoris phaff (pLib16) processing and excretory KBD-B.
Embodiment 4: use induction type alcA promoter, as expression plasmid pLib 19, by aspergillus nidulans bacterial strain expressing K BD (shaking bottle)
In order to express, use the aspergillus nidulans wild-type strain, for example RMS011 or SRF200.Explanation as an example, what describe herein is to come expressing K BD-B with the aspergillus nidulans that pLib19 (Fig. 6) transforms.
-in order to make up pLib19, (embodiment 2 with carrier pQE30-KBD-B, Fig. 3) as template, use following oligonucleotide by PCR the increase dna fragmentation of encoded K BD-B of the about 900bp of size: Lib151 (5 '-CACCATGCATCACCATCACCATCACGAGCCACATACTGGTCTGCT-3 ') and Lib152 (5 '-GCTAATTAAGCTTGGCTGCA-3 ').The PCR product is linked carrier pENTR/D (pENTR
TMDirectional TOPO
The Cloning test kit, Version E, Invitrogen) in.Verify correct KBD-B amplified matter by checking order.
-use " Gateway
LR clonaseTM enzyme mix " (Invitrogen), the dna fragmentation of encoded K BD-B is recombinated among the carrier pMT-OvE (Toews MW, Warmbold J, Konzack S; Rischitor P, Veith D, Vienken K; Vinuesa C, Wei H, Fischer R; Establishment of mRFP1 as a fluorescent marker in Aspergillus nidulansand construction of expression vectors for high-throughput protein taggingusing recombination in vitro (GATEWAY). (2004) Curr Genet 45:383-389).This can prepare carrier pLib19 (Fig. 6).
-use circular vectors pLib19 to transform the protoplast of aspergillus nidulans wild-type strain.Carry out Southern engram analysis transformant by PCR and use chromosomal DNA.
-be the pre-cultivation of carrying out the aspergillus nidulans transformant of expressing K BD-B, in the 500ml flask, with 10
6-10
7Spore inoculating 100ml minimal medium (0.6%NaNO
3, 0.152%KH
2PO
4, 0.052%KCl[pH6.5], 0.8% glucose, 0.05%MgSO
4, 1ml trace element solution [1g/lFeSO
4* 7H
2O, 8.8g/l ZnSO
4* 7H
2O, 0.4g/l CuSO
4* 5H
2O, 0.15g/l MnSO
4* 4H
2O, 0.1g/l Na
2B
4O
7* 10H
2O, 0.05g/l (NH
4)
6Mo
7O
24* 4H
2O]+the specific fill-in of bacterial strain) or 100ml complete medium (2% malt extract, 0.1% peptone, the specific fill-in of 2% glucose+bacterial strain), and in 200-250rpm and 37 ℃ of incubation 16-24h.
-after pre-the cultivation, collect fungal mycelium, with distilled water wash and change in the flask that contains the fresh minimal medium of 100-500ml by filtering.In this main medium, use 0.1% fructose to replace glucose to be used as carbon source.In order to induce KBD to express, in culture medium, add ethanol (1% final concentration) or glycerol (50mM) or sodium acetate (50mM) or ethamine or threonine in addition.
Additive of mentioning that is used for abduction delivering and unrestricted claim.With master culture in 200-250rpm and 37 ℃ of other incubation 5-48h.
-after cultivating end, collected fungal mycelium in centrifugal 5 minutes by 1500-3000 * g under the room temperature, and carry out fragmentation by Menton-Gaulin.
-in peptide sequence SEQ ID NO:1 the 2193-2481 position, the KBD-B that expresses in aspergillus nidulans (pLib19) comprises the aminoacid MHHHHHH of N-terminal and the aminoacid KGGRADPAFLYKVVMIRLLTKPERKLLEGGPGTQLLFPLVRVNCALGVIMVIAVSC VKLLSAHNSTQHTSRKHKV of C-terminal in addition.
Embodiment 5: cell breakage and inclusion body purification (pQE30-KBD-B)
Can directly use institute behind the KBD purification of solubility expression.The following purification of KBD (as in inclusion body) that non-solubility is expressed:
-centrifugal fermented material is suspended in precipitation in the 20mM phosphate buffer (pH=7.4), and carries out fragmentation by Menton-Gaulin.
The cell of-recentrifuge fragmentation (15000g) is handled the therefrom precipitation of gained with 20mm phosphate, 500mm NaCl and 8M carbamide, and is stirred.
(dissolving of inclusion body)
-adjusting supernatant pH to 7.5.
-and then carry out centrifugally, and supernatant is applied on the agarose gel post of Ni chelating.
Embodiment 6: the purification of keratin binding structural domain B on the agarose gel post of Ni chelating
By on the Ni post to the absorption of His label, but chromatogram purification KBD.
Column material: high performance Ni-agarose gel,
The Amersham Biosciences number of ordering No.:17-5268-02
Material is inserted in the post (as diameter 2.6cm, height 10cm), and carried out balance with buffer A+4% buffer B (being equivalent to the 20mM imidazoles).
Use Superloop (
The KTA system) (the about 5ml/min of flow velocity) is added to protein extract (referring to cell breakage and inclusion body purification) on the post when pH 7.5.
Behind the strutting, wash with buffer A+20mM imidazoles.Carry out eluting with buffer B (buffer A of 500mM imidazoles).
Use fraction collector, collect the eluent in the fraction.
Buffer A: 20mM sodium dihydrogen phosphate
500mM?NaCl
8M carbamide
pH=7.40
Buffer B: 20mM sodium dihydrogen phosphate
500mM?NaCl
8M carbamide
The 500mM imidazoles
pH=7.40
Embodiment 7: the renaturation of keratin binding structural domain B.
As follows, renaturation also activates the keratin binding structural domain (as from inclusion body) that non-solubility is expressed:
Method 1: intermittently dialysis
8 M carbamide (Ni chelating eluent, HiTrap) in, 6.5ml Cellytic IB (Sigma, the number of ordering No.C5236) and 5mM DTT are joined in the 6.5ml KBD-B inclusion body.To treat that then the solution of renaturation pours in the Dialysis tubing (Spectrum:Spectra Por MWCO:12-14kD).
At 4 ℃,, dialysed about 12 hours with the 6M urea liquid of 1L by careful stirring.
The 25mM Tris/HCl (pH=7.50) that adds 500ml then, and dialysed like this 9 hours at 4 ℃.Add other 250ml Tris buffer (seeing above) subsequently, and dialysed in addition 12 hours.
And then add the Tris/HCl (pH=7.50) of 500ml 25mM, and dialysed like this 9 hours at 4 ℃.Add other 250ml Tris buffer (seeing above) subsequently, and dialysed in addition 12 hours.
And then add the Tris/HCl (pH=7.50) of 500ml 25mM, and dialysed like this 9 hours at 4 ℃.The Dialysis tubing that will comprise dialysis solution is then put into the 25mM Tris+150mMNaCl (pH=7.50) of 2L.Dialysed once more 12 hours at 4 ℃ then.
Take out the inclusions in the Dialysis tubing then.
Method 2: dialysis continuously
The 8M urea liquid (Ni chelating eluent, HiTrap) in, with 10ml Cellytic IB (Sigma, the number of ordering No.C5236) and 5mM DTT processing 20ml KBD-B inclusion body.Pour solution into dialysate chamber then: Slide-A-Lyzer Dialyses Cassette PIERCE, MWCO:10kD.The number of ordering No.:66830.
Dialysed about 1 hour at 4 ℃ of 6M urea liquids then with 1L.
Then, during 48h in, by the following buffer of peristaltic pump continuous metering 2L: 25mMTris/HCl (pH=7.5).
In the Dialysis tubing that contains dialysis solution, add 2L stop buffer: 25mM Tris+150mM NaCl (pH=7.50) then, and dialysed about 12 hours at 4 ℃.
Take out the inclusions in the Dialysis tubing then.
Embodiment 8: with 1 (qualitative) that combine of skin
Developed visual qualitative test whether to study KBD in conjunction with skin.
Solutions employed:
Confining liquid: DIG washing liquid+be diluted in buffer series 1585762 BoehringerMA (10 * solution) among the TBS.
TBS:20mM?Tris;150mM?NaCl,pH?7.5
TTBS:TBS+0.05%Tween20
The first step is that the outer keratin of skin is transferred on the stable holder.For this purpose, adhesive tape is adhered to securely on the application on human skin of depilation, and take off once more.Can directly on adhesive tape, test, perhaps utilize new adhesion that adherent keratin layer is forwarded on the microscope slide.Following checking combination:
-in order to carry out incubation, change the Falcon pipe over to plurality of reagents;
If-be suitable for, add ethanol and carry out defat, remove ethanol and dry microscope slide;
Under-the room temperature with sealing buffer incubation 1h;
-wash 2 times each 5 minutes with TTBS;
-washed 1 time 5 minutes with TBS;
-in TBS/0.05%Tween 20, (be coupled to label, as His with KBD to be measured
6, HA etc.) or control protein in room temperature incubation 2-4h;
-remove supernatant;
-wash 3 times with TBS;
-with in the TBS+0.01% confining liquid by 1: 2000 the dilution monoclonal anti polyhistidyl (or specific rabbit KBD) antibody in room temperature incubation 1h;
-wash 2 times each 5 minutes with TTBS;
-washed 1 time 5 minutes with TBS;
-with in the TBS+0.01% confining liquid by 1: 5000 the dilution anti-mice IgG alkali phosphatase conjugate in room temperature incubation 1h;
-wash 2 times each 5 minutes with TTBS;
-washed 1 time 5 minutes with TBS;
-adding phosphatase substrate (NBT-BCIP; 1/40ml of Boehringer MA water reacted 2.5 minutes; The water cessation reaction)
-with the naked eye or use Optics in Microscope to detect coloured precipitate.Blue precipitate represents that KBD has been incorporated into skin.
Embodiment 9: with 2 (quantitatively) that combine of skin
Developed quantitative test, available comparison nonspecific proteins matter and KBD be to the bond strength of hair/skin.
Use the 5mm card punch on skin that thaw, atrichous (people or pig) dry crushing sheet, to get out section (or with regard to surface test, skin biopsy being inserted in the Falcon slide glass).It is thick then skin samples to be processed into 2-3mm, to remove any tissue that exists.Then skin samples is changed over to Eppendorf pipe (the weak combination of protein) to carry out combination checking (referring to Fig. 7):
-wash 2 times with PBS/0.05%Tween 20;
-add the PBS solution of 1ml 1%BSA, and softly rotate (900rpm) incubation 1h in room temperature.
-remove supernatant.
-in PBS, add 100 μ g KBD with 0.05%Tween 20; Room temperature incubation 2h and soft rotate (900rpm).
-remove supernatant
-wash 3 times with PBS/0.05%Tween 20.
-with the peroxidase conjugated thing of 1ml monoclonal mouse anti label (His6 or HA or specificity KBD) antibody (be dissolved at 1: 2000 PBS) [the monoclonal anti polyhistidyl peroxidase conjugated thing lyophilized powder that in mice, prepares with 0.05%Tween 20, Sigma] in room temperature incubation 2-4h, soft rotate (900rpm).
-wash 3 times with PBS/0.05%Tween 20.
-(1ml/Eppendorf manages to add peroxidase substrate; Form and vide infra).
-allow reaction to proceed to (about 90 seconds) till the blue colour developing.
-with 100 μ l, 2 M H
2SO
4Cessation reaction.
-in 450nm measure light absorption value.
Peroxidase substrate (preparation newly in advance):
0.1ml TMB solution (the DMSO liquid of 42mM TMB)
+ 10ml substrate buffer solution (the 0.1M sodium acetate, pH4.9)
+ 14.7 μ l H
2O
2, concentration is 3%
Embodiment 10: with combine (quantitatively) of hair
In order to prove that KBD is also relevant with other albumen to the bond strength of hair, has developed quantitative determination process (referring to Fig. 7).In this test, at first with hair with the KBD incubation, and the excessive KBD of flush away.Pass through His label and the antibody-peroxidase conjugated thing coupling of KBD then.The unconjugated antibody of flush away-peroxidase conjugated thing once more.Bonded antibody-peroxidase conjugated thing [monoclonal anti polyhistidyl peroxidase conjugated thing, the lyophilized powder for preparing in mice, Sigma] can be converted into colourless substrate (TMB) coloured product that can carry out photometric measurement at the 405nm place.Photon absorbing intensity is represented the amount of bonded KBD or control protein.For example, control protein is selected from the YaaD of bacillus subtilis, its have equally [for this test necessary] the His label that is used to detect.Also can use the peroxidase conjugated thing of other specific antibody to replace the His label.
5mg hair (people) is cut into the long section of 5mm, and changes Eppendorf pipe (the weak combination of albumen) over to so that carry out the combination checking:
-adding is used for the 1ml ethanol of defat;
-centrifugal, remove ethanol and use H
2The O washing;
-add the PBS solution of 1ml 1%BSA, and softly rotate incubation 1h in room temperature;
-centrifugal, remove supernatant;
-adding keratin binding structural domain (being coupled to label) or control protein to be measured in the PBS/0.05%Tween 20 of 1ml as His6, HA or the like; 4 ℃ of soft rotations with incubation 16h (or room temperature incubation 2h) at least;
-centrifugal, remove supernatant;
-wash 3 times with PBS/0.05%Tween 20;
-the peroxidase conjugated thing of 1ml monoclonal mouse anti label (His6 or HA or specificity KBD) antibody (be dissolved at 1: 2000 PBS/0.05%Tween 20) [the peroxidase conjugated thing lyophilized powder of the monoclonal anti polyhistidyl for preparing in mice, Sigma] is softly rotated in room temperature incubation 2-4h together;
-wash 3 times with PBS/0.05%Tween 30;
-adding peroxidase substrate (1ml/Eppendorf pipe);
-allow reaction to proceed to (about 2 minutes) till the blue colour developing;
-with the 2 M H of 100 μ l
2SO
4Cessation reaction.
-in 450nm measure light absorption value.
Peroxidase substrate (preparation newly in advance):
0.1ml TMB solution (the DMSO liquid of 42mM TMB);
+ 10ml substrate buffer solution (the 0.1M sodium acetate, pH4.9);
+ 14.7 μ l H
2O
2, concentration is 3%.
The BSA=bovine serum albumin;
The PBS=phosphate buffered saline;
Tween 20=polyoxyethylene mono laurate sorbitan ester, n about 20;
TMB=3,5,3 ', 5 '-the N tetramethyl benzidine.
What carry out on hair is the combination test of example with KBD-B, proves with the significantly weak combination of control protein YaaD to compare, and KBD-B has suitable advantage to the combination of hair:
1 | Buffer | ?A 405nm=0.000 |
?2 | Control protein YaaD | ?A 405nm=0.088 |
?3 | The KBD-B of degeneration | ?A 405nm=0.254 |
?4 | The KBD-B of renaturation | ?A 405nm=1.591 |
Table 1: the quantitative active testing of the KBD of hair: 1) buffer; 2) control protein YaaD; 3) KBD-B of degeneration; 4) KBD-B of renaturation.This table has shown the absorption value of surveying at 405nm.
Embodiment 10a: the coupling of dyestuff and KBD-B
For with fluorescent dye (Alexa Fluor 532, Molecular Probes/Invitrogen) and KBD-B albumen coupling, come the coupling dyestuff according to the maleic acid imidodicarbonic diamide joint of following method by the cysteine mercapto.Reaction as shown in Figure 8.
-1mg Alexa Fluor 532 is dissolved among the 150 μ l PBS buffer (pH=7.0); Of short duration subsequently centrifugal to remove any indissolvable component;
-the dissolved dyestuff of 10 μ l is added among the 100 μ g KBD-B (1mg/ml);
-use the aluminium foil covering mixture, and on agitator with 450pm in 24 ℃ of incubations 1 hour;
The 1 M DTT of-adding 10 μ l comes the maleic acid imidodicarbonic diamide functional group of the unreacted Alexa Fluor 532 of inactivation;
-then 450pm and 24 ℃ of incubations (covering) 30 minutes with aluminium foil.
By active testing (referring to embodiment 9 and 10), be measured to the coupling that coupling has KBD-B and the skin/hair of Alexa Fluor 532.Be similar to embodiment 9 or 10 and be combined in KBD-B-Alexa Fluor 532 couplings on skin or the hair, can be at an easy rate with fluorescence microscope (launch in absorption: 532nm/: the 590nm place is detected) on the hair or with the naked eye on the hair of bleaching, detect.
The effect of embodiment 11:KBD in oil-in-water type day nursing Emulsion
AI1%:
% composition (INCI)
A 1.7 ceteareth-6, octadecanol
0.7 ceteareth-25
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
2.0 PEG-14 dimethicone
3.6 cetearyl alcohol
6.0 ethylhexyl Methoxycinnamate
2.0 dibutyl adipate
B 5.0 glycerol
0.2 sodium ethylene diamine tetracetate
1.0 pantothenylol
An amount of antiseptic
67.8 water
C 4.0 caprylic/capric triglyceride, sodium acrylate copolymer
D 0.2 vitamin C sodium phosphate
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
1.0 caprylic/capric triglyceride, sodium ascorbate, tocopherol, retinol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of sodium hydroxide of E
AI?5%:
% composition (INCI)
A 1.7 ceteareth-6, octadecanol
0.7 ceteareth-25
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
2.0 PEG-14 dimethicone
3.6 cetearyl alcohol
6.0 basic hexyl Methoxycinnamate
2.0 dibutyl adipate
B 5.0 glycerol
0.2 sodium ethylene diamine tetracetate
1.0 pantothenylol
An amount of antiseptic
63.8 water
C 4.0 caprylic/capric triglyceride, sodium acrylate copolymer
D 0.2 vitamin C sodium phosphate
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
1.0 caprylic/capric triglyceride, sodium ascorbate, tocopherol, retinol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of sodium hydroxide of E
Preparation: heat A independent of one another mutually and extremely about 80 ℃ mutually of B.With B pour into while stirring mutually A mutually in, and stir evenly.C is mixed in the mixed phase of A and B mutually while stirring, and stirs evenly once more.Stirring is cooled to about 40 ℃, adds the D phase, regulates pH mutually to about 6.5 with E, stirs evenly, and stirs and be cooled to room temperature.
Attention: the preparation preparation need not to protect gas.Must in the packing of oxygen flow not, carry out fill, as aluminum pipe.
The purposes of embodiment 12:KBD in oil-in-water type protectiveness day cream
AI?1%:
% composition (INCI)
A 1.7 ceteareth-6, octadecanol
0.7 ceteareth-25
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
2.0 PEG-14 dimethicone
3.6 cetearyl alcohol
6.0 basic hexyl Methoxycinnamate
2.0 dibutyl adipate
B 5.0 glycerol
0.2 sodium ethylene diamine tetracetate
1.0 pantothenylol
An amount of antiseptic
68.6 water
C 4.0 caprylic/capric triglyceride, sodium acrylate copolymer
D 1.0 vitamin C sodium phosphates
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of sodium hydroxide of E
AI?5%:
% composition (INCI)
A 1.7 ceteareth-6, octadecanol
0.7 ceteareth-25
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
2.0 PEG-14 dimethicone
3.6 cetearyl alcohol
6.0 basic hexyl Methoxycinnamate
2.0 dibutyl adipate
B 5.0 glycerol
0.2 sodium ethylene diamine tetracetate
1.0 pantothenylol
An amount of antiseptic
64.6 water
C 4.0 caprylic/capric triglyceride, sodium acrylate copolymer
D 1.0 vitamin C sodium phosphates
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of sodium hydroxide of E
Preparation: heat A independent of one another mutually and extremely about 80 ℃ mutually of B.With B pour into while stirring mutually A mutually in, and stir evenly.C is poured into mutually in the mixed phase of A and B, and stir evenly.Stirring is cooled to about 40 ℃.Add the D phase, regulate pH mutually to about 6.5 and stir evenly with E.Stirring is cooled to room temperature.The purposes of embodiment 13:KBD in clean lotion of oil-in-water type
AI?1%:
% composition (INCI)
A 10.0 cetearyl ethylhexoates
10.0 caprylic/capric triglyceride
1.5 encircle penta siloxanes, hexamethylene siloxanes
2.0 PEG-40 castor oil hydrogenated
B 3.5 caprylic/capric triglyceride, sodium acrylate copolymer
C 1.0 tocopheryl acetates
0.2 Bisabolol terpene alcohol
An amount of antiseptic
An amount of aromatic oil
D 3.0 polyquaternary ammonium salt-44
0.5 cocos nucifera oil trimethyl sulfate methyl ammonium
0.5 ceteareth-25
2.0 pantothenylol, propylene glycol
4.0 propylene glycol
0.1 sodium ethylene diamine tetracetate
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
60.7 water
AI?5%:
% composition (INCI)
A 10.0 cetearyl ethylhexoates
10.0 caprylic/capric triglyceride
1.5 encircle penta siloxanes, hexamethylene siloxanes
2.0 PEG-40 castor oil hydrogenated
B 3.5 caprylic/capric triglyceride, sodium acrylate copolymer
C 1.0 tocopheryl acetates
0.2 Bisabolol terpene alcohol
An amount of antiseptic
An amount of aromatic oil
D 3.0 polyquaternary ammonium salt-44
0.5 cocos nucifera oil trimethyl sulfate methyl ammonium
0.5 ceteareth-25
2.0 pantothenylol, propylene glycol
4.0 propylene glycol
0.1 sodium ethylene diamine tetracetate
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
56.7 water
Preparation: dissolving A phase.With B pour into while stirring mutually A mutually in.C is poured into mutually in the mixed phase of A and B.Dissolving D phase is poured into while stirring in the mixed phase of A, B and C, and is stirred evenly.Stirred afterwards 15 minutes.
The purposes of embodiment 14:KBD in the daily nursing body sprays
AI?1%:
% composition (INCI)
A 3.0 basic hexyl Methoxycinnamates
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
1.0 polyquaternary ammonium salt-44
3.0 propylene glycol
2.0 pantothenylol, propylene glycol
1.0 encircle penta siloxanes, hexamethylene siloxanes
10.0 octyl dodecanol
0.5 PVP
10.0 caprylic/capric triglyceride
3.0 C12-15 alkyl benzoate
3.0 glycerol
1.0 tocopheryl acetate
0.3 Bisabolol terpene alcohol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
59.2 alcohol
% composition (INCI)
A 3.0 basic hexyl Methoxycinnamates
20 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
1.0 polyquaternary ammonium salt-44
3.0 propylene glycol
2.0 pantothenylol, propylene glycol
1.0 encircle penta siloxanes, hexamethylene siloxanes
10.0 octyl dodecanol
0.5 PVP
10.0 caprylic/capric triglyceride
3.0 C12-15 alkyl benzoate
3.0 glycerol
1.0 tocopheryl acetate
0.3 Bisabolol terpene alcohol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
55.2 alcohol
Preparation: weigh and dissolve the A phase component until clarification.
The purposes of embodiment 15:KBD in the skin nursing gel
% composition (INCI)
A 3.6 PEG-40 castor oil hydrogenated
15.0 alcohol
0.1 Bisabolol terpene alcohol
0.5 tocopheryl acetate
An amount of aromatic oil
B 3.0 pantothenylol
0.6 carbomer
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
75.4 water
C 0.8 triethanolamine
AI?5%:
% composition (INCI)
A 3.6 PEG-40 castor oil hydrogenated
15.0 alcohol
0.1 Bisabolol terpene alcohol
0.5 tocopheryl acetate
An amount of aromatic oil
B 3.0 pantothenylol
0.6 carbomer
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
71.4 water
C 0.8 triethanolamine
Preparation: A is up to clarification in dissolving.Make B expand mutually and neutralize mutually with C.With A pour into while stirring mutually uniform B mutually in, and stir evenly.
The purposes of embodiment 16:KBD in the back maintenance liquid that shaves
AI?1%:
% composition (INCI)
A 10.0 cetearyl ethylhexoates
5.0 tocopheryl acetate
1.0 Bisabolol terpene alcohol
0.1 aromatic oil
0.3 acrylate/C10-30 alkyl acrylate cross-linked polymer
B 15.0 alcohol
1.0 pantothenylol
3.0 glycerol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.1 triethanolamine
63.5 water
AI?5%:
% composition (INCI)
A 10.0 cetearyl ethylhexoates
5.0 tocopheryl acetate
1.0 Bisabolol terpene alcohol
0.1 aromatic oil
0.3 acrylate/C10-30 alkyl acrylate cross-linked polymer
B 15.0 alcohol
1.0 pantothenylol
3.0 glycerol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.1 triethanolamine
59.5 water
Preparation: the component of mixing the A phase.Dissolving B phase, be incorporated into A mutually in and stir evenly.
Embodiment 17:KBD is the purposes in the lotion after Exposure to Sunlight
AI?1%:
% composition (INCI)
A 0.4 acrylate/C10-30 alkyl acrylate cross-linked polymer
15.0 cetearyl ethylhexoate
0.2 Bisabolol terpene alcohol
1.0 tocopheryl acetate
An amount of aromatic oil
B 1.0 pantothenylol
15.0 alcohol
3.0 glycerol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
63.2 water
C 0.2 triethanolamine
AI?5%:
% composition (INCI)
A 0.4 acrylate/C10-30 alkyl acrylate cross-linked polymer
15.0 cetearyl ethylhexoate
0.2 Bisabolol terpene alcohol
1.0 tocopheryl acetate
An amount of aromatic oil
B 1.0 pantothenylol
15.0 alcohol
3.0 glycerol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
59.2 water
C 0.2 triethanolamine
Preparation: the component of mixing the A phase.With B pour into while stirring mutually A mutually in.Neutralize mutually and stir evenly once more with C.
The purposes of embodiment 18:KBD in sunscreen lotion
AI?1%:
% composition (INCI)
A 4.5 basic hexyl Methoxycinnamates
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
3.0 1-Octyl acrylate
2.5 two C12-13 alkyl malates
0.5 tocopheryl acetate
4.0 polyglycereol-3 methyl glucoside distearate
B 3.5 different n-nonanoic acid cetearyl alcohol esters
1.0 VP/ icosane copolymer
5.0 2-Methylpentadecane
2.5 two C12-13 alkyl malates
30 titanium dioxide, trimethoxy decoyl silane
C 5.0 glycerol
1.0 cetearyl alcohol sodium sulfate
0.5 xanthan gum
59.7 water
D 1.0 has the aqueous solution of about 5% keratin binding structural domain active component
1.0 phenoxyethanol, methyl parahydroxybenzoate, ethylparaben,
Butyl p-hydroxybenzoate, propyl parabene, p-Hydroxybenzoic acid isobutyl ester
0.3 Bisabolol terpene alcohol
AI?5%:
% composition (INCI)
A 4.5 basic hexyl Methoxycinnamates
2.0 diethyl base ammonia (2-hydroxybenzoyl) hexyl benzene formic acid esters
3.0 1-Octyl acrylate
2.5 two C12-13 alkyl malates
0.5 tocopheryl acetate
4.0 polyglycereol-3 methyl glucoside distearate
B 3.5 different n-nonanoic acid cetearyl alcohol esters
1.0 VP/ icosane copolymer
5.0 2-Methylpentadecane
2.5 two C12-13 alkyl malic acids
3.0 titanium dioxide, trimethoxy decoyl silane
C 5.0 glycerol
1.0 cetearyl alcohol sodium sulfate
0.5 xanthan gum
55.7 water
D 5.0 has the aqueous solution of about 5% keratin binding structural domain active component
1.0 phenoxyethanol, methyl parahydroxybenzoate, ethylparaben,
Butyl p-hydroxybenzoate, propyl parabene, p-Hydroxybenzoic acid isobutyl ester
0.3 Bisabolol terpene alcohol
Preparation: heat A phase and extremely about 80 ℃ of B components mutually independent of one another.With B pour into while stirring mutually A mutually in, and stir evenly.To about 80 ℃, stirring is poured the mixed phase of A and B into and is stirred evenly with the C heat phase.Stirring is cooled to about 40 ℃, adds D and also stirs evenly once more mutually.
The purposes of embodiment 19:KBD in the oil-in-water type sunscreen lotion
AI?1%:
% composition (INCI)
A 2.0 ceteareth-6, octadecanol
2.0 ceteareth-25
3.0 methyl behenate
2.0 cetearyl alcohol
2.0 cetearyl ethylhexoate
5.0 ethylhexyl Methoxycinnamate
1.0 basic hexyl triazinone
1.0 VP/ icosane copolymer
7.0 isopropyl myristate
B 5.0 zinc oxides, the sad silane of triethoxy
C 0.2 xanthan gum
0.5 hydroxy ethyl methacrylate/sodium acryloyldimethyl taurate copolymers, squalane,
Polysorbate 60
0.2 sodium ethylene diamine tetracetate
5.0 propylene glycol
0.5 pantothenylol
60.9 water
D 1.0 has the aqueous solution of about 5% keratin binding structural domain active component
0.5 phenoxyethanol, methyl parahydroxybenzoate, ethylparaben,
Ethylparaben, propyl parabene, p-Hydroxybenzoic acid isopropyl ester
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
AI?5%:
% composition (INCI)
A 2.0 ceteareth-6, octadecanol
2.0 ceteareth-25
3.0 methyl behenate
2.0 cetearyl alcohol
2.0 cetearyl ethylhexoate
5.0 ethylhexyl Methoxycinnamate
1.0 basic hexyl triazinone
1.0 VP/ icosane copolymer
7.0 isopropyl myristate
B 5.0 zinc oxides, the sad silane of triethoxy
C 0.2 xanthan gum
0.5 hydroxy ethyl methacrylate/sodium acryloyldimethyl taurate copolymers, squalane,
Polysorbate 60
0.2 sodium ethylene diamine tetracetate
5.0 propylene glycol
0.5 pantothenylol
56.9 water
D 5.0 has the aqueous solution of about 5% keratin binding structural domain active component
0.5 phenoxyethanol, methyl parahydroxybenzoate, ethylparaben,
Ethylparaben, propyl parabene, p-Hydroxybenzoic acid isopropyl ester
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
Prepare: heating A is mutually to about 80 ℃, and stirring is poured the B phase into and stirred evenly 3 minutes.Similarly heat C to 80 ℃, stirring is poured in A and the B mixed phase and is stirred evenly.Be cooled to about 40 ℃, stirring is poured D into and is also stirred evenly once more mutually
The purposes of embodiment 20:KBD in the oil-in-water type sunscreen lotion
AI?1%:
% composition (INCI)
A 3.5 ceteareth-6, octadecanol
1.5 ceteareth-25
7.5 ethylhexyl Methoxycinnamate
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
2.0 encircle penta siloxanes, hexamethylene siloxanes
0.5 Cera Flava
3.0 cetearyl alcohol
10.0 caprylic/capric triglyceride
B 5.0 titanium dioxide, Silicon stone, methyl-silicone oil, Alumina
C 3.0 glycerol
0.2 sodium ethylene diamine tetracetate
0.3 xanthan gum
1.0 decyl glucosides
2.0 pantothenylol, propylene glycol
56.3 water
D 1.0 has the aqueous solution of about 5% keratin binding structural domain active component
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
An amount of aromatic oil
An amount of antiseptic
AI?5%:
% composition (INCI)
A 3.5 ceteareth-6, pantothenylol
1.5 ceteareth-25
7.5 ethylhexyl Methoxycinnamate
2.0 diethylamino (2-hydroxybenzoyl) hexyl benzene formic acid esters
2.0 encircle penta siloxanes, hexamethylene siloxanes
0.5 Cera Flava
3.0 cetearyl alcohol
10.0 caprylic/capric triglyceride
B 5.0 titanium dioxide, Silicon stone, methyl-silicone oil, Alumina
C 3.0 glycerol
0.2 sodium ethylene diamine tetracetate
0.3 xanthan gum
1.0 decyl glucosides
2.0 pantothenylol, propylene glycol
52.3 water
D 5.0 has the aqueous solution of about 5% keratin binding structural domain active component
1.0 tocopheryl acetate
0.2 Bisabolol terpene alcohol
An amount of aromatic oil
An amount of antiseptic
Prepare: heating A is mutually to about 80 ℃, and stirring is poured the B phase into and stirred evenly 3 minutes.Similarly, heat C to 80 ℃, stir in the mixed phase pour A and B into and stir evenly.Be cooled to about 40 ℃, stirring is poured D into and is also stirred evenly once more mutually.
The purposes of embodiment 21:KBD in the foot balsam
AI?1%:
% composition (INCI)
A 2.0 ceteareth-6, pantothenylol
2.0 ceteareth-25
5.0 cetearyl ethylhexoate
4.0 spermol
4.0 tristerin
5.0 mineral oil
0.2 menthol
0.5 Camphora
B 69.3 water
An amount of antiseptic
C 1.0 Bisabolol terpene alcohol
1.0 tocopheryl acetate
D 1.0 has the aqueous solution of about 5% keratin binding structural domain active component
5.0 Radix Hamamelidis Mollis extract
AI?5%:
% composition (INCI)
A 2.0 ceteareth-6, pantothenylol
2.0 ceteareth-25
5.0 cetearyl ethylhexoate
4.0 spermol
4.0 tristerin
5.0 mineral oil
0.2 menthol
0.5 Camphora
B 65.3 water
An amount of antiseptic
C 1.0 Bisabolol terpene alcohol
1.0 tocopheryl acetate
D 5.0 has the aqueous solution of about 5% keratin binding structural domain active component
5.0 Radix Hamamelidis Mollis extract
Preparation: heat A phase and extremely about 80 ℃ of B components mutually independent of one another.With B stir mutually pour into A mutually in.Stirring is cooled to about 40 ℃, of short duration stir evenly the back add C mutually with D mutually.Stirring is cooled to room temperature.
The purposes of embodiment 22:KBD in water-in-oil emulsion with Bisabolol terpene alcohol
AI?1%:
% composition (INCI)
A 6.0 PEG-7 castor oil hydrogenated
8.0 cetearyl ethylhexoate
5.0 isopropyl myristate
15.0 mineral oil
0.3 magnesium stearate
0.3 aluminium stearate
2.0 PEG-45/ dodecyl glycol copolymer
B 5.0 glycerol
0.7 magnesium sulfate
55.6 water
C 1.0 has the aqueous solution of about 5% keratin binding structural domain active component
0.5 tocopheryl acetate
0.6 Bisabolol terpene alcohol
AI?5%:
% composition (INCI)
A 6.0 PEG-7 castor oil hydrogenated
8.0 cetearyl ethylhexoate
5.0 isopropyl myristate
15.0 mineral oil
0.3 magnesium stearate
0.3 aluminium stearate
2.0 PEG-45/ dodecyl glycol copolymer
B 5.0 glycerol
0.7 magnesium sulfate
51.6 water
C 5.0 has the aqueous solution of about 5% keratin binding structural domain active component
0.5 tocopheryl acetate
Preparation: heat A independent of one another mutually and extremely about 85 ℃ mutually of B.With B stir mutually pour into A mutually in, and stir evenly.Stirring is cooled to about 40 ℃, adds C phase and of short duration once more stirring evenly.Stirring is cooled to room temperature.
Preparation tabulation-the hair care that is used for patent keratin binding structural domain
Embodiment 23: the foamed glue conditioner with setting agent
AI?1%
% composition (INCI)
A 10.0 PVP/VA copolymers
0.2 ethoxy spermaceti dimethyl ammonium phosphate
0.2 ceteareth-25
0.5 dimethicone copolyol
An amount of aromatic oil
10.0 alcohol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
68.1 water
10.0 propane/butane
AI?5%
% composition (INCI)
A 10.0 PVP/VA copolymers
0.2 ethoxy spermaceti dimethyl ammonium phosphate
0.2 ceteareth-25
0.5 dimethicone copolyol
An amount of aromatic oil
10.0 alcohol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
64.1 water
10.0 propane/butane
Preparation: the component of the A phase of weighing together, stir until all the components dissolving and fill.
Embodiment 24: the foamed glue conditioner
AI?1%
% composition (INCI)
A 1.0 polyquaternary ammonium salt-4
0.5 ethoxy spermaceti dimethyl ammonium phosphate
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of aromatic oil
An amount of antiseptic
91.5 water
6.0 propane/butane
AI?5%
% composition (INCI)
A 1.0 polyquaternary ammonium salt-4
0.5 ethoxy spermaceti dimethyl ammonium phosphate
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of aromatic oil
An amount of antiseptic
87.5 water
6.0 propane/butane
Preparation: the component of the A phase of weighing together, stir until all the components dissolving and produce clear liquid and fill.
Embodiment 25: the foamed glue conditioner
AI?1%
% composition (INCI)
A 1.0 polyquaternary ammonium salt-11
0.5 ethoxy spermaceti dimethyl ammonium phosphate
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of aromatic oil
An amount of antiseptic
91.5 water
6.0 propane/butane
AI?5%
% composition (INCI)
A 1.0 polyquaternary ammonium salt-11
0.5 ethoxy spermaceti dimethyl ammonium phosphate
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of aromatic oil
An amount of antiseptic
87.5 water
6.0 propane/butane
Preparation: the component of the A phase of weighing together, stir until all the components dissolving and produce clear liquid and fill.
Embodiment 26: the hair style foamed glue
AI?1?%
% composition (INCI)
A 0.5 lauryl alcohol-4
An amount of aromatic oil
B 77.3 water
10.0 polyquaternary ammonium salt-28
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 dimethicone copolyol
0.2 ceteareth-25
0.2 pantothenylol
0.1 PEG-25?PABA
0.2 hydroxyethyl-cellulose
C 10.0 HFC?152?A
% composition (INCI)
A 0.5 lauryl alcohol-4
An amount of aromatic oil
B 73.3 water
10.0 polyquaternary ammonium salt-28
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 methyl-silicone oil copolyol
0.2 ceteareth-25
0.2 pantothenylol
0.1 PEG-25?PABA
0.2 hydroxyethyl-cellulose
C 10.0 HFC?152?A
Preparation: the component of mixing the A phase.The component and the dissolving that add the B phase one by one.With C fill together mutually.
Embodiment 27: the hair style foamed glue
AI?1%
% composition (INCI)
A 2.0 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 78.5 water
6.7 acrylate copolymer
0.6 AMP
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 dimethicone copolyol
0.2 ceteareth-25
0.2 pantothenylol
0.1 PEG-25?PABA
0.2 hydroxyethyl-cellulose
C 10.0 HFC?152?A
AI?5%
% composition (INCI)
A 2.0 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 74.5 water
6.7 acrylate copolymer
0.6 AMP
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 dimethicone copolyol
0.2 ceteareth-25
0.2 pantothenylol
0.1 PEG-25?PABA
0.2 hydroxyethyl-cellulose
C?10.0 HFC?152?A
Preparation: the component of mixing the A phase.The component and the dissolving that add the B phase one by one.With C fill together mutually.
Embodiment 28: the hair style foamed glue
AI?1%
% composition (INCI)
A 2,0 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 7.70 polyquaternary ammonium salt-44
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of antiseptic
79.3 water
C 10.0 propane/butane
AI?5%
% composition (INCI)
A 2.0 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 7.70 polyquaternary ammonium salt-44
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of antiseptic
75.3 water
C 10.0 propane/butane
Preparation: the component of mixing the A phase.Dissolving B phase component stirs B mutually then and pours the A phase into until clarification.Regulate pH to 6-7, with C fill together mutually.
Embodiment 29: the hair style foamed glue
AI?1%
% composition (INCI)
A 2.00 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 72.32 water
2.00 VP/ acrylate/metering system dodecyl gallate copolymer
0.53 AMP
1.00 have the aqueous solution of about 5% keratin binding structural domain active component
0.20 ceteareth-25
0.50 pantothenylol
0.05 benzophenone-4
0.20 amino dimethicone, hexadecyltrimethylammonium chloride,
Tridecyl polyoxyethylene ether-12
15.00 alcohol
C 0.20 hydroxyethyl-cellulose
D 6.00 propane/butane
AI?5%
% composition (INCI)
A 2.00 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 68.32 water
2.00 VP/ acrylate/metering system dodecyl gallate copolymer
0.53 AMP
5.00 have the aqueous solution of about 5% keratin binding structural domain active component
0.20 ceteareth-25
0.50 pantothenylol
0.05 benzophenone-4
0.20 amino dimethicone, hexadecyltrimethylammonium chloride,
Tridecyl polyoxyethylene ether-12
15.00 alcohol
C 0.20 hydroxyethyl-cellulose
D 6.00 propane/butane
Preparation: the component of mixing the A phase.The component and the dissolving that add the B phase one by one.C is dissolved in A and the B mixed phase mutually, regulates pH to 6-7 then.With D fill together mutually.
Embodiment 30: the hair style foamed glue
AI?1%
% composition (INCI)
A 2.00 hexadecyltrimethylammonium chlorides
An amount of aromatic oil
B 67.85 water
7.00 polyquaternary ammonium salt-46
1.00 have the aqueous solution of about 5% keratin binding structural domain active component
0.20 ceteareth-25
0.50 pantothenylol
0.05 benzophenone-4
0.20 amino dimethicone, hexadecyltrimethylammonium chloride,
Tridecyl polyoxyethylene ether-12
15.00 alcohol
C 0.20 hydroxyethyl-cellulose
D 6.00 propane/butane
AI?5%
% composition (INCI)
A 2.00 hexadecyltrimethylammonium chlorides
An amount of aromatic oil
B 63.85 water
7.00 polyquaternary ammonium salt-46
5.00 have the aqueous solution of about 5% keratin binding structural domain active component
0.20 ceteareth-25
0.50 pantothenylol
0.05 benzophenone-4
0.20 amino dimethicone, hexadecyltrimethylammonium chloride,
Tridecyl polyoxyethylene ether-12
15.00 alcohol
C 0.20 hydroxyethyl-cellulose
D 6.00 propane/butane
Preparation: the component of mixing the A phase.The component and the dissolving that add the B phase one by one.C is dissolved in A and the B mixed phase mutually, regulates pH to 6-7 then.With D fill together mutually.
Embodiment 31: the hair style foamed glue
AI?1%
% composition (INCI)
A appropriate amount of PEG-40 castor oil hydrogenated
An amount of aromatic oil
85.5 water
B 7.0 kayexalates
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 cetyl trimethyl ammonium bromide
An amount of antiseptic
C 6.0 propane/butane
The hair style foamed glue
AI?5%
% composition (INCI)
A appropriate amount of PEG-40 castor oil hydrogenated
An amount of aromatic oil
81.5 water
B 7.0 kayexalates
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 cetyl trimethyl ammonium bromide
An amount of antiseptic
C 6.0 propane/butane
Preparation: dissolving A phase.Take by weighing B be added to A mutually in, and the dissolving until clarification.Regulate pH to 6-7, with C fill together mutually.
Embodiment 32: the hair style foamed glue
AI?1%
% composition (INCI)
A appropriate amount of PEG-40 castor oil hydrogenated
An amount of aromatic oil
92.0 water
B 0.5 polyquaternary ammonium salt-10
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 cetyl trimethyl ammonium bromide
An amount of antiseptic
C 6.0 propane/butane
AI?5%
% composition (INCI)
A appropriate amount of PEG-40 castor oil hydrogenated
An amount of aromatic oil
88.0 water
B 0.5 polyquaternary ammonium salt-10
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 cetyl trimethyl ammonium bromide
An amount of antiseptic
C 6.0 propane/butane
Preparation: dissolving A phase.Take by weighing B be added to A mutually in, and the dissolving until clarification.Regulate pH to 6-7, with C fill together mutually.
Embodiment 32: the hair style foamed glue
AI?1%
% composition (INCI)
A appropriate amount of PEG-40 castor oil hydrogenated
An amount of aromatic oil
82.5 water
B 10.0 polyquaternary ammonium salt-16
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 ethoxy spermaceti dimethyl ammonium phosphate
An amount of antiseptic
C 6.0 propane/butane
AI?5%
% composition (INCI)
A appropriate amount of PEG-40 castor oil hydrogenated
An amount of aromatic oil
78.5 water
B 10.0 polyquaternary ammonium salt-16
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 ethoxy spermaceti dimethyl ammonium phosphate
An amount of antiseptic
C 6.0 propane/butane
Preparation: dissolving A phase.Take by weighing B be added to A mutually in, and the dissolving until clarification.Regulate pH to 6-7, with C fill together mutually.
Embodiment 33: the hair style foamed glue
AI?1%
% composition (INCI)
A 2.0 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 84.0 water
2.0 chitosan
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 dimethicone copolyol
0.2 ceteareth-25
0.2 pantothenylol
0.1 PEG-25?PABA
C 10.0?HFC?152?A
AI?5%
% composition (INCI)
A 2.0 cocos nucifera oil trimethyl sulfate methyl ammoniums
An amount of aromatic oil
B 80.0 water
2.0 chitosan
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.5 dimethicone copolyol
0.2 ceteareth-25
0.2 pantothenylol
0.1 PEG-25?PABA
C 10.0?HFC?152?A
Preparation: the component of mixing the A phase.The component and the dissolving that add the B phase one by one.With C fill together mutually.
Embodiment 34: nursing shampoo
AI?1%
% composition (INCI)
A 30.0 lauryl alcohol sodium sulfate
6.0 cocos nucifera oil acyl both sexes guanidine-acetic acid sodium
6.0 cocoamidopropyl
3.0 lauryl alcohol sodium sulfate, glycol distearate, coconut oleoyl amine MEA,
Lauryl alcohol-10
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
7.7 polyquaternary ammonium salt-44
2.0 amino dimethicone
An amount of aromatic oil
An amount of antiseptic
1.0 sodium chloride
43.3 water
An amount of citric acid of B
AI?5%
% composition (INCI)
A 30.0 lauryl alcohol sodium sulfate
6.0 cocos nucifera oil acyl both sexes guanidine-acetic acid sodium
6.0 cocoamidopropyl
3.0 lauryl alcohol sodium sulfate, glycol distearate, coconut oleoyl amine MEA,
Lauryl alcohol-10
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
7.7 polyquaternary ammonium salt-44
2.0 amino dimethicone
An amount of aromatic oil
An amount of antiseptic
1.0 sodium chloride
39.3 water
An amount of citric acid of B
Preparation: mix the component and the dissolving of A phase.With the Fructus Citri Limoniae acid for adjusting pH to 6-7.
Embodiment 35: shower lotion
AI?1%
% composition (INCI)
A 40.0 lauryl alcohol sodium sulfate
5.0 decyl glucosides
5.0 cocoamidopropyl
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
1.0 pantothenylol
An amount of aromatic oil
An amount of antiseptic
2.0 sodium chloride
46.0 water
An amount of citric acid of B
AI?5%
% composition (INCI)
A 40.0 lauryl alcohol sodium sulfate
5.0 decyl glucosides
5.0 cocoamidopropyl
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
1.0 pantothenylol
An amount of aromatic oil
An amount of antiseptic
2.0 sodium chloride
42.0 water
An amount of citric acid of B
Preparation: the component of mixing the A phase.With the Fructus Citri Limoniae acid for adjusting pH to 6-7.
Embodiment 36: shampoo
AI?1%
% composition (INCI)
A 40.0 lauryl alcohol sodium sulfate
5.0 C12-15 Petiolus Trachycarpi oil ether-15 sodium sulfonate
5.0 decyl glucosides
An amount of aromatic oil
0.1 phytantriol
44.6 water
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.3 polyquaternary ammonium salt-10
1.0 pantothenylol
An amount of antiseptic
1.0 lauryl alcohol-3
2.0 sodium chloride
AI?5%
% composition (INCI)
A 40.0 lauryl alcohol sodium sulfate
5.0 C12-15 Petiolus Trachycarpi oil ether-15 sodium sulfonate
5.0 decyl glucosides
An amount of aromatic oil
0.1 phytantriol
40.6 water
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
0.3 polyquaternary ammonium salt-10
1.0 pantothenylol
An amount of antiseptic
1.0 lauryl alcohol-3
2.0 sodium chloride
Preparation: the component of mixing the A phase.With the Fructus Citri Limoniae acid for adjusting pH to 6-7.
Embodiment 37: shampoo
AI?1%
% composition (INCI)
A 15.00 cocoamidopropyl
10.00 cocos nucifera oil both sexes two acetic acid disodiums
5.00 poly mountain alcohol ester 20
5.00 decyl glucosides
An amount of aromatic oil
An amount of antiseptic
1.00 have the aqueous solution of about 5% keratin binding structural domain active component
0.15 guar gum hydroxypropyl-trimethyl ammonium chloride
2.00 lauryl alcohol-3
58.00 water
An amount of citric acid
B 3.00 PEG-150 distearates
AI?5%
% composition (INCI)
A 15.00 cocoamidopropyl
10.00 cocos nucifera oil both sexes two acetic acid disodiums
5.00 poly mountain alcohol ester 20
5.00 decyl glucosides
An amount of aromatic oil
An amount of antiseptic
5.00 have the aqueous solution of about 5% keratin binding structural domain active component
0.15 guar gum hydroxypropyl-trimethyl ammonium chloride
2.00 lauryl alcohol-3
54.00 water
An amount of citric acid
B 3.00 PEG-150 distearates
Preparation: weigh and dissolve the component of A phase.Regulate pH to 6-7.Add the B phase and be heated to about 50 ℃.Stirring is cooled to room temperature.
Embodiment 38: the watch box moisturiser
AI?1%
% composition (INCI)
A 2.0 ceteareth-25
2.0 ceteareth-6, pantothenylol
3.0 cetearyl ethylhexoate
1.0 dimethicone
4.0 cetearyl alcohol
3.0 tristerin SE
5.0 mineral oil
4.0 jojoba seed oil
3.0 mineral oil, lanolin alcohol
B 5.0 propylene glycol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
1.0 pantothenylol
0.5 aluminium-magnesium silicate
An amount of antiseptic
65.5 water
An amount of aromatic oil of C
An amount of citric acid of D
AI5%
% composition (INCI)
A 2.0 ceteareth-25
2.0 ceteareth-6, pantothenylol
3.0 cetearyl ethylhexoate
1.0 dimethicone
4.0 cetearyl alcohol
3.0 tristerin SE
5.0 mineral oil
4.0 jojoba seed oil
3.0 mineral oil, lanolin alcohol
B 5.0 propylene glycol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
1.0 pantothenylol
0.5 aluminium-magnesium silicate
An amount of antiseptic
61.5 water
An amount of aromatic oil of C
An amount of citric acid of D
Preparation: heat A separately mutually and extremely about 80 ℃ mutually of B.The of short duration B phase that stirs evenly in advance stirs B then and pours A mutually into mutually and stir evenly once more.Be cooled to about 40 ℃, add C and also thoroughly stir evenly once more mutually.With the Fructus Citri Limoniae acid for adjusting pH to 6-7.
Embodiment 39: the watch box moisturiser
AI1%
% composition (INCI)
A 6.0 PEG-7 castor oil hydrogenated
10.0 cetearyl ethylhexoate
5.0 isopropyl myristate
7.0 mineral oil
0.5 Adeps Bovis seu Bubali resin (Butyrospermum)
0.5 aluminium stearate
0.5 magnesium stearate
0.2 Bisabolol terpene alcohol
0.7 quaternary ammonium salt-18-hectorite
B 5.0 dipropylene glycol
0.7 magnesium sulfate
An amount of antiseptic
62.9 water
An amount of aromatic oil of C
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
AI5%
% composition (INCI)
A 6.0 PEG-7 castor oil hydrogenated
10.0 cetearyl ethylhexoate
5.0 isopropyl myristate
7.0 mineral oil
0.5 Adeps Bovis seu Bubali resin (Butyrospermum)
0.5 aluminium stearate
0.5 magnesium stearate
0.2 Bisabolol terpene alcohol
0.7 quaternary ammonium salt-18-hectorite
B 5.0 dipropylene glycol
0.7 magnesium sulfate
An amount of antiseptic
58.9 water
An amount of aromatic oil of C
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
Preparation: heat A individually mutually and extremely about 80 ℃ mutually of B.With B stir mutually pour into A mutually in, and stir evenly.Stirring is cooled to about 40 ℃, adds C and also stirs evenly once more mutually.Stirring is cooled to room temperature.Embodiment 40: the liquid make-up of oil-in-water type
AI?1%
% composition (INCI)
A 2.0 ceteareth-6, pantothenylol
2.0 ceteareth-25
6.0 tristerin
1.0 spermol
8.0 mineral oil
7.0 cetearyl ethylhexoate
0.2 dimethicone
B 3.0 propylene glycol
1.0 pantothenylol
An amount of antiseptic
61.9 water
C 0.1 Bisabolol terpene alcohol
1.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of aromatic oil
D 5.7 C.I.77 891, titanium dioxide
1.1 iron oxides
AI5%
% composition (INCI)
A 2.0 ceteareth-6, pantothenylol
2.0 ceteareth-25
6.0 tristerin
1.0 spermol
8.0 mineral oil
7.0 cetearyl ethylhexoate
0.2 dimethicone
B 3.0 propylene glycol
1.0 pantothenylol
An amount of antiseptic
57.9 water
C 0.1 Bisabolol terpene alcohol
5.0 have the aqueous solution of about 5% keratin binding structural domain active component
An amount of aromatic oil
D 5.7 C.I.77 891, titanium dioxide
1.1 iron oxides
Preparation: heat A individually mutually and extremely about 80 ℃ mutually of B.With B stir mutually pour into A mutually in, and stir evenly.Stirring is cooled to about 40 ℃, adds C and also thoroughly stirs evenly once more mutually with D mutually.Stirring is cooled to room temperature.
Embodiment 41
In following exemplary preparation, the active component of employing is 5% of keratin binding structural domain aqueous solution or keratin-binding effector molecules aqueous solution by weight.Following data are weight ratio parts.
The cleaning shampoo
Composition (INCI) | ?1 | ?2 | ?3 | ?4 | ?5 |
Texapon?N?70 | ?13.00 | ?15.00 | ?10.50 | ?12.50 | ?10.00 |
Dehyaufn?PK?45 | ?7.50 | ?7.00 | ?5.00 | ?5.50 | ?10.00 |
Cetiol?HE | ?2.00 | ?2.50 | ?3.50 | ?5.00 | ?2.30 |
Fragrance | ?0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Aqueous solution with keratin binding structural domain active component | ?1.0 | ?5.0 | ?0.1 | ?0.5 | ?10.0 |
D-panthenol USP | ?1.00 | ?1.50 | ?1.80 | ?1.70 | ?1.40 |
Antiseptic | ?0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Citric acid | ?0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Luviquat?Ultra?Care | ?1.50 | ?1.00 | ?1.50 | ?1.20 | ?1.10 |
Sodium chloride | ?1.50 | ?1.40 | ?1.40 | ?1.30 | ?1.50 |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Shampoo
Composition (INCI) | ?1 | ?2 | ?3 | ?4 | ?5 |
Texapon?NSO | ?35.00 | ?40.00 | ?30.00 | ?45.00 | ?27.00 |
Plantacare?2000 | ?5.00 | ?5.50 | ?4.90 | ?3.50 | ?7.00 |
Tego betanin L7 | ?10.00 | ?5.00 | ?12.50 | ?7.50 | ?15.00 |
Fragrance | ?0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Aqueous solution with keratin binding structural domain active component | ?1.0 | ?5.0 | ?0.1 | ?0.5 | ?10.0 |
D-panthenol USP | ?0.50 | ?1.00 | ?0.80 | ?1.50 | ?0.50 |
Antiseptic | 0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Citric acid | 0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Rewopal?LA?3 | 0.50 | ?2.00 | ?0.50 | ?0.50 | ?2.00 |
Sodium chloride | 1.50 | ?1.50 | ?1.50 | ?1.50 | ?1.50 |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
The cleaning conditioner shampoo
Composition (INCI) | ?1 | ?2 | ?3 | ?4 | ?5 |
Amphotensid?GB?2009 | ?10.00 | ?15.00 | ?20.00 | ?12.00 | ?17.00 |
Plantacare?2000 | ?5.00 | ?6.00 | ?7.00 | ?8.00 | ?4.00 |
Tego betanin L7 | ?15.00 | ?12.00 | ?10.00 | ?18.00 | ?20.00 |
Luviquat?FC?550 | ?0.30 | ?0.20 | ?0.20 | ?0.20 | ?0.30 |
Fragrance | ?0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Aqueous solution with keratin binding structural domain active component | ?20.0 | ?5.0 | ?1.0 | ?0.5 | ?10.0 |
Cremophor?PS?20 | ?5.00 | ?1.00 | ?1.00 | ?7.00 | ?5.00 |
Antiseptic | ?0.10 | ?0.10 | ?0.10 | ?0.10 | ?0.10 |
Rewopal?LA?3 | ?2.00 | ?1.00 | ?0.50 | ?2.00 | ?2.00 |
Citric acid | ?0.20 | ?0.20 | ?0.20 | ?0.20 | ?0.20 |
Stepan?PEG-600?DS | ?3.00 | ?2.00 | ?2.00 | ?3.00 | ?2.50 |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
The oil-in-water type whipped cream
? | |
? | |
? |
? | Weight % | Volume % | Weight % | Volume % |
Stearic acid | 5.00 | ? | 1.00 | ? |
Spermol | 5.50 | ? | ? | ? |
Cetearyl alcohol | ? | ? | 2.00 | ? |
The PEG-40 stearate | 8.50 | ? | ? | ? |
The PEG-20 stearate | ? | ? | 1.00 | ? |
Caprylic/capric triglyceride | 4.00 | ? | 2.00 | ? |
The C12-15 alkyl benzoate | 10.00 | ? | 15.00 | ? |
Cyclomethicone | 4.00 | ? | ? | ? |
Dimethicone | ? | ? | 0.50 | ? |
Aqueous solution with keratin binding structural domain active component | 5.0 | ? | 10.0 | ? |
The isostearic acid monooctyl ester | ? | ? | 5.00 | ? |
The myristyl myristinate | ? | ? | 2.00 | ? |
Ceresine | 1.50 | ? | ? | ? |
Glycerol | ? | ? | 3.00 | ? |
Lightscreening agent | ? | ? | ? | ? |
Hydroxypropyl starch phosphate | 1.00 | ? | 3.50 | ? |
BHT | ? | ? | 0.02 | ? |
Sodium ethylene diamine tetracetate | 0.50 | ? | 0.10 | ? |
Aromatic, antiseptic | In right amount | ? | In right amount | ? |
Coloring agent | In right amount | ? | In right amount | ? |
Potassium hydroxide | In right amount | ? | In right amount | ? |
Water | Add to 100 | ? | Add to 100 | ? |
? | PH transfers to 6.5-7.5 | ? | PH transfers to 5.0-6.0 | ? |
|
? | 70 | ? | ? |
|
? | ? | ? | 35 |
Gas (nitrogen) | ? | 30 | ? | ? |
Gas (helium) | ? | ? | ? | 65 |
Conditioner shampoo with Margarita powder
? | 1 | ?2 | ?3 |
Polyquaternary ammonium salt-10 | 0.50 | ?0.50 | ?0.40 |
Lauryl alcohol sodium sulfate | 9.00 | ?8.50 | ?8.90 |
Cocoamidopropyl | 2.50 | ?2.60 | ?3.00 |
Benzophenone-4 | 1.50 | ?0.50 | ?1.00 |
Aqueous solution with keratin binding structural domain active component | 1.0 | ?5.0 | ?0.5 |
Margarita powder aqueous solution with keratin binding structural domain active component | 2.00 | ?2.50 | ? |
Sodium ethylene diamine tetracetate | 0.10 | ?0.15 | ?0.05 |
Antiseptic, aromatic, thickening agent | In right amount | In right amount | In right amount |
Water | Add to 100 | Add to 100 | Add to 100 |
Regulate pH to 6.0
The cleaning conditioner shampoo
? | 1 | ?2 | ?3 |
Polyquaternary ammonium salt-10 | 0.50 | ?0.50 | ?0.50 |
Lauryl alcohol sodium sulfate | 9.00 | ?8.50 | ?9.50 |
Aqueous solution with keratin binding structural domain active component | 5.0 | ?0.1 | ?3.0 |
Benzophenone-3 | 1.00 | ?1.50 | ?0.50 |
The imido sodium succinate | 0.20 | ?0.20 | ?0.80 |
Antiseptic, aromatic, thickening agent | In right amount | In right amount | In right amount |
Water | Add to 100 | Add to 100 | Add to 100 |
Regulate pH to 6.0
Cleaning conditioner shampoo with volume effects
? | 1 | ?2 | ?3 |
Lauryl alcohol sodium sulfate | 10.00 | ?10.50 | ?11.00 |
The ethylhexyl Methoxycinnamate | 2.00 | ?1.50 | ?2.30 |
Aqueous solution with keratin binding structural domain active component | 10.0 | ?0.1 | ?0.5 |
Cocoamidopropyl | 2.50 | ?2.60 | ?2.20 |
Sodium ethylene diamine tetracetate | 0.01 | ?0.10 | ?0.01 |
Antiseptic, aromatic oil, thickening agent | In right amount | In right amount | In right amount |
Water | Add to 100 | Add to 100 | Add to 100 |
Regulate pH to 6.0
The gel cream
? | 1 | ?2 | ?3 | ?4 |
Acrylate/C10-30 alkyl acrylate cross-linked polymer | 0.40 | ?0.35 | ?0.40 | ?0.35 |
Polyacrylic acid | 0.20 | ?0.22 | ?0.20 | ?0.22 |
Xanthan gum | 0.10 | ?0.13 | ?0.10 | ?0.13 |
Cetearyl alcohol | 3.00 | ?2.50 | ?3.00 | ?2.50 |
The C12-15 alkyl benzoate | 4.00 | ?4.50 | ?4.00 | ?4.50 |
Caprylic/capric triglyceride | 3.00 | ?3.50 | ?3.00 | ?3.50 |
Uvinul?A?Plus TM | 2.00 | ?1.50 | ?0.75 | ?1.00 |
UvaSorb?K2A | ? | ?3.00 | ? | ? |
The ethylhexyl Methoxycinnamate | 3.00 | ? | ?1.00 | ? |
Two ethylhexyl phenol anisyl triazines | ? | 1.50 | ? | ?2.00 |
Butyl methoxydibenzoylmethise | ? | ? | ?2.00 | ? |
Phenyl bisbenzimidazole tetrasulfonic acid disodium | 2.50 | ? | ?0.50 | ?2.00 |
The ethylhexyl triazinone | 4.00 | ? | ?3.00 | ?4.00 |
1-Octyl acrylate | ? | 4.00 | ? | ? |
Diethylhexyl fourth ammonia triazinone | 1.00 | ? | ? | ?2.00 |
Phenylbenzimidazolesulfonic acid | 0.50 | ? | ?3.00 | ? |
Di-2-ethylhexylphosphine oxide-benzotriazole base tetramethyl butylbenzene phenol | 2.00 | ? | ?0.50 | ?1.50 |
Ethylhexyl salicylate | ? | ? | ?3.00 | ? |
The drometrizole trisiloxanes | ? | ? | ?0.50 | ? |
The Terephthalidene Dicamphor Sulfonic Acid | ? | 1.50 | ? | ?1.00 |
|
3.50 | 4.00 | ?7.00 | ?9.00 |
The meticulous powder of titanium dioxide | 1.00 | ? | ?3.00 | ? |
The meticulous powder of zinc oxide | ? | ? | ? | ?0.25 |
Aqueous solution with keratin binding structural domain active component | 0.1 | 0.5 | ?1.0 | ?0.02 |
The ring dimethyl polysiloxane | 5.00 | 5.50 | ?5.00 | ?5.50 |
The dimethicone polydimethylsiloxane | 1.00 | 0.60 | ?1.00 | ?0.60 |
Glycerol | 1.00 | 1.20 | ?1.00 | ?1.20 |
Sodium hydroxide | In right amount | In right amount | In right amount | In right amount |
Antiseptic | 0.30 | 0.23 | ?0.30 | ?0.23 |
Aromatic | 0.20 | ? | ?0.20 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Regulate pH to 6.0 | ? | ? | ? | ? |
The oil-in-water type sunscreen formulations
? | 1 | 2 | 3 | ?4 | ?5 | ?6 | ?7 |
Glyceryl monostearate SE | 0.50 | 1.00 | 3.00 | ? | ? | ?1.50 | ? |
Tristerin | 2.00 | ? | 1.00 | ?2.00 | ?4.00 | ? | ? |
Stearic acid | ? | 3.00 | ? | ?2.00 | ? | ? | ? |
The PEG-40 stearate | 0.50 | ? | ? | ? | ? | ?2.00 | ? |
Hexadecanyl phosphate | ? | ? | ? | ? | ? | ?1.00 | ? |
Cetearyl alcohol sodium sulfate | ? | ? | ? | ? | ? | ? | ?0.75 |
Octadecanol | ? | ? | 3.00 | ? | ? | ?2.00 | ?0.60 |
Spermol | 2.50 | 1.10 | ? | ?1.50 | ?0.60 | ? | ?2.00 |
Aqueous solution with keratin binding structural domain active component | 10.0 | 0.5 | 3.0 | ?5.0 | ?0.1 | ?0.02 | ?7.5 |
Uvinul?A?Plus TM | 2.00 | 1.50 | 0.75 | ?1.00 | ?2.10 | ?4.50 | ?5.00 |
UVASorb?K2A | ? | ? | ? | ? | ? | ? | ? |
The ethylhexyl methoxy cinnamic acid | ? | ? | ? | ? | ?5.00 | ?6.00 | ?8.00 |
Two ethylhexyl phenol anisyl triazines | ? | 1.50 | ? | ?2.00 | ?2.50 | ? | ?2.50 |
Butyl methoxy dibenzoyl methane | ? | ? | 2.00 | ? | ?2.00 | ?1.50 | ? |
Phenyl bisbenzimidazole tetrasulfonic acid disodium | 2.50 | ? | 0.50 | ?2.00 | ? | ?0.30 | ? |
The ethylhexyl triazinone | 4.00 | ? | 3.00 | ?4.00 | ? | ?2.00 | ? |
1-Octyl acrylate | ? | 4.00 | ? | ? | ? | ? | ?7.50 |
Diethylhexyl fourth ammonia triazinone | 1.00 | ? | ? | ?2.00 | ?1.00 | ? | ?1.00 |
Phenylbenzimidazolesulfonic acid | 0.50 | ? | 3.00 | ? | ? | ? | ? |
Di-2-ethylhexylphosphine oxide-benzotriazole base tetramethyl butylbenzene phenol | 2.00 | ? | 0.50 | ?1.50 | ?2.50 | ? | ? |
Ethylhexyl salicylate | ? | ? | 3.00 | ? | ? | ? | ?5.00 |
The drometrizole trisiloxanes | ? | ? | 0.50 | ? | ? | ?1.00 | ? |
The Terephthalidene Dicamphor Sulfonic Acid | ? | 1.50 | ? | ?1.00 | ?1.00 | ? | ?0.50 |
|
3.50 | ? | ?7.00 | ? | ?6.00 | ?9.00 | ? |
The meticulous powder of titanium dioxide | 1.00 | ? | ?3.00 | ? | ?3.50 | ? | ?1.50 |
The meticulous powder of zinc oxide | ? | ? | ? | ?0.25 | ? | ?2.00 | ? |
The C12-15 alkyl benzoate | ? | 0.25 | ? | ? | ?4.00 | ?7.00 | ? |
Two caprylyl ethers | ? | ? | ?3.50 | ? | ?2.00 | ? | ? |
Butanediol dicaprylate/dicaprate | 5.00 | ? | ?6.00 | ? | ? | ? | ? |
Cocos nucifera oil glyceride | ? | ? | ?6.00 | ? | ?2.00 | ? | ? |
Dimethicone | 0.50 | ? | ?1.00 | ? | ?2.00 | ? | ? |
Cyclomethicone | 2.00 | ? | ?0.50 | ? | ?0.50 | ? | ? |
Adeps Bovis seu Bubali resin | ? | 2.00 | ? | ? | ? | ? | ? |
PVP hexadecene copolymer | 0.20 | ? | ? | ?0.50 | ? | ?1.00 | ? |
Glycerol | 3.00 | 7.50 | ? | ?7.50 | ?5.00 | ? | ?2.50 |
Xanthan gum | 0.15 | ? | ?0.05 | ? | ? | ?0.30 | ? |
Carbomer sodium | ? | 0.20 | ? | ?0.15 | ?0.25 | ? | ? |
Vitamin e acetate | 0.60 | ? | ?0.23 | ? | ?0.70 | ?1.00 | ? |
Fucogel?1000 | ? | 3.00 | ?10.0?0 | ? | ? | ? | ? |
Glycine Semen Glycines (Semen sojae atricolor) oil | ? | ? | ? | ?0.50 | ? | ?1.50 | ?1.00 |
The ethyl hexyl oxy glycine | 0.30 | ? | ? | ? | ? | ? | ? |
DMDM?Hydantaufin | ? | 0.60 | ?0.40 | ?0.20 | ? | ? | ? |
Glyacil-L | ? | ? | ? | ?0.18 | ?0.20 | ? | ? |
Methyl parahydroxybenzoate | 0.15 | ? | ?0.25 | ? | ?0.50 | ? | ? |
Phenoxyethanol | 1.00 | 0.40 | ? | ? | ?0.40 | ?0.50 | ?0.40 |
Sodium versenate | 0.02 | ? | ?0.05 | ? | ? | ? | ? |
The imido succinic acid | ? | ? | ? | ?0.25 | ?1.00 | ? | ? |
Ethanol | 2.00 | 1.50 | ? | ?3.00 | ? | ?1.20 | ?5.00 |
Aromatic | 0.10 | 0.25 | ?0.30 | ? | ?0.40 | ?0.20 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Aqueous dispersion
? | 1 | 2 | 3 | ?4 | ?5 |
Ceteareth | 1.00 | ? | ? | ?0.50 | ? |
Spermol | ? | ? | 1.00 | ? | ? |
Carbomer sodium | ? | 0.20 | ? | ?0.30 | ? |
Acrylate/C10-30 alkyl acrylate cross-linked polymer | 0.50 | ? | 0.40 | ?0.10 | ?0.50 |
Xanthan gum | ? | 0.30 | 0.15 | ? | ? |
Aqueous solution with keratin binding structural domain active component | 5.0 | 0.5 | 3.0 | ?0.1 | ?10.0 |
Uvinul?A?Plus TM | 2.00 | 1.50 | 0.75 | ?1.00 | ?2.10 |
UVASorb?K2A | ? | 3.50 | ? | ? | ? |
The ethylhexyl methoxy cinnamic acid | ? | ? | ? | ? | ?5.00 |
Two ethylhexyl phenol anisyl triazines | ? | 1.50 | ? | ?2.00 | ?2.50 |
Butyl methoxy dibenzoyl methane | ? | ? | 2.00 | ? | ?2.00 |
Phenyl bisbenzimidazole tetrasulfonic acid disodium | 2.50 | ? | 0.50 | ?2.00 | ? |
The ethylhexyl triazinone | 4.00 | ? | 3.00 | ?4.00 | ? |
1-Octyl acrylate | ? | 4.00 | ? | ? | ? |
Diethylhexyl fourth ammonia triazinone | 1.00 | ? | ? | ?2.00 | ?1.00 |
Phenylbenzimidazolesulfonic acid | 0.50 | ? | 3.00 | ? | ? |
Di-2-ethylhexylphosphine oxide-benzotriazole base tetramethyl butylbenzene phenol | 2.00 | ? | 0.50 | ?1.50 | ?2.50 |
Ethylhexyl salicylate | ? | ? | 3.00 | ? | ? |
The drometrizole trisiloxanes | ? | ? | 0.50 | ? | ? |
The Terephthalidene Dicamphor Sulfonic Acid | ? | ?1.50 | ? | ?1.00 | 1.00 |
|
? | ? | ?7.00 | ? | 9.00 |
The meticulous powder of titanium dioxide | 1.00 | ? | ?3.00 | ? | 3.50 |
The meticulous powder of zinc oxide | ? | ? | ? | ?0.25 | ? |
The C12-15 alkyl benzoate | 2.00 | ?2.50 | ? | ? | ? |
Two caprylyl ethers | ? | ?4.00 | ? | ? | ? |
Butanediol dicaprylate/dicaprate | 4.00 | ? | ?2.00 | ?6.00 | ? |
Two caprylyl carbonic esters | ? | ?2.00 | ?6.00 | ? | ? |
Dimethicone | ? | ?0.50 | ?1.00 | ? | ? |
Phenyl trimethyl silicone oil | 2.00 | ? | ?0.50 | ? | ? |
Adeps Bovis seu Bubali resin | ? | ?2.00 | ? | ?5.00 | ? |
PVP hexadecene copolymer | 0.50 | ? | ? | ?0.50 | 1.00 |
Herba leucadis ciliatae alkyl PVP (Tricontanyl PVP) | 0.50 | ? | ?1.00 | ? | ? |
Ethylhexyl glycerol | ? | ? | ?1.00 | ? | 0.80 |
Glycerol | 3.00 | ?7.50 | ? | ?7.50 | 8.50 |
The Semen Glycines glycine | ? | ? | ?1.50 | ? | 1.00 |
Vitamin e acetate | 0.50 | ? | ?0.25 | ? | 1.00 |
α glucose rutin (Glucosilrutin) | 0.60 | ? | ? | ?0.25 | ? |
Fucogel?1060 | ? | ?2.50 | ?0.50 | ? | 2.00 |
DMDM?Hydanaufin | ? | ?0.60 | ?0.45 | ?0.25 | ? |
Glyacil-S | 0.20 | ? | ? | ? | ? |
Methyl parahydroxybenzoate | 0.50 | ? | ?0.25 | ?0.15 | ? |
Phenoxyethanol | 0.50 | ?0.40 | ? | ?1.00 | ? |
Sodium versenate | ? | ?0.01 | ?0.05 | ? | 0.10 |
Ethanol | 3.00 | ?2.00 | ?1.50 | ? | 7.00 |
Aromatic | 0.20 | ? | ?0.05 | ?0.40 | ? |
Water | To 100 | To 100 | To 100 | To 100 | To 100 |
The oil-in-water type sunscreen emulsion
? | 1 | 2 | 3 | ?4 | ?5 |
Cetyl dimethicone copolyol | ? | 2.50 | ? | ?4.00 | ? |
Polyglyceryl-2 dimerization hydroxy stearic acid ester | 5.00 | ? | ? | ? | ?4.50 |
PEG-30 dimerization hydroxy stearic acid ester | ? | ? | 5.00 | ? | ? |
Aqueous solution with keratin binding structural domain active component | 5.0 | 1.0 | 10.0 | ?0.5 | ?0.1 |
Uvinul?A?Plus TM | 2.00 | 1.50 | 0.75 | ?1.00 | ?2.10 |
UVASorb?K2A | ? | 2.00 | ? | ? | ? |
The ethylhexyl Methoxycinnamate | ? | ? | ? | ? | ?5.00 |
Diethylhexyl phenol anisyl triazine | ? | 1.50 | ? | ?2.00 | ?2.50 |
Butyl methoxy dibenzoyl methane | ? | ? | 2.00 | ? | ?2.00 |
Phenyl bisbenzimidazole tetrasulfonic acid disodium | 2.50 | ? | 0.50 | ?2.00 | ? |
The ethylhexyl triazinone | 4.00 | ? | 3.00 | ?4.00 | ? |
1-Octyl acrylate | ? | 4.00 | ? | ? | ? |
Two ethylhexyl fourth ammonia triazinones | 1.00 | ? | ? | ?2.00 | ?1.00 |
Phenylbenzimidazolesulfonic acid | 0.50 | ? | 3.00 | ? | ? |
Di-2-ethylhexylphosphine oxide-benzotriazole base tetramethyl butylbenzene phenol | 2.00 | ? | 0.50 | ?1.50 | ?2.50 |
Ethylhexyl salicylate | ? | ? | 3.00 | ? | ? |
The drometrizole trisiloxanes | ? | ? | 0.50 | ? | ? |
The Terephthalidene Dicamphor Sulfonic Acid | ? | 1.50 | ? | ?1.00 | ?1.00 |
|
? | ? | 7.00 | ? | ?4.00 |
The meticulous powder of titanium dioxide | 1.00 | ? | 3.00 | ? | ?3.50 |
The meticulous powder of zinc oxide | ? | ? | ? | ?0.25 | ? |
Mineral oil | ? | 12.00 | 10.00 | ? | ?8.00 |
The C12-15 alkyl benzoate | ? | ? | ? | ?9.00 | ? |
Two caprylyl ethers | 10.00 | ? | ? | ? | ?7.00 |
Butanediol dicaprylate/dicaprate | ? | ? | ?2.00 | ?8.00 | ?4.00 |
Two caprylyl carbonic esters | 5.00 | ? | ?6.00 | ? | ? |
Dimethicone | ? | ?4.00 | ?1.00 | ?5.00 | ? |
Cyclomethicone | 2.00 | ?25.00 | ? | ? | ?2.00 |
Adeps Bovis seu Bubali resin | ? | ? | ?3.00 | ? | ? |
Vaseline | ? | ?4.50 | ? | ? | ? |
PVP hexadecene copolymer | 0.50 | ? | ? | ?0.50 | ?1.00 |
Ethylhexyl glycerol | ? | ?0.30 | ?1.00 | ? | ?0,50 |
Glycerol | 3.00 | ?7.50 | ? | ?7.50 | ?8.50 |
The Semen Glycines glycine | ? | ?1.00 | ?1.50 | ? | ?1.00 |
MgSO 4 | 1.00 | ?0.50 | ? | ?0.50 | ? |
MgCl 2 | ? | ? | ?1.00 | ? | ?0.70 |
Vitamin e acetate | 0.50 | ? | ?0.25 | ? | ?1.00 |
Ascorbyl palmitate | 0.50 | ? | ? | ?2.00 | ? |
Fucogel?1000 | ? | ? | ? | ?3.50 | ?1.00 |
DMDM?Hydanaufin | ? | ?0.60 | ?0.40 | ?0.20 | ? |
Methyl parahydroxybenzoate | 0.50 | ? | ?0.25 | ?0.15 | ? |
Phenoxyethanol | 0.50 | ?0.40 | ? | ?1.00 | ? |
Sodium versenate | 0.12 | ?0.05 | ? | ?0.30 | ? |
Ethanol | 3.00 | ? | ?1.50 | ? | ?5.00 |
Aromatic | 0.20 | ? | ?0.40 | ?0.35 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Stick
? | 1 | 2 | ?3 | ?4 |
Caprylic/capric triglyceride | 12.00 | 10.00 | ?6.00 | ? |
Octyl dodecanol | 7.00 | 14.00 | ?8.00 | ?3.00 |
Butanediol dicaprylate/dicaprate | ? | ? | ? | ?12.00 |
Tetramethylolmethane base tetraoctyl stearate | 10.00 | 6.00 | ?8.00 | ?7.00 |
Polyglyceryl-3 diisopstearate | 2.50 | ? | ? | ? |
Two-polyamides base adipic acid two sweet esters-2 | 9.00 | 8.00 | ?10.00 | ?8.00 |
Cetearyl alcohol | 8.00 | 11.00 | ?9.00 | ?7.00 |
The myristyl myristinate | 3.50 | 3.00 | ?4.00 | ?3.00 |
Cera Flava | 5.00 | 5.00 | ?6.00 | ?6.00 |
Brazil wax | 1.50 | 2.00 | ?2.00 | ?1.50 |
Cera alba | 0.50 | 0.50 | ?0.50 | ?0.40 |
C16-40 alkyl stearate | ? | 1.50 | ?1.50 | ?1.50 |
Aqueous solution with keratin binding structural domain active component | 0.5 | 3.0 | ?1.0 | ?5.0 |
Uvinul?A?Plus TM | 2.00 | 1.50 | ?0.75 | ?9.00 |
UVASorb?K2A | ? | 2.00 | ? | ?4.00 |
The ethylhexyl methoxy cinnamic acid | ? | 3.00 | ? | ? |
Two ethylhexyl phenol anisyl triazines | ? | 1.50 | ? | ?2.00 |
Butyl methoxy dibenzoyl methane | ? | ? | ?2.00 | ? |
Phenyl bisbenzimidazole tetrasulfonic acid disodium | 2.50 | ? | ?0.50 | ?2.00 |
The ethylhexyl triazinone | 4.00 | ? | ?3.00 | ?4.00 |
1-Octyl acrylate | ? | 4.00 | ? | ? |
Two ethylhexyl fourth ammonia triazinones | 1.00 | ? | ? | ?2.00 |
Phenylbenzimidazolesulfonic acid | 0.50 | ? | ?3.00 | ? |
Di-2-ethylhexylphosphine oxide-benzotriazole base tetramethyl butylbenzene | 2.00 | ? | ?0.50 | ?1.50 |
Phenol | ? | ? | ? | ? |
Ethylhexyl salicylate | ? | ? | ?3.00 | ? |
The drometrizole trisiloxanes | ? | ? | ?0.50 | ? |
The Terephthalidene Dicamphor Sulfonic Acid | ? | ?1.50 | ? | ?1.00 |
|
? | ? | ?7.00 | ? |
The meticulous powder of titanium dioxide | ?1.00 | ? | ?3.00 | ? |
The meticulous powder of zinc oxide | ? | ? | ? | ?0.25 |
Vitamin e acetate | ?0.50 | ?1.00 | ? | ? |
Ascorbyl palmitate | ?0.05 | ? | ?0.05 | ? |
Buxux?Chinensis | ?2.00 | ?1.00 | ? | ?1.00 |
Aromatic, BHT | ?0.10 | ?0.25 | ? | ?0.35 |
Oleum Ricini | To 100 | To 100 | To 100 | To 100 |
The PIT emulsifying agent
? | 1 | ?2 | ?3 | ?4 | ?5 | ?6 | ?7 | ?8 |
Glyceryl monostearate SE | 0.50 | ?2.00 | ?3.00 | ?5.00 | ? | ?0.50 | ?4.00 | ? |
Glyceryl isostearate | ? | ? | ? | ? | ?3.50 | ?4.00 | ?2.00 | ? |
Different spermaceti alcohol ether-20 | ? | ?0.50 | ? | ? | ?2.00 | ? | ? | ? |
Ceteareth-12 | ? | ?5.00 | ? | ?1.00 | ? | ? | ?3.50 | ?5.00 |
Ceteareth-20 | ? | ?5.00 | ? | ?1.00 | ? | ? | ? | ?3.50 |
The PEG-100 stearate | ? | ? | ? | ?2.80 | ? | ?2.30 | ?3.30 | ? |
Spermol | 5.20 | ? | ?1.20 | ?1.00 | ?1.30 | ? | ?0.50 | ?0.30 |
Cetyl palmitate | 2.50 | ?1.20 | ? | ?1.50 | ? | ?0.50 | ? | ?1.50 |
The cetyl dimethicone copolyol | ? | ? | ? | ?0.50 | ? | ?1.00 | ? | ? |
Polyglyceryl-2 | ? | ? | ? | ?0.75 | ?0.30 | ? | ? | ? |
Has the keratin binding structural domain | 0.1 | ?5.0 | ?0.01 | ?0.5 | ?3.0 | ?0.25 | ?10.0 | ?3.0 |
The aqueous solution of active component | ? | ? | ? | ? | ? | ? | ? | ? |
Uvinul?A?Plus TM | 2.00 | 1.50 | ?0.75 | ?1.00 | ?2.10 | ?4.50 | ?5.00 | ?2.10 |
UVASorb?K2A | ? | ? | ?4.00 | ? | ? | ? | ?1.50 | ? |
The ethylhexyl methoxy cinnamic acid | ? | ? | ? | ? | ?5.00 | ?6.00 | ?8.00 | ?5.00 |
Two ethylhexyl phenol anisyl triazines | ? | 1.50 | ? | ?2.00 | ?2.50 | ? | ?2.50 | ?2.50 |
Butyl methoxybenzophenone | ? | ? | ?2.00 | ? | ?2.00 | ?1.50 | ? | ?2.00 |
Phenyl bisbenzimidazole tetrasulfonic acid disodium | 2.50 | ? | ?0.50 | ?2.00 | ? | ?0.30 | ? | ? |
The ethylhexyl triazinone | 4.00 | ? | ?3.00 | ?4.00 | ? | ?2.00 | ? | ? |
1-Octyl acrylate | ? | 4.00 | ? | ? | ? | ? | ?7.50 | ? |
Two ethylhexyl fourth ammonia triazinones | 1.00 | ? | ? | ?2.00 | ?1.00 | ? | ?1.00 | ?1.00 |
Phenylbenzimidazolesulfonic acid | 0.50 | ? | ?3.00 | ? | ? | ? | ? | ? |
Di-2-ethylhexylphosphine oxide-benzotriazole base tetramethyl butylbenzene phenol | 2.00 | ? | ?0.50 | ?1.50 | ?2.50 | ? | ? | ?2.50 |
Ethylhexyl salicylate | ? | ? | ?3.00 | ? | ? | ? | ?5.00 | ? |
The drometrizole trisiloxanes | ? | ? | ?0.50 | ? | ? | ?1.00 | ? | ? |
The Terephthalidene Dicamphor Sulfonic Acid | ? | 1.50 | ? | ?1.00 | ?1.00 | ? | ?0.50 | ?1.00 |
|
? | ? | ?7.00 | ? | ?10.0?0 | ?7.50 | ? | ?8.00 |
The meticulous powder of titanium dioxide | 1.00 | ? | ?3.00 | ? | ?3.50 | ? | ?1.50 | ?3.50 |
The meticulous powder of zinc oxide | ? | ? | ? | ?0.25 | ? | ?2.00 | ? | ? |
The C12-15 alkyl benzoate | 3.50 | ? | ? | ?6.35 | ? | ? | ? | ?0.10 |
Cocos nucifera oil glyceride | ? | 3.00 | ? | ?3.00 | ? | ? | ? | ?1.00 |
Two caprylyl ethers | 4.50 | ? | ? | ? | ? | ? | ? | ? |
Two caprylyl carbonic esters | ? | 4.30 | ? | ?3.00 | ? | ? | ? | ?7.00 |
Dibutyl adipate | ? | ? | ? | ?0.50 | ? | ? | ? | ?0.30 |
Phenyl trimethyl silicone oil | 2.00 | ? | ? | ?3.50 | ? | ?2.00 | ? | ? |
Cyclomethicone | ? | 3.00 | ? | ? | ? | ? | ? | ? |
The ethyl galactomannan | ? | 0.50 | ? | ? | ?2.00 | ? | ? | ? |
Hydrogenation cocos nucifera oil glyceride | ? | ? | ? | ? | ?3.00 | ?4.00 | ? | ? |
Spermaceti (Abil Wax) 2440 | ? | ? | ? | ? | ? | ?1.50 | ?2.00 | ? |
PVP hexadecene copolymer | ? | ? | ? | ?1.00 | ?1.20 | ? | ? | ? |
Glycerol | 4.00 | 6.00 | ?5.00 | ? | ?8.00 | ?10.0?0 | ? | ? |
Vitamin e acetate | 0.20 | 0.30 | ?0.40 | ? | ?0.30 | ? | ? | ? |
Adeps Bovis seu Bubali resin | ? | 2.00 | ? | ?3.60 | ? | ?2.00 | ? | ? |
Iodine third butyl carbamate | 0.12 | ? | ? | ? | ?0.20 | ? | ? | ? |
Fucogel?1000 | ? | ? | ? | ?0.10 | ? | ? | ? | ? |
DMDM?Hydanaufin | 0.10 | ? | ? | ? | ?0.12 | ? | ?0.13 | ? |
Methyl parahydroxybenzoate | ? | 0.50 | ?0.30 | ? | ?0.35 | ? | ? | ? |
Phenoxyethanol | 0.50 | 0.40 | ? | ?1.00 | ? | ? | ? | ? |
Ocaufxy glycerol | ? | 0.30 | ? | ? | ?1.00 | ? | ?0.35 | ? |
Ethanol | 2.00 | ? | ?2.00 | ? | ? | ?5.00 | ? | ? |
Sodium versenate | 0.40 | ? | ?0.15 | ? | ? | ?0.20 | ? | ? |
Aromatic | 0.20 | ? | ?0.20 | ? | ?0.24 | ?0.16 | ?0.10 | ?0.10 |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
The gel cream
? | 1 | ?2 | ?3 | ?4 |
Acrylate/C10-30 alkyl acrylate is handed over | 0.40 | ?0.35 | ?0.40 | ?0.35 |
Linked polymer | ? | ? | ? | ? |
Polyacrylic acid | 0.20 | ?0.22 | ?0.20 | ?0.22 |
Luvigel?EM | 1.50 | ?2.50 | ?2.80 | ?3.50 |
Xanthan gum | 0.10 | ?0.13 | ?0.10 | ?0.13 |
Cetearyl alcohol | 3.00 | ?2.50 | ?3.00 | ?2.50 |
The C12-15 alkyl benzoate | 4.00 | ?4.50 | ?4.00 | ?4.50 |
Caprylic/capric triglyceride | 3.00 | ?3.50 | ?3.00 | ?3.50 |
The meticulous powder of titanium dioxide | 1.00 | ? | ?1.50 | ? |
The meticulous powder of zinc oxide | ? | ?2.00 | ? | ?0.25 |
Aqueous solution with keratin binding structural domain active component | 0.5 | ?10.0 | ?3.0 | ?5.0 |
Dihydroxyaceaufn | ? | ? | ?3.00 | ?5.00 |
The ring dimethyl polysiloxane | 5.00 | ?5.50 | ?5.00 | ?5.50 |
The dimethicone dimethione | 1.00 | ?0.60 | ?1.00 | ?0.60 |
Glycerol | 1.00 | ?1.20 | ?1.00 | ?1.20 |
Sodium hydroxide | In right amount | In right amount | In right amount | In right amount |
Antiseptic | 0.30 | ?0.23 | ?0.30 | ?0.23 |
Aromatic | 0.20 | ? | ?0.20 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Regulate pH to 6.0 | ? | ? | ? | ? |
The self-service U.S. black preparation of oil-in-water type
? | 1 | 2 | ?3 | ?4 | ?5 | ?6 | ?7 |
Glyceryl monostearate SE | 0.50 | 1.00 | ?3.00 | ? | ? | ?1.50 | ? |
Tristerin | 2.00 | ? | ?1.00 | ?2.00 | ?4.00 | ? | ? |
Stearic acid | ? | 3.00 | ? | ?2.00 | ? | ? | ? |
The PEG-40 stearate | 0.50 | ? | ? | ? | ? | ?2.00 | ? |
Hexadecanyl phosphate | ? | ? | ? | ? | ? | ?1.00 | ? |
Cetearyl alcohol sulfate | ? | ? | ? | ? | ? | ? | ?0.75 |
Octadecanol | ? | ? | ?3.00 | ? | ? | ?2.00 | ?0.60 |
Spermol | 2.50 | ?1.10 | ? | ?1.50 | ?0.60 | ? | ?2.00 |
Aqueous solution with keratin binding structural domain active component | 0.1 | ?0.5 | ?0.025 | ?5.0 | ?3.0 | ?10.0 | ?1.0 |
Dihydroxy acetone (Dihydroxyaceaufn) | ? | ? | ?3.00 | ?5.00 | ? | ?4 | ? |
The meticulous powder of titanium dioxide | 1.00 | ? | ? | ? | ?1.50 | ? | ?1.50 |
The meticulous powder of zinc oxide | ? | ? | ? | ?0.25 | ? | ?2.00 | ? |
The C12-15 alkyl benzoate | ? | ?0.25 | ? | ? | ?4.00 | ?7.00 | ? |
Two caprylyl ethers | ? | ? | ?3.50 | ? | ?2.00 | ? | ? |
Butanediol dicaprylate/dicaprate | 5.00 | ? | ?6.00 | ? | ? | ? | ? |
Cocos nucifera oil glyceride | ? | ? | ?6.00 | ? | ?2.00 | ? | ? |
Dimethicone | 0.50 | ? | ?1.00 | ? | ?2.00 | ? | ? |
Cyclomethicone | 2.00 | ? | ?0.50 | ? | ?0.50 | ? | ? |
Adeps Bovis seu Bubali resin | ? | ?2.00 | ? | ? | ? | ? | ? |
PVP hexadecene copolymer | 0.20 | ? | ? | ?0.50 | ? | ?1.00 | ? |
Glycerol | 3.00 | ?7.50 | ? | ?7.50 | ?5.00 | ? | ?2.50 |
Xanthan gum | 0.15 | ? | ?0.05 | ? | ? | ?0.30 | ? |
Carbomer sodium | ? | ?0.20 | ? | ?0.15 | ?0.25 | ? | ? |
Vitamin e acetate | 0.60 | ? | ?0.23 | ? | ?0.70 | ?1.00 | ? |
Fucogel?1000 | ? | ?3.00 | ?10.00 | ? | ? | ? | ? |
The Semen Glycines glycine | ? | ? | ? | ?0.50 | ? | ?1.50 | ?1.00 |
The ethyl hexyl oxy glycine | 0.30 | ? | ? | ? | ? | ? | ? |
DMDM?Hydanaufin | ? | ?0.60 | ?0.40 | ?0.20 | ? | ? | ? |
Glyacil-L | ? | ? | ? | 0.18 | ?0.20 | ? | ? |
Methyl parahydroxybenzoate | 0.15 | ? | 0.25 | ? | ?0.50 | ? | ? |
Phenoxyethanol | 1.00 | 0.40 | ? | ? | ?0.40 | ?0.50 | ?0.40 |
Sodium versenate | 0.02 | ? | 0.05 | ? | ? | ? | ? |
The imido succinic acid | ? | ? | ? | 0.25 | ?1.00 | ? | ? |
Ethanol | 2.00 | 1.50 | ? | 3.00 | ? | ?1.20 | ?5.00 |
Aromatic | 0.10 | 0.25 | 0.30 | ? | ?0.40 | ?0.20 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
The oil-in-water type cosmetics
? | 1 | 2 | ?3 | ?4 | ?5 | ?6 | ?7 |
Glyceryl monostearate SE | 0.50 | 1.00 | ?3.00 | ? | ? | ?1.50 | ? |
Tristerin | 2.00 | ? | ?1.00 | ?2.00 | ?4.00 | ? | ? |
Stearic acid | ? | 3.00 | ? | ?2.00 | ? | ? | ? |
The PEG-40 stearate | 0.50 | ? | ? | ? | ? | ?2.00 | ? |
Hexadecanyl phosphate | ? | ? | ? | ? | ? | ?1.00 | ? |
Cetearyl alcohol sulfate | ? | ? | ? | ? | ? | ? | ?0.75 |
Octadecanol | ? | ? | ?3.00 | ? | ? | ?2.00 | ?0.60 |
Spermol | 2.50 | 1.10 | ? | ?1.50 | ?0.60 | ? | ?2.00 |
Aqueous solution with keratin binding structural domain active component | 3.0 | 5.0 | ?2.0 | ?0.5 | ?1.0 | ?5.0 | ?10.0 |
Titanium dioxide | 10.00 | 12.00 | ?9.00 | ?8.50 | ?11.00 | ?9.50 | ?10.00 |
Ferrum oxide | 2.00 | 4.00 | ?3.00 | ?5.00 | ?3.40 | ?6.00 | ?4.40 |
Zinc oxide | ? | 4.00 | ? | ?2.00 | ? | ?3.00 | ? |
The C12-15 alkyl benzoate | ? | 0.25 | ? | ? | ?4.00 | ?7.00 | ? |
Dicaprylyl ether | ? | ? | ?3.50 | ? | ?2.00 | ? | ? |
Butanediol dicaprylate/dicaprate | 5.00 | ? | ?6.00 | ? | ? | ? | ? |
Cocos nucifera oil glyceride | ? | ? | ?6.00 | ? | ?2.00 | ? | ? |
Dimethicone | 0.50 | ? | ?1.00 | ? | ?2.00 | ? | ? |
Cyclomethicone | 2.00 | ? | ?0.50 | ? | ?0.50 | ? | ? |
Adeps Bovis seu Bubali resin | ? | ?2.00 | ? | ? | ? | ? | ? |
PVP hexadecene copolymer | 0.20 | ? | ? | ?0.50 | ? | ?1.00 | ? |
Glycerol | 3.00 | ?7.50 | ? | ?7.50 | ?5.00 | ? | ?2.50 |
Xanthan gum | 0.15 | ? | ?0.05 | ? | ? | ?0.30 | ? |
Carbomer sodium | ? | ?0.20 | ? | ?0.15 | ?0.25 | ? | ? |
Vitamin e acetate | 0.60 | ? | ?0.23 | ? | ?0.70 | ?1.00 | ? |
The Semen Glycines glycine | ? | ? | ? | ?0.50 | ? | ?1.50 | ?1.00 |
The ethyl hexyl oxy glycine | 0.30 | ? | ? | ? | ? | ? | ? |
DMDM?Hydanaufin | ? | ?0.60 | ?0.40 | ?0.20 | ? | ? | ? |
Glyacil-L | ? | ? | ? | ?0.18 | ?0.20 | ? | ? |
Methyl parahydroxybenzoate | 0.15 | ? | ?0.25 | ? | ?0.50 | ? | ? |
Phenoxyethanol | 1.00 | ?0.40 | ? | ? | ?0.40 | ?0.50 | ?0.40 |
Sodium versenate | 0.02 | ? | ?0.05 | ? | ? | ? | ? |
The imido succinic acid | ? | ? | ? | ?0.25 | ?1.00 | ? | ? |
Ethanol | 2.00 | ?1.50 | ? | ?3.00 | ? | ?1.20 | ?5.00 |
Aromatic | 0.10 | ?0.25 | ?0.30 | ? | ?0.40 | ?0.20 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Self-service U.S. Heisui River dispersion
? | ?1 | ?2 | ?3 | ?4 | ?5 |
Ceteareth-20 | ?1.00 | ? | ? | ?0.50 | ? |
Spermol | ? | ? | 1.00 | ? | ? |
Luvigel?EM | ? | 2.00 | ? | ?2.50 | ?2.00 |
Acrylate/C10-30 alkyl acrylate cross-linked polymer | 0.50 | ? | ?0.40 | ?0.10 | ?0.50 |
Xanthan gum | ? | 0.30 | ?0.15 | ? | ? |
Aqueous solution with keratin binding structural domain active component | 3.0 | 1.0 | ?0.5 | ?0.1 | ?5.0 |
Dihydroxy acetone (Dihydroxyaceaufn) | ? | ? | ?3.00 | ?5.00 | ? |
Uvinul?A?Plus TM | 2.00 | 1.50 | ?0.75 | ?1.00 | ?2.10 |
The meticulous powder of titanium dioxide | 1.00 | ? | ?1.00 | ? | ?1.00 |
The meticulous powder of zinc oxide | ? | 1.90 | ? | ?0.25 | ? |
The C12-15 alkyl benzoate | 2.00 | 2.50 | ? | ? | ? |
Dicaprylyl ether | ? | 4.00 | ? | ? | ? |
Butanediol dicaprylate/dicaprate | 4.00 | ? | ?2.00 | ?6.00 | ? |
The dioctyl carbonic ester | ? | 2.00 | ?6.00 | ? | ? |
Dimethicone | ? | 0.50 | ?1.00 | ? | ? |
Phenyl trimethyl silicone oil | 2.00 | ? | ?0.50 | ? | ? |
Adeps Bovis seu Bubali resin | ? | 2.00 | ? | ?5.00 | ? |
PVP hexadecene copolymer | 0.50 | ? | ? | ?0.50 | ?1.00 |
Herba leucadis ciliatae alkyl PVP | 0.50 | ? | ?1.00 | ? | ? |
Ethylhexyl glycerol | ? | ? | ?1.00 | ? | ?0.80 |
Glycerol | 3.00 | 7.50 | ? | ?7.50 | ?8.50 |
The Semen Glycines glycine | ? | ? | ?1.50 | ? | ?1.00 |
Vitamin e acetate | 0.50 | ? | ?0.25 | ? | ?1.00 |
The phlorose rutin | 0.60 | ? | ? | ?0.25 | ? |
DMDM?Hydan?aufin | ? | 0.60 | ?0.45 | ?0.25 | ? |
Glyacil-S | 0.20 | ? | ? | ? | ? |
Methyl parahydroxybenzoate | 0.50 | ? | ?0.25 | ?0.15 | ? |
Phenoxyethanol | 0.50 | 0.40 | ? | 1.00 | ? |
Sodium versenate | ? | 0.01 | ?0.05 | ? | ?0.10 |
Ethanol | 3.00 | 2.00 | ?1.50 | ? | ?7.00 |
Aromatic | 0.20 | ? | ?0.05 | 0.40 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Aqueous dispersion after the Exposure to Sunlight
? | ?1 | ?2 | ?3 | ?4 | ?5 |
Ceteareth-20 | ?1.00 | ? | ? | ?0.50 | ? |
Spermol | ? | ? | ?1.00 | ? | ? |
Luvigel EM | ? | ?2.00 | ? | ?2.50 | ?2.00 |
Acrylate/C10-30 alkyl acrylate cross-linked polymer | ?0.50 | ?0.30 | ?0.40 | ?0.10 | ?0.50 |
Xanthan gum | ? | ?0.30 | ?0.15 | ? | ? |
Aqueous solution with keratin binding structural domain active component | ?0.1 | ?5.0 | ?0.5 | ?3.0 | ?1.0 |
The C12-15 alkyl benzoate | ?2.00 | ?2.50 | ? | ? | ? |
Dicaprylyl ether | ? | ?4.00 | ? | ? | ? |
Butanediol dicaprylate/dicaprate | ?4.00 | ? | ?2.00 | ?6.00 | ? |
The dioctyl carbonic ester | ? | ?2.00 | ?6.00 | ? | ? |
Dimethicone | ? | ?0.50 | ?1.00 | ? | ? |
Phenyl trimethyl silicone oil | ?2.00 | ? | ?0.50 | ? | ? |
Herba leucadis ciliatae alkyl PVP | ?0.50 | ? | ?1.00 | ? | ? |
Ethylhexyl glycerol | ? | ? | ?1.00 | ? | ?0.80 |
Glycerol | ?3.00 | ?7.50 | ? | ?7.50 | ?8.50 |
The Semen Glycines glycine | ? | ? | ?1.50 | ? | ?1.00 |
Vitamin e acetate | 0.50 | ? | ?0.25 | ? | ?1.00 |
Phlorose rutin (Alpha-Glucosilrutin) | 0.60 | ? | ? | ?0.25 | ? |
Sodium versenate | ? | 0.01 | ?0.05 | ? | ?0.10 |
Ethanol | 15.00 | 10.00 | ?8.00 | ?12.00 | ?9.00 |
Aromatic | 0.20 | ? | ?0.05 | ?0.40 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Water-in-oil emulsion
? | 1 | ?2 | ?3 | ?4 | ?5 |
The cetyl dimethicone copolyol | ? | ?2.50 | ? | ?4.00 | ? |
Polyglyceryl-2 dimerization hydroxy stearic acid ester | 5.00 | ? | ? | ? | ?4.50 |
PEG-30 dimerization hydroxy stearic acid ester | ? | ? | ?5,00 | ? | ? |
Aqueous solution with keratin binding structural domain active component | 5.0 | ?10.0 | ?0.1 | ?0.5 | ?1.0 |
Uvinul?A?Plus TM | 2.00 | ?1.50 | ?0.75 | ?1.00 | ?2.10 |
The meticulous powder of titanium dioxide | 1.00 | ? | ?3.00 | ? | ?3.50 |
The meticulous powder of zinc oxide | ? | ?0.90 | ? | ?0.25 | ? |
Mineral oil | ? | ?12.00 | ?10.00 | ? | ?8.00 |
The C12-15 alkyl benzoate | ? | ? | ? | ?9.00 | ? |
Two caprylyl ethers | 10.00 | ? | ? | ? | ?7.00 |
Butanediol dicaprylate/dicaprate | ? | ? | ?2.00 | ?8.00 | ?4.00 |
Two caprylyl carbonic esters | 5.00 | ? | ?6.00 | ? | ? |
Dimethicone | ? | ?4.00 | ?1.00 | ?5.00 | ? |
Cyclomethicone | 2.00 | ?25.00 | ? | ? | ?2.00 |
Adeps Bovis seu Bubali resin | ? | ? | ?3.00 | ? | ? |
Vaseline | ? | 4.50 | ? | ? | ? |
PVP hexadecene copolymer | 0.50 | ? | ? | ?0.50 | ?1.00 |
Ethylhexyl glycerol | ? | 0.30 | 1.00 | ? | ?0.50 |
Glycerol | 3.00 | 7.50 | ? | ?7.50 | ?8.50 |
The Semen Glycines glycine | ? | 1.00 | 1.50 | ? | ?1.00 |
MgSO 4 | 1.00 | 0.50 | ? | ?0.50 | ? |
MgCl 2 | ? | ? | 1.00 | ? | ?0.70 |
Vitamin e acetate | 0.50 | ? | 0.25 | ? | ?1.00 |
Ascorbyl palmitate | 0.50 | ? | ? | ?2.00 | ? |
Fucogel?1000 | ? | ? | ? | ?3.50 | ?7.00 |
DMDM?Hydanaufin | ? | 0.60 | 0.40 | ?0.20 | ? |
Methyl parahydroxybenzoate | 0.50 | ? | 0.25 | ?0.15 | ? |
Phenoxyethanol | 0.50 | 0.40 | ? | ?1.00 | ? |
Sodium versenate | 0.12 | 0.05 | ? | ?0.30 | ? |
Ethanol | 3.00 | ? | 1.50 | ? | ?5.00 |
Aromatic | 0.20 | ? | 0.40 | ?0.35 | ? |
Water | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Pickering Emulsion (Pickering Emulsion)
? | 1 | ?2 | ?3 | ?4 | ?5 |
Mineral oil | ? | ? | ?16.00 | ?16.00 | ? |
Octyl dodecanol | 9.00 | ?9.00 | ?5.00 | ? | ? |
Caprylic/capric triglyceride | 9.00 | ?9.00 | ?6.00 | ? | ? |
The C12-15 alkyl benzoate | ? | ? | ? | ?5.00 | ?8.00 |
Butanediol dicaprylate/dicaprate | ? | ? | ? | ? | ?8.00 |
Two caprylyl ethers | 9.00 | ? | ? | ?4.00 | ? |
Two caprylyl carbonic esters | ? | ?9.00 | ? | ? | ? |
Hydroxyl octacosanol hydroxy stearic acid ester | ?2.00 | ?2.00 | ?2.20 | ?2.50 | ?1.50 |
Disteardimonium?Hecaufrite | ?1.00 | ?0.75 | ? | ?0.50 | ?0.25 |
Microwax+paraffin oil | ? | ?0.35 | ? | ? | ?5.00 |
Hydroxypropyl emthylcellulose | ? | ? | ?0.10 | ? | ?0.05 |
Dimethicone | ? | ? | ? | ? | ?3.00 |
Aqueous solution with keratin binding structural domain active component | 1.0 | ?0.5 | ?0.1 | ?3.0 | ?5.0 |
Titanium dioxide+Alumina+dimethicone+water | ? | ?3.00 | ? | ? | ? |
Titanium dioxide+trimethoxy decoyl silane | ? | ?2.00 | ?4.00 | ?2.00 | ?4.00 |
Dimethyl silane silicon (Silica dimethyl silylate) | 2.50 | ? | ? | ?6.00 | ?2.50 |
Boron nitride | ? | ? | ?1.00 | ? | ? |
Starch/Polymeric sodium metaphosphate. polymer | 2.00 | ? | ? | ? | ? |
Tapioca | ? | ?0.50 | ? | ? | ? |
Sodium chloride | 5.00 | ?7.00 | ?8.50 | ?3.00 | ?4.50 |
Glycerol | ? | ? | ? | ?1.00 | ? |
Sodium versenate | 1.00 | ?1.00 | ?1.00 | ?1.00 | ?1.00 |
Vitamin e acetate | 5.00 | ?10.00 | ?3.00 | ?6.00 | ?10.00 |
Ascorbyl palmitate | 1.00 | ?1.00 | ? | ?1.00 | ? |
Methyl parahydroxybenzoate | ? | ?0.60 | ? | ? | ?0.20 |
Propyl p-hydroxybenzoate | ? | ? | ? | ? | ?0.20 |
Phenoxyethanol | ? | ? | ?0.20 | ? | ? |
Amidine is decided dihydroxy ethyl sulfonic acid | ? | ? | ?0.40 | ?0.50 | ?0.40 |
Two imidazolidinyl urea | ? | ? | ? | ? | ?0.08 |
Ethanol | ? | ? | ?0.23 | ?0.20 | ? |
Aromatic | 5.00 | ? | ?3.00 | ?4.00 | ? |
Water | 0.20 | ? | 0.30 | 0.10 | ? |
? | Add to 100 | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Stick
? | ?1 | ?2 | ?3 | ?4 |
Caprylic/capric triglyceride | ?12.00 | ?10.00 | ?6.00 | ? |
Octyl dodecanol | ?7.00 | ?14.00 | ?8.00 | ?3.00 |
Butanediol dicaprylate/dicaprate | ? | ? | ? | ?12.00 |
Tetramethylolmethane base tetraoctyl stearate | ?10.00 | ?6.00 | ?8.00 | ?7.00 |
Polyglyceryl-3 diisopstearate | ?2.50 | ? | ? | ? |
Two-polyamides base adipic acid two sweet esters-2 | ?9.00 | ?8.00 | ?10.00 | ?8.00 |
Cetearyl alcohol | ?8.00 | ?11.00 | ?9.00 | ?7.00 |
The myristyl myristate | ?3.50 | ?3.00 | ?4.00 | ?3.00 |
Cera Flava | ?5.00 | ?5.00 | ?6.00 | ?6.00 |
Brazil wax | ?1.50 | ?2.00 | ?2.00 | ?1.50 |
Cera alba | ?0.50 | ?0.50 | ?0.50 | ?0.40 |
C16-40 alkyl stearate | ? | ?1.50 | ?1.50 | ?1.50 |
Aqueous solution with keratin binding structural domain active component | ?10.0 | ?1.0 | ?3.0 | ?0.1 |
Uvinul?A?Plus TM | ?2.00 | ?1.50 | ?0.75 | ?9.00 |
The meticulous powder of titanium dioxide | ?1.00 | ? | ?3.00 | ? |
The meticulous powder of zinc oxide | ? | ?1.00 | ? | ?0.25 |
Vitamin e acetate | ?0.50 | ?1.00 | ? | ? |
Ascorbyl palmitate | ?0.05 | ? | ?0.05 | ? |
Buxux?Chinensis | ?2.00 | ?1.00 | ? | ?1.00 |
Aromatic, BHT | ?0.10 | ?0.25 | ? | ?0.35 |
Semen Ricini | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Self-service U.S. deceives PIT Emulsion
? | 1 | 2 | ?3 | ?4 | ?5 | ?6 | ?7 | ?8 |
Glyceryl monostearate SE | 0.50 | 2.00 | ?3.00 | ?5.00 | ? | ?0.50 | ?4.00 | ? |
The glyceryl isostearate | ? | ? | ? | ? | ?3.50 | ?4.00 | ?2.00 | ? |
Different spermaceti alcohol ether-20 | ? | 0.50 | ? | ? | ?2.00 | ? | ? | ? |
Ceteareth-12 | ? | 5.00 | ? | ?1.00 | ? | ? | ?3.50 | ?5.00 |
Ceteareth-20 | ? | 5.00 | ? | ?1.00 | ? | ? | ? | ?3.50 |
The PEG-100 stearate | ? | ? | ? | ?2.80 | ? | ?2.30 | ?3.30 | ? |
Spermol | 5.20 | ? | ?1.20 | ?1.00 | ?1.30 | ? | ?0.50 | ?0.30 |
The spermol cetylate | 2.50 | 1.20 | ? | ?1.50 | ? | ?0.50 | ? | ?1.50 |
The cetyl dimethicone copolyol | ? | ? | ? | ?0.50 | ? | ?1.00 | ? | ? |
Polyglyceryl-2 | ? | ? | ? | ?0.75 | ?0.30 | ? | ? | ? |
Aqueous solution with keratin binding structural domain active component | 0.1 | 0.5 | ?0.01 | ?5.0 | ?0.5 | ?3.0 | ?0.025 | ?10.0 |
Dihydroxyaceaufn | ? | ? | ?3.00 | ?5.00 | ? | ? | ?4.00 | ? |
Uvinul?A?Plus TM | 2.00 | 1.50 | ?0.75 | ?1.00 | ?2.10 | ?4.50 | ?5.00 | ?2.10 |
The meticulous powder of titanium dioxide | 1.00 | ? | ?1.50 | ? | ?3.50 | ? | ?1.50 | ?1.00 |
The meticulous powder of zinc oxide | ? | 1.00 | ? | ?0.25 | ? | ?2.00 | ? | ?1.50 |
The C12-15 alkyl benzoate | 3.50 | ? | ? | ?6.35 | ? | ? | ? | ?0.10 |
Cocos nucifera oil glyceride | ? | 3.00 | ? | ?3.00 | ? | ? | ? | ?1.00 |
Dicaprylyl ether | 4.50 | ? | ? | ? | ? | ? | ? | ? |
Two caprylyl carbonic esters | ? | 4.30 | ? | ?3.00 | ? | ? | ? | ?7.00 |
Dibutyl adipate | ? | ? | ? | ?0.50 | ? | ? | ? | ?0.30 |
Phenyl trimethyl silicone oil | 2.00 | ? | ? | ?3.50 | ? | ?2.00 | ? | ? |
Cyclomethicone | ? | 3.00 | ? | ? | ? | ? | ? | ? |
The ethyl galactomannan | ? | 0.50 | ? | ? | ?2.00 | ? | ? | ? |
Hydrogenation cocos nucifera oil glyceride | ? | ? | ? | ? | ?3.00 | ?4.00 | ? | ? |
Spermaceti (Abil Wax) 2440 | ? | ? | ? | ? | ? | ?1.50 | ?2.00 | ? |
PVP hexadecene copolymer | ? | ? | ? | ?1.00 | ?1.20 | ? | ? | ? |
Glycerol | 4.00 | 6.00 | ?5.00 | ? | ?8.00 | ?10.00 | ? | ? |
Vitamin e acetate | 0.20 | 0.30 | ?0.40 | ? | ?0.30 | ? | ? | ? |
Adeps Bovis seu Bubali resin | ? | 2.00 | ? | ?3.60 | ? | ?2.00 | ? | ? |
Iodine third butyl carbamate | 0.12 | ? | ? | ? | ?0.20 | ? | ? | ? |
DMDM?Hydanaufin | 0.10 | ? | ? | ? | ?0.12 | ? | ?0.13 | ? |
Methyl parahydroxybenzoate | ? | 0.50 | ?0.30 | ? | ?0.35 | ? | ? | ? |
Phenoxyethanol | 0.50 | 0.40 | ? | ?1.00 | ? | ? | ? | ? |
Ocaufxyglycerin | ? | 0.30 | ? | ? | ?1.00 | ? | ?0.35 | ? |
Ethanol | 2.00 | ? | ?2.00 | ? | ? | ?5.00 | ? | ? |
Sodium versenate | 0.40 | ? | ?0.15 | ? | ? | ?0.20 | ? | ? |
Aromatic | 0.20 | ? | ?0.20 | ? | ?0.24 | ?0.16 | ?0.10 | ?0.10 |
Water | To 100 | To 100 | To 100 | To 100 | To 100 | To 100 | To 100 | To 100 |
The oleogel agent
? | 1 | ?2 | ?3 | ?4 |
Caprylic/capric triglyceride | 12.00 | ?10.00 | ?6.00 | ? |
Octyl dodecanol | 7.00 | ?14.00 | ?8.00 | ?3.00 |
Butanediol dicaprylate/dicaprate | ? | ? | ? | ?12.00 |
Tetramethylolmethane base tetraoctyl stearate | 10.00 | ?6.00 | ?8.00 | ?7.00 |
Polyglyceryl-3 diisopstearate | 2.50 | ? | ? | ? |
Two-polyamides base adipic acid two sweet esters-2 | 9.00 | ?8.00 | ?10.00 | ?8.00 |
The myristyl myristinate | 3.50 | ?3.00 | ?4.00 | ?3.00 |
Benaufne-34 | 5.00 | ?5.00 | ?6.00 | ?6.00 |
Allyl carbonate | 15.00 | ?20.00 | ?18.00 | ?19.50 |
Aqueous solution with keratin binding structural domain active component | 1.0 | ?0.5 | ?3.0 | ?5.0 |
Vitamin e acetate | 0.50 | ?1.00 | ? | ? |
Ascorbyl palmitate | 0.05 | ? | ?0.05 | ? |
Buxux?Chinensis | 2.00 | ?1.00 | ? | ?1.00 |
Aromatic, BHT | 0.10 | ?0.25 | ? | ?0.35 |
Semen Ricini | Add to 100 | Add to 100 | Add to 100 | Add to 100 |
Sequence table
<110〉BASF Aktiengesellchaft
<120〉keratin-binding polypeptides
<130>AE20040313
<140>PF55618
<141>2005-05-24
<160>1
<170>PatentIn?version?3.1
<210>1
<211>2871
<212>PRT
<213〉homo sapiens (Homo sapiens)
<400>1
Met?Ser?Cys?Asn?Gly?Gly?Ser?His?Pro?Arg?Ile?Asn?Thr?Leu?Gly?Arg
1 5 10 15
Met?Ile?Arg?Ala?Glu?Ser?Gly?Pro?Asp?Leu?Arg?Tyr?Glu?Val?Thr?Ser
20 25 30
Gly?Gly?Gly?Gly?Thr?Ser?Arg?Met?Tyr?Tyr?Ser?Arg?Arg?Gly?Val?Ile
35 40 45
Thr?Asp?Gln?Asn?Ser?Asp?Gly?Tyr?Cys?Gln?Thr?Gly?Thr?Met?Ser?Arg
50 55 60
His?Gln?Asn?Gln?Asn?Thr?Ile?Gln?Glu?Leu?Leu?Gln?Asn?Cys?Ser?Asp
65 70 75 80
Cys?Leu?Met?Arg?Ala?Glu?Leu?Ile?Val?Gln?Pro?Glu?Leu?Lys?Tyr?Gly
85 90 95
Asp?Gly?Ile?Gln?Leu?Thr?Arg?Ser?Arg?Glu?Leu?Asp?Glu?Cys?Phe?Ala
100 105 110
Gln?Ala?Asn?Asp?Gln?Met?Glu?Ile?Leu?Asp?Ser?Leu?Ile?Arg?Glu?Met
115 120 125
Arg?Gln?Met?Gly?Gln?Pro?Cys?Asp?Ala?Tyr?Gln?Lys?Arg?Leu?Leu?Gln
130 135 140
Leu?Gln?Glu?Gln?Met?Arg?Ala?Leu?Tyr?Lys?Ala?Ile?Ser?Val?Pro?Arg
145 150 155 160
Val?Arg?Arg?Ala?Ser?Ser?Lys?Gly?Gly?Gly?Gly?Tyr?Thr?Cys?Gln?Ser
165 170 175
Gly?Ser?Gly?Trp?Asp?Glu?Phe?Thr?Lys?His?Val?Thr?Ser?Glu?Cys?Leu
180 185 190
Gly?Trp?Met?Arg?Gln?Gln?Arg?Ala?Glu?Met?Asp?Met?Val?Ala?Trp?Gly
195 200 205
Val?Asp?Leu?Ala?Ser?Val?Glu?Gln?His?Ile?Asn?Ser?His?Arg?Gly?Ile
210 215 220
His?Asn?Ser?Ile?Gly?Asp?Tyr?Arg?Trp?Gln?Leu?Asp?LysIle?Lys?Ala
225 230 235 240
Asp?Leu?Arg?Glu?Lys?Ser?Ala?Ile?Tyr?Gln?Leu?Glu?Glu?Glu?Tyr?Glu
245 250 255
Asn?Leu?Leu?Lys?Ala?Ser?Phe?Glu?Arg?Met?Asp?His?Leu?Arg?Gln?Leu
260 265 270
Gln?Asn?Ile?Ile?Gln?Ala?Thr?Ser?Arg?Glu?Ile?Met?Trp?Ile?Asn?Asp
275 280 285
Cys?Glu?Glu?Glu?Glu?Leu?Leu?Tyr?Asp?Trp?Ser?Asp?Lys?Asn?Thr?Asn
290 295 300
Ile?Ala?Gln?Lys?Gln?Glu?Ala?Phe?Ser?Ile?Arg?Met?Ser?Gln?Leu?Glu
305 310 315 320
Val?Lys?Glu?Lys?Glu?Leu?Asn?Lys?Leu?Lys?Gln?Glu?Ser?Asp?Gln?Leu
325 330 335
Val?Leu?Asn?Gln?His?Pro?Ala?Ser?Asp?Lys?Ile?Glu?Ala?Tyr?Met?Asp
340 345 350
Thr?Leu?Gln?Thr?Gln?Trp?Ser?Trp?Ile?Leu?Gln?Ile?Thr?Lys?Cys?Ile
355 360 365
Asp?Val?His?Leu?Lys?Glu?Asn?Ala?Ala?Tyr?Phe?Gln?Phe?Phe?Glu?Glu
370 375 380
Ala?Gln?Ser?Thr?Glu?Ala?Tyr?Leu?Lys?Gly?Leu?Gln?Asp?Ser?Ile?Arg
385 390 395 400
Lys?Lys?Tyr?Pro?Cys?Asp?Lys?Asn?Met?Pro?Leu?Gln?His?Leu?Leu?Glu
405 410 415
Gln?Ile?Lys?Glu?Leu?Glu?Lys?Glu?Arg?Glu?Lys?Ile?Leu?Glu?Tyr?Lys
420 425 430
Arg?Gln?Val?Gln?Asn?Leu?Val?Asn?Lys?Ser?Lys?Lys?Ile?Val?Gln?Leu
435 440 445
Lys?Pro?Arg?Asn?Pro?Asp?Tyr?Arg?Ser?Asn?Lys?Pro?Ile?Ile?Leu?Arg
450 455 460
Ala?Leu?Cys?Asp?Tyr?Lys?Gln?Asp?Gln?LysIle?Val?Hi?s?Lys?Gly?Asp
465 470 475 480
Glu?Cys?Ile?Leu?Lys?Asp?Asn?Asn?Glu?Arg?Ser?Lys?Trp?Tyr?Val?Thr
485 490 495
Gly?Pro?Gly?Gly?Val?Asp?Met?Leu?Val?Pro?Ser?Val?Gly?Leu?Ile?Ile
500 505 510
Pro?Pro?Pro?Asn?Pro?Leu?Ala?Val?Asp?Leu?Ser?Cys?Lys?Ile?Glu?Gln
515 520 525
Tyr?Tyr?Glu?Ala?Ile?Leu?Ala?Leu?Trp?Asn?Gln?Leu?Tyr?Ile?Asn?Met
530 535 540
Lys?Ser?Leu?Val?Ser?Trp?His?Tyr?Cys?Met?Ile?Asp?Ile?Glu?Lys?Ile
545 550 555 560
Arg?Ala?Met?Thr?Ile?Ala?Lys?Leu?Lys?Thr?Met?Arg?Gln?Glu?Asp?Tyr
565 570 575
Met?Lys?Thr?Ile?Ala?Asp?Leu?Glu?Leu?His?Tyr?Gln?Glu?Phe?Ile?Arg
580 585 590
Asn?Ser?Gln?Gly?Ser?Glu?Met?Phe?Gly?Asp?Asp?Asp?Lys?Arg?Lys?Ile
595 600 605
Gln?Ser?Gln?Phe?Thr?Asp?Ala?Gln?Lys?His?Tyr?Gln?Thr?Leu?Val?Ile
610 615 620
Gln?Leu?Pro?Gly?Tyr?Pro?Gln?His?Gln?Thr?Val?Thr?Thr?Thr?Glu?Ile
625 630 635 640
Thr?His?His?Gly?Thr?Cys?Gln?Asp?Val?Asn?His?Asn?Lys?Val?Ile?Glu
645 650 655
Thr?Asn?Arg?Glu?Asn?Asp?Lys?Gln?Glu?Thr?Trp?Met?Leu?Met?Glu?Leu
660 665 670
Gln?Lys?Ile?Arg?Arg?Gln?Ile?Glu?His?Cys?Glu?Gly?Arg?Met?Thr?Leu
675 680 685
Lys?Asn?Leu?Pro?Leu?Ala?Asp?Gln?Gly?Ser?Ser?His?His?Ile?Thr?Val
690 695 700
Lys?Ile?Asn?Glu?Leu?Lys?Ser?Val?Gln?Asn?Asp?Ser?Gln?Ala?Ile?Ala
705 710 715 720
Glu?Val?Leu?Asn?Gln?Leu?Lys?Asp?Met?Leu?Ala?Asn?Phe?Arg?Gly?Ser
725 730 735
Glu?Lys?Tyr?Cys?Tyr?Leu?Gln?Asn?Glu?Val?Phe?Gly?Leu?Phe?Gln?Lys
740 745 750
Leu?Glu?Asn?Ile?Asn?Gly?Val?Thr?Asp?Gly?Tyr?Leu?Asn?Ser?Leu?Cys
755 760 765
Thr?Val?Arg?Ala?Leu?Leu?Gln?Ala?Ile?Leu?Gln?Thr?Glu?Asp?Met?Leu
770 775 780
Lys?Val?Tyr?Glu?Ala?Arg?Leu?Thr?Glu?Glu?Glu?Thr?Val?Cys?Leu?Asp
785 790 795 800
Leu?Asp?Lys?Val?Glu?Ala?Tyr?Arg?Cys?Gly?Leu?Lys?Lys?Ile?Lys?Asn
805 810 815
Asp?Leu?Asn?Leu?Lys?Lys?Ser?Leu?Leu?Ala?Thr?Met?Lys?Thr?Glu?Leu
820 825 830
Gln?Lys?Ala?Gln?Gln?Ile?His?Ser?Gln?Thr?Ser?Gln?Gln?Tyr?Pro?Leu
835 840 845
Tyr?Asp?Leu?Asp?Leu?Gly?Lys?Phe?Gly?Glu?Lys?Val?Thr?Gln?Leu?Thr
850 855 860
Asp?Arg?Trp?Gln?Arg?Ile?Asp?Lys?Gln?Ile?Asp?Phe?Arg?Leu?Trp?Asp
865 870 875 880
Leu?Glu?Lys?Gln?Ile?Lys?Gln?Leu?Arg?Asn?Tyr?Arg?Asp?Asn?Tyr?Gln
885 890 895
Ala?Phe?Cys?Lys?Trp?Leu?Tyr?Asp?Arg?Lys?Arg?Arg?Gln?Asp?Ser?Leu
900 905 910
Glu?Ser?Met?Lys?Phe?Gly?Asp?Ser?Asn?Thr?Val?Met?Arg?Phe?Leu?Asn
915 920 925
Glu?Gln?Lys?Asn?Leu?His?Ser?Glu?Ile?Ser?Gly?Lys?Arg?Asp?Lys?Ser
930 935 940
Glu?Glu?Val?Gln?Lys?Ile?Ala?Glu?Leu?Cys?Ala?Asn?Ser?Ile?Lys?Asp
945 950 955 960
Tyr?Glu?Leu?Gln?Leu?Ala?Ser?Tyr?Thr?Ser?Gly?Leu?Glu?Thr?Leu?Leu
965 970 975
Asn?Ile?Pro?Ile?Lys?Arg?Thr?Met?Ile?Gln?Ser?Pro?Ser?Gly?Val?Ile
980 985 990
Leu?Gln?Glu?Ala?Ala?Asp?Val?His Ala?Arg?Tyr?Ile?Glu Leu?Leu?Thr
995 1000 1005
Arg?Ser Gly?Asp?Tyr?Tyr?Arg Phe?Leu?Ser?Glu?Met Leu?Lys?Ser
1010 1015 1020
Leu?Glu Asp?Leu?Lys?Leu?Lys Asn?Thr?Lys?Ile?Glu Val?Leu?Glu
1025 1030 1035
Glu?Glu Leu?Arg?Leu?Ala?Arg Asp?Ala?Asn?Ser?Glu Asn?Cys?Asn
1040 1045 1050
Lys?Asn Lys?Phe?Leu?Asp?Gln Asn?Leu?Gln?Lys?Tyr Gln?Ala?Glu
1055 1060 1065
Cys?Ser Gln?Phe?Lys?Ala?Lys Leu?Ala?Ser?Leu?Glu Glu?Leu?Lys
1070 1075 1080
Arg?Gln Ala?Glu?Leu?Asp?Gly Lys?Ser?Ala?Lys?Gln Asn?Leu?Asp
1085 1090 1095
Lys?Cys Tyr?Gly?Gln?Ile?Lys Glu?Leu?Asn?Glu?Lys Ile?Thr?Arg
1100 1105 1110
Leu?Thr Tyr?Glu?Ile?Glu?Asp Glu?Lys?Arg?Arg?Arg Lys?Ser?Val
1115 1120 1125
Glu?Asp Arg?Phe?Asp?Gln?Gln Lys?Asn?Asp?Tyr?Asp Gln?Leu?Gln
1130 1135 1140
Lys?Ala Arg?Gln?Cys?Glu?Lys Glu?Asn?Leu?Gly?Trp Gln?Lys?Leu
1145 1150 1155
Glu?Ser Glu?Lys?Ala?Ile?Lys Glu?Lys?Glu?Tyr?Glu Ile?Glu?Arg
1160 1165 1170
Leu?Arg Val?Leu?Leu?Gln?Glu Glu?Gly?Thr?Arg?Lys Arg?Glu?Tyr
1175 1180 1185
Glu?Asn Glu?Leu?Ala?Lys?Val Arg?Asn?His?Tyr?Asn Glu?Glu?Met
1190 1195 1200
Ser?Asn Leu?Arg?Asn?Lys?Tyr Glu?Thr?Glu?Ile?Asn Ile?Thr?Lys
1205 1210 1215
Thr?Thr Ile?Lys?Glu?Ile?Ser Met?Gln?Lys?Glu?Asp Asp?Ser?Lys
1220 1225 1230
Asn?Leu Arg?Asn?Gln?Leu?Asp Arg?Leu?Ser?Arg?Glu Asn?Arg?Asp
1235 1240 1245
Leu?Lys Asp?Glu?Ile?Val?Arg Leu?Asn?Asp?Ser?Ile Leu?Gln?Ala
1250 1255 1260
Thr?Glu Gln?Arg?Arg?Arg?Ala Glu?Glu?Asn?Ala?Leu Gln?Gln?Lys
1265 1270 1275
Ala?Cys Gly?Ser?Glu?Ile?Met Gln?Lys?Lys?Gln?His Leu?Glu?Ile
1280 1285 1290
Glu?Leu Lys?Gln?Val?Met?Gln Gln?Arg?Ser?Glu?Asp Asn?Ala?Arg
1295 1300 1305
His?Lys Gln?Ser?Leu?Glu?Glu Ala?Ala?Lys?Thr?Ile Gln?Asp?Lys
1310 1315 1320
Asn?Lys Glu?Ile?Glu?Arg?Leu Lys?Ala?Glu?Phe?Gln Glu?Glu?Ala
1325 1330 1335
Lys?Arg Arg?Trp?Glu?Tyr?Glu Asn?Glu?Leu?Ser?Lys Val?Arg?Asn
1340 1345 1350
Asn?Tyr Asp?Glu?Glu?Ile?Ile Ser?Leu?Lys?Asn?Gln Phe?Glu?Thr
1355 1360 1365
Glu?Ile Asn?Ile?Thr?Lys?Thr Thr?Ile?His?Gln?Leu Thr?Met?Gln
1370 1375 1380
Lys?Glu Glu?Asp?Thr?Ser?Gly Tyr?Arg?Ala?Gln?Ile Asp?Asn?Leu
1385 1390 1395
Thr?Arg Glu?Asn?Arg?Ser?Leu Ser?Glu?Glu?Ile?Lys Arg?Leu?Lys
1400 1405 1410
Asn?Thr Leu?Thr?Gln?Thr?Thr Glu?Asn?Leu?Arg?Arg Val?Glu?Glu
1415 1420 1425
Asp?Ile Gln?Gln?Gln?Lys?Ala Thr?Gly?Ser?Glu?Val Ser?Gln?Arg
1430 1435 1440
Lys?Gln Gln?Leu?Glu?Val?Glu Leu?Arg?Gln?Val?Thr Gln?Met?Arg
1445 1450 1455
Thr?Glu Glu?Ser?Val?Arg?Tyr Lys?Gln?Ser?Leu?Asp Asp?Ala?Ala
1460 1465 1470
Lys?Thr Ile?Gln?Asp?Lys?Asn Lys?Glu?Ile?Glu?Arg Leu?Lys?Gln
1475 1480 1485
Leu?Ile Asp?Lys?Glu?Thr?Asn Asp?Arg?Lys?Cys?Leu Glu?Asp?Glu
1490 1495 1500
Asn?Ala Arg?Leu?Gln?Arg?Val Gln?Tyr?Asp?Leu?Gln Lys?Ala?Asn
1505 1510 1515
Ser?Ser Ala?Thr?Glu?Thr?Ile Asn?Lys?Leu?Lys?Val Gln?Glu?Gln
1520 1525 1530
Glu?Leu Thr?Arg?Leu?Arg?Ile Asp?Tyr?Glu?Arg?Val Ser?Gln?Glu
1535 1540 1545
Arg?Thr Val?Lys?Asp?Gln?Asp Ile?Thr?Arg?Phe?Gln Asn?Ser?Leu
1550 1555 1560
Lys?Glu Leu?Gln?Leu?Gln?Lys Gln?Lys?Val?Glu?Glu Glu?Leu?Asn
1565 1570 1575
Arg?Leu Lys?Arg?Thr?Ala?Ser Glu?Asp?Ser?Cys?Lys Arg?Lys?Lys
1580 1585 1590
Leu?Glu Glu?Glu?Leu?Glu?Gly Met?Arg?Arg?Ser?Leu Lys?Glu?Gln
1595 1600 1605
Ala?Ile Lys?Ile?Thr?Asn?Leu Thr?Gln?Gln?Leu?Glu Gln?Ala?Ser
1610 1615 1620
Ile?Val Lys?Lys?Arg?Ser?Glu Asp?Asp?Leu?Arg?Gln Gln?Arg?Asp
1625 1630 1635
Val?Leu Asp?Gly?His?Leu?Arg Glu?Lys?Gln?Arg?Thr Gln?Glu?Glu
1640 1645 1650
Leu?Arg Arg?Leu?Ser?Ser?Glu Val?Glu?Ala?Leu?Arg Arg?Gln?Leu
1655 1660 1665
Leu?Gln Glu?Gln?Glu?Ser?Val Lys?Gln?Ala?His?Leu Arg?Asn?Glu
1670 1675 1680
His?Phe Gln?Lys?Ala?Ile?Glu Asp?Lys?Ser?Arg?Ser Leu?Asn?Glu
1685 1690 1695
Ser?Lys Ile?Glu?Ile?Glu?Arg Leu?Gln?Ser?Leu?Thr Glu?Asn?Leu
1700 1705 1710
Thr?Lys Glu?His?Leu?Met?Leu Glu?Glu?Glu?Leu?Arg Asn?Leu?Arg
1715 1720 1725
Leu?Glu Tyr?Asp?Asp?Leu?Arg Arg?Gly?Arg?Ser?Glu Ala?Asp?Ser
1730 1735 1740
Asp?Lys Asn?Ala?Thr?Ile?Leu Glu?Leu?Arg?Ser?Gln Leu?Gln?Ile
1745 1750 1755
Ser?Asn Asn?Arg?Thr?Leu?Glu Leu?Gln?Gly?Leu?Ile Asn?Asp?Leu
1760 1765 1770
Gln?Arg Glu?Arg?Glu?Asn?Leu Arg?Gln?Glu?Ile?Glu Lys?Phe?Gln
1775 1780 1785
Lys?Gln Ala?Leu?Glu?Ala?Ser Asn?Arg?Ile?Gln?Glu Ser?Lys?Asn
1790 1795 1800
Gln?Cys Thr?Gln?Val?Val?Gln Glu?Arg?Glu?Ser?Leu Leu?Val?Lys
1805 1810 1815
Ile?Lys Val?Leu?Glu?Gln?Asp Lys?Ala?Arg?Leu?Gln Arg?Leu?Glu
1820 1825 1830
Asp?Glu Leu?Asn?Arg?Ala?Lys Ser?Thr?Leu?Glu?Ala Glu?Thr?Arg
1835 1840 1845
Val?Lys Gln?Arg?Leu?Glu?Cys Glu?Lys?Gln?Gln?Ile Gln?Asn?Asp
1850 1855 1860
Leu?Asn Gln?Trp?Lys?Thr?Gln Tyr?Ser?Arg?Lys?Glu Glu?Ala?Ile
1865 1870 1875
Arg?Lys Ile?Glu?Ser?Glu?Arg Glu?Lys?Ser?Glu?Arg Glu?Lys?Asn
1880 1885 1890
Ser?Leu Arg?Ser?Glu?Ile?Glu Arg?Leu?Gln?Ala?Glu Ile?Lys?Arg
1895 1900 1905
Ile?Glu Glu?Arg?Cys?Arg?Arg Lys?Leu?Glu?Asp?Ser Thr?Arg?Glu
1910 1915 1920
Thr?Gln Ser?Gln?Leu?Glu?Thr Glu?Arg?Ser?Arg?Tyr Gln?Arg?Glu
1925 1930 1935
Ile?Asp Lys?Leu?Arg?Gln?Arg Pro?Tyr?Gly?Ser?His Arg?Glu?Thr
1940 1945 1950
Gln?Thr Glu?Cys?Glu?Trp?Thr Val?Asp?Thr?Ser?Lys Leu?Val?Phe
1955 1960 1965
Asp?Gly Leu?Arg?Lys?Lys?Val Thr?Ala?Met?Gln?Leu Tyr?Glu?Cys
1970 1975 1980
Gln?Leu Ile?Asp?Lys?Thr?Thr Leu?Asp?Lys?Leu?Leu Lys?Gly?Lys
1985 1990 1995
Lys?Ser Val?Glu?Glu?Val?Ala Ser?Glu?Ile?Gln?Pro Phe?Leu?Arg
2000 2005 2010
Gly?Ala Gly?Ser?Ile?Ala?Gly Ala?Ser?Ala?Ser?Pro Lys?Glu?Lys
2015 2020 2025
Tyr?Ser Leu?Val?Glu?Ala?Lys Arg?Lys?Lys?Leu?Ile Ser?Pro?Glu
2030 2035 2040
Ser?Thr Val?Met?Leu?Leu?Glu Ala?Gln?Ala?Ala?Thr Gly?Gly?Ile
2045 2050 2055
Ile?Asp Pro?His?Arg?Asn?Glu Lys?Leu?Thr?Val?Asp Ser?Ala?Ile
2060 2065 2070
Ala?Arg Asp?Leu?Ile?Asp?Phe Asp?Asp?Arg?Gln?Gln Ile?Tyr?Ala
2075 2080 2085
Ala?Glu Lys?Ala?Ile?Thr?Gly Phe?Asp?Asp?Pro?Phe Ser?Gly?Lys
2090 2095 2100
Thr?Val Ser?Val?Ser?Glu?Ala Ile?Lys?Lys?Asn?Leu Ile?Asp?Arg
2105 2110 2115
Glu?Thr Gly?Met?Arg?Leu?Leu Glu?Ala?Gln?Ile?Ala Ser?Gly?Gly
2120 2125 2130
Val?Val Asp?Pro?Val?Asn?Ser Val?Phe?Leu?Pro?Lys Asp?Val?Ala
2135 2140 2145
Leu?Ala Arg?Gly?Leu?Ile?Asp Arg?Asp?Leu?Tyr?Arg Ser?Leu?Asn
2150 2155 2160
Asp?Pro Arg?Asp?Ser?Gln?Lys Asn?Phe?Val?Asp?Pro Val?Thr?Lys
2165 2170 2175
Lys?Lys Val?Ser?Tyr?Val?Gln Leu?Lys?Glu?Arg?Cys Arg?Ile?Glu
2180 2185 2190
Pro?His Thr?Gly?Leu?Leu?Leu Leu?Ser?Val?Gln?Lys Arg?Ser?Met
2195 2200 2205
Ser?Phe Gln?Gly?Ile?Arg?Gln Pro?Val?Thr?Val?Thr Glu?Leu?Val
2210 2215 2220
Asp?Ser Gly?Ile?Leu?Arg?Pro Ser?Thr?Val?Asn?Glu Leu?Glu?Ser
2225 2230 2235
Gly?Gln Ile?Ser?Tyr?Asp?Glu Val?Gly?Glu?Arg?Ile Lys?Asp?Phe
2240 2245 2250
Leu?Gln Gly?Ser?Ser?Cys?Ile Ala?Gly?Ile?Tyr?Asn Glu?Thr?Thr
2255 2260 2265
Lys?Gln Lys?Leu?Gly?Ile?Tyr Glu?Ala?Met?Lys?Ile Gly?Leu?Val
2270 2275 2280
Arg?Pro Gly?Thr?Ala?Leu?Glu Leu?Leu?Glu?Ala?Gln Ala?Ala?Thr
2285 2290 2295
Gly?Phe Ile?Val?Asp?Pro?Val Ser?Asn?Leu?Arg?Leu Pro?Val?Glu
2300 2305 2310
Glu?Ala Tyr?Lys?Arg?Gly?Leu Val?Gly?Ile?Glu?Phe Lys?Glu?Lys
2315 2320 2325
Leu?Leu Ser?Ala?Glu?Arg?Ala Val?Thr?Gly?Tyr?Asn Asp?Pro?Glu
2330 2335 2340
Thr?Gly Asn?Ile?Ile?Ser?Leu Phe?Gln?Ala?Met?Asn Lys?Glu?Leu
2345 2350 2355
Ile?Glu Lys?Gly?His?Gly?Ile Arg?Leu?Leu?Glu?Ala Gln?Ile?Ala
2360 2365 2370
Thr?Gly Gly?Ile?Ile?Asp?Pro Lys?Glu?Ser?His?Arg Leu?Pro?Val
2375 2380 2385
Asp?Ile Ala?Tyr?Lys?Arg?Gly Tyr?Phe?Asn?Glu?Glu Leu?Ser?Glu
2390 2395 2400
Ile?Leu Ser?Asp?Pro?Ser?Asp Asp?Thr?Lys?Gly?Phe Phe?Asp?Pro
2405 2410 2415
Asn?Thr Glu?Glu?Asn?Leu?Thr Tyr?Leu?Gln?Leu?Lys Glu?Arg?Cys
2420 2425 2430
Ile?Lys Asp?Glu?Glu?Thr?Gly Leu?Cys?Leu?Leu?Pro Leu?Lys?Glu
2435 2440 2445
Lys?Lys Lys?Gln?Val?Gln?Thr Ser?Gln?Lys?Asn?Thr Leu?Arg?Lys
2450 2455 2460
Arg?Arg Val?Val?Ile?Val?Asp Pro?Glu?Thr?Asn?Lys Glu?Met?Ser
2465 2470 2475
Val?Gln Glu?Ala?Tyr?Lys?Lys Gly?Leu?Ile?Asp?Tyr Glu?Thr?Phe
2480 2485 2490
Lys?Glu Leu?Cys?Glu?Gln?Glu Cys?Glu?Trp?Glu?Glu Ile?Thr?Ile
2495 2500 2505
Thr?Gly Ser?Asp?Gly?Ser?Thr Arg?Val?Val?Leu?Val Asp?Arg?Lys
2510 2515 2520
Thr?Gly Ser?Gln?Tyr?Asp?Ile Gln?Asp?Ala?Ile?Asp Lys?Gly?Leu
2525 2530 2535
Val?Asp Arg?Lys?Phe?Phe?Asp Gln?Tyr?Arg?Ser?Gly Ser?Leu?Ser
2540 2545 2550
Leu?Thr Gln?Phe?Ala?Asp?Met Ile?Ser?Leu?Lys?Asn Gly?Val?Gly
2555 2560 2565
Thr?Ser Ser?Ser?Met?Gly?Ser Gly?Val?Ser?Asp?Asp Val?Phe?Ser
2570 2575 2580
Ser?Ser Arg?His?Glu?Ser?Val Ser?Lys?Ile?Ser?Thr Ile?Ser?Ser
2585 2590 2595
Val?Arg Asn?Leu?Thr?Ile?Arg Ser?Ser?Ser?Phe?Ser Asp?Thr?Leu
2600 2605 2610
Glu?Glu Ser?Ser?Pro?Ile?Ala Ala?Ile?Phe?Asp?Thr Glu?Asn?Leu
2615 2620 2625
Glu?Lys Ile?Ser?Ile?Thr?Glu Gly?Ile?Glu?Arg?Gly Ile?Val?Asp
2630 2635 2640
Ser?Ile Thr?Gly?Gln?Arg?Leu Leu?Glu?Ala?Gln?Ala Cys?Thr?Gly
2645 2650 2655
Gly?Ile Ile?His?Pro?Thr?Thr Gly?Gln?Lys?Leu?Ser Leu?Gln?Asp
2660 2665 2670
Ala?Val Ser?Gln?Gly?Val?Ile Asp?Gln?Asp?Met?Ala Thr?Ser?Val
2675 2680 2685
Lys?Pro Ala?Gln?Lys?Ala?Phe Ile?Gly?Phe?Glu?Gly Val?Lys?Gly
2690 2695 2700
Lys?Lys Lys?Met?Ser?Ala?Ala Glu?Ala?Val?Lys?Glu Lys?Trp?Leu
2705 2710 2715
Pro?Tyr Glu?Ala?Gly?Gln?Arg Phe?Leu?Glu?Phe?Gln Tyr?Leu?Thr
2720 2725 2730
Gly?Gly Leu?Val?Asp?Pro?Glu Val?His?Gly?Arg?Ile Ser?Thr?Glu
2735 2740 2745
Glu?Ala Ile?Arg?Lys?Gly?Phe Ile?Asp?Gly?Arg?Ala Ala?Gln?Arg
2750 2755 2760
Leu?Gln Asp?Thr?Ser?Ser?Tyr Ala?Lys?Ile?Leu?Thr Cys?Pro?Lys
2765 2770 2775
Thr?Lys Leu?Lys?Ile?Ser?Tyr Lys?Asp?Ala?Ile?Asn Arg?Ser?Met
2780 2785 2790
Val?Glu Asp?Ile?Thr?Gly?Leu Arg?Leu?Leu?Glu?Ala Ala?Ser?Val
2795 2800 2805
Ser?Ser Lys?Gly?Leu?Pro?Ser Pro?Tyr?Asn?Met?Ser Ser?Ala?Pro
2810 2815 2820
Gly?Ser Arg?Ser?Gly?Ser?Arg Ser?Gly?Ser?Arg?Ser Gly?Ser?Arg
2825 2830 2835
Ser?Gly Ser?Arg?Ser?Gly?Ser Arg?Arg?Gly?Ser?Phe Asp?Ala?Thr
2840 2845 2850
Gly?Asn Ser?Ser?Tyr?Ser?Tyr Ser?Tyr?Ser?Phe?Ser Ser?Ser?Ser
2855 2860 2865
Ile?Gly?His
2870
Claims (28)
1. be used to handle the make-up composition that contains the keratin thing, comprise at least a keratin-binding polypeptides sequence (i) in the cosmetic compatible media, wherein peptide sequence (i) comprises at least a following peptide sequence:
(a) the 2193rd to 2481 of peptide sequence SEQ ID NO:1 the,
(b) the 2606th to 2871 of peptide sequence SEQ ID NO:1 the,
(c) compare with (a), go up to the adorned peptide sequence of 60% aminoacid,
(d) compare with (b), go up to the adorned peptide sequence of 50% aminoacid, condition be peptide sequence (c) or keratin (d) in conjunction with equal peptide sequence (a) or (b) shown value at least 10%.
2. make-up composition according to claim 1, wherein peptide sequence (i) has binding affinity to human hair keratin, fingernail keratin or skin keratin.
3. make-up composition according to claim 1, comprising is the peptide sequence (i) of 0.01% to 30% amount by weight.
4. make-up composition according to claim 1 wherein except that peptide sequence (i), also comprises at least a cosmetic active component.
5. make-up composition according to claim 4, the active component of wherein making up are selected from natural or synthetic polymer, pigment, humidizer, oil, wax, enzyme, mineral, vitamin, opacifier, dyestuff, spice, antioxidant and antiseptic.
6. the purposes of each described make-up composition in improving the hair cardability among the claim 1-5.
7. the purposes of each described make-up composition in improving Hairsetting among the claim 1-5.
8. keratin-binding polypeptides sequence (i) is in the purposes of preparation in the make-up composition, and described make-up composition is used to regulate skin effects, and wherein peptide sequence (i) as defined in claim 1.
Among the claim 1-5 each described make-up composition in the purposes of preparation in skin, fingernail and the hair make-up composition.
10. be used to handle the pharmaceutical composition that contains the keratin thing, comprise at least a keratin-binding polypeptides sequence (i) in the medicine compatible media,
Wherein peptide sequence (i) comprises at least a following peptide sequence:
(a) the 2269th to 2508 of peptide sequence SEQ ID NO:1 the,
(b) the 2606th to 2871 of peptide sequence SEQ ID NO:1 the,
(c) compare with (a), go up to the adorned peptide sequence of 70% aminoacid,
(d) compare with (b), go up to the adorned peptide sequence of 70% aminoacid,
Condition be peptide sequence (c) or keratin (d) in conjunction with equal peptide sequence (a) or (b) shown value at least 10%.
11. keratin-binding effector molecules, by:
(i) at least a have the peptide sequence of binding affinity to keratin,
The (ii) effector molecule that is connected with peptide sequence (i) and non-natural
Form,
Wherein peptide sequence (i) comprises at least a following peptide sequence:
(a) the 2269th to 2508 of peptide sequence SEQ ID NO:1 the,
(b) the 2606th to 2871 of peptide sequence SEQ ID NO:1 the,
(c) compare with (a), go up to the adorned peptide sequence of 70% aminoacid,
(d) compare with (b), go up to the adorned peptide sequence of 70% aminoacid,
Condition be peptide sequence (c) or keratin (d) in conjunction with equal peptide sequence (a) or (b) shown value at least 10%.
12. keratin-binding effector molecules according to claim 11, wherein peptide sequence (i) has binding affinity to the keratin of Crinis Carbonisatus, fingernail or skin.
13. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) comprises peptide sequence.
14. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) has enzymatic activity.
15. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) is dyestuff or dye component.
16. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) is the ultraviolet filter agent.
17. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) is an antioxidant.
18. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) is a carotenoid.
19. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) is antifungal, insecticide or Biocide.
20. keratin-binding effector molecules according to claim 11, wherein effector molecule (ii) is vitamin or provitamin.
21. the purposes of the described keratin-binding effector molecules of each of claim 11-20 in preparation skin, fingernail and hair make-up composition.
22. according to the keratin-binding effector molecules of claim 11, wherein effector molecule (ii) is connected in peptide sequence (i) by covalent bond.
23. keratin-binding effector molecules according to claim 11, two chemical functional groups that wherein utilize polypeptide (i) and effector molecule to exist already in (ii) (ii) are covalently attached to effector molecule the functional group of side chain, C-terminal or the N-terminal of polypeptide (i).
24. keratin-binding effector molecules according to claim 11 wherein (ii) is covalently attached to one or more effector molecules the functional group of side chain, C-terminal or the N-terminal of polypeptide (i) by dual functional at least joint.
25. keratin-binding effector molecules according to claim 11 wherein (ii) and between the polypeptide (i) mixes spacer element at effector molecule.
26. according to claim 24 or 25 described keratin-binding effector molecules, it at effector molecule (ii) and have the potential cleavage site of protease, lipase, esterase, phosphatase or hydrolytic enzyme between the polypeptide (i).
27. according to claim 24 or 25 described keratin-binding effector molecules, it at effector molecule (ii) and have another peptide sequence that allows to be easy to purified fusion protein between the polypeptide (i).
28. be used to prepare the method for the described keratin-binding effector molecules of claim 11, comprise utilize joint with at least one effector molecule (ii) with keratin-binding polypeptides sequence (i) coupling.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200410025805 DE102004025805A1 (en) | 2004-05-24 | 2004-05-24 | Cosmetic compound for incorporation in pharmaceutical products for treatment of e.g. human skin, hair and nails |
DE102004025805.8 | 2004-05-24 | ||
DE200510011988 DE102005011988A1 (en) | 2005-03-14 | 2005-03-14 | The present invention relates to the use of keratin-binding polypeptides and their preparation |
DE102005011988.3 | 2005-03-14 | ||
PCT/EP2005/005599 WO2005115306A2 (en) | 2004-05-24 | 2005-05-24 | Keratin-binding polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1960699A CN1960699A (en) | 2007-05-09 |
CN1960699B true CN1960699B (en) | 2011-12-28 |
Family
ID=35454792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800167278A Expired - Fee Related CN1960699B (en) | 2004-05-24 | 2005-05-24 | Keratin-binding polypeptides |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1960699B (en) |
DE (1) | DE102004025805A1 (en) |
ZA (1) | ZA200610812B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8859106B2 (en) | 2005-03-31 | 2014-10-14 | Basf Se | Use of polypeptides in the form of adhesive agents |
US8535535B2 (en) | 2005-04-01 | 2013-09-17 | Basf Se | Use of hydrophobin as a phase stabilizer |
EP1869138B1 (en) | 2005-04-01 | 2009-11-25 | Basf Se | Drilling fluid containing hydrophobin |
DE102005029704A1 (en) * | 2005-06-24 | 2007-01-11 | Basf Ag | Use of hydrophobin polypeptides and conjugates of hydrophobin polypeptides with active or effect substances and their preparation and their use in cosmetics |
DE102005048720A1 (en) | 2005-10-12 | 2007-04-19 | Basf Ag | Use of proteins as an antifoam component in fuels |
BRPI0619199A2 (en) * | 2005-12-01 | 2016-09-06 | Basf Se | keratin binding effector molecule, use of keratin binding effector molecules, hair dye, and method for coloring hair or skin |
ES2374320T3 (en) | 2006-08-15 | 2012-02-15 | Basf Se | PROCEDURE FOR THE PRODUCTION OF FREE FLOW DRY HYDROPHOBINE PREPARATIONS. |
CN108525007B (en) * | 2018-05-15 | 2020-10-27 | 北京航空航天大学 | Keratin fiber-nerve growth factor composite scaffold for nerve tissue engineering |
MX2022015033A (en) * | 2020-06-02 | 2023-01-04 | Unilever Ip Holdings B V | A high spf skin cleansing composition. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000055320A1 (en) * | 1999-03-12 | 2000-09-21 | Human Genome Sciences, Inc. | Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
CN1324850A (en) * | 2000-05-24 | 2001-12-05 | 上海博德基因开发有限公司 | New polypeptide human ceratin 30.36 and polynuceltides for encoding same |
-
2004
- 2004-05-24 DE DE200410025805 patent/DE102004025805A1/en not_active Withdrawn
-
2005
- 2005-05-24 CN CN2005800167278A patent/CN1960699B/en not_active Expired - Fee Related
-
2006
- 2006-12-21 ZA ZA200610812A patent/ZA200610812B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000055320A1 (en) * | 1999-03-12 | 2000-09-21 | Human Genome Sciences, Inc. | Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
CN1324850A (en) * | 2000-05-24 | 2001-12-05 | 上海博德基因开发有限公司 | New polypeptide human ceratin 30.36 and polynuceltides for encoding same |
Also Published As
Publication number | Publication date |
---|---|
ZA200610812B (en) | 2008-06-25 |
CN1960699A (en) | 2007-05-09 |
DE102004025805A1 (en) | 2005-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005247092B2 (en) | Keratin-binding polypeptides | |
CN101203207B (en) | Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry | |
CN101370556A (en) | Use of protein microbeads in cosmetics | |
CN101278051B (en) | Personal care compositions and methods of use thereof | |
US20100015070A1 (en) | Use of natural, recombinant and synthetic resilins in cosmetics | |
US20090099075A1 (en) | Chimeric Keratin-Binding Effector Proteins | |
JP2009521404A (en) | Coupling method of keratin-binding polypeptide and effector molecule having carboxyl group or sulfonic acid group | |
MX2011003803A (en) | Modified variant bowman birk protease inhibitors. | |
CN1960699B (en) | Keratin-binding polypeptides | |
US20090098076A1 (en) | Method For the Production of a Keratin-Binding Effector Molecule | |
WO2006097432A2 (en) | Keratin-binding desmoplakin polypeptide sequences | |
AU2012203584B2 (en) | Personal care compositions and methods for their use | |
CN101365416A (en) | Chimeric keratin-binding effector proteins | |
CN101610792A (en) | The effector molecule of keratin-binding and by with the polypeptide of keratin-binding with carry carboxyl or sulfonic effector molecule coupling and prepare its method | |
NZ591599A (en) | Personal care compositions and methods for their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111228 Termination date: 20120524 |